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ABSTRACT 
 
The environmental bacterium Pseudomonas putida is known for its metabolic versatility and 
endurance to various types of stresses. This requires various layers of control to coordinate the 
expression of specific genes to the overall physiology of the cell in diverse conditions. One 
prevalent physiological sensor to this end is the phosphoenolpyruvate-carbohydrate 
phosphotransferase transport system (PTS), which carries out both uptake of carbohydrates to 
central metabolism as well as regulatory functions such as carbon catabolite repression.  Apart 
from the classical PTS system many prokaryotes harbour also a PTS branch that is not involved 
in carbohydrate traffic, but participates in regulation of some metabolic processes. In P. putida, 
one sugar-specific PTS for fructose transport (FruA/EIIBC and FruB/EI-HPr-EIIA) coexists 
with the PTSNtr (PtsP/EINtr, PtsO/NPr, and PtsN/EIIANtr). 
 
 This work analyzes: [i] the carbon flow in the central metabolism in P. putida as well its interplay 
with the PTSNtr system, and [ii] the control exerted by the catabolite repressor activator (Cra) 
protein on PTS systems in this bacterium. Specifically, in Chapter 1 we analyzed the carbon 
utilization of PTS and no-PTS substrates through metabolic flux analysis and metabolomic 
approaches. The results showed that the Entner-Doudoroff (ED) pathway is the most prevalent 
pathway for sugar degradation in P. putida and that this pathway operates in an unusual cyclical 
mode. Moreover, flux analysis and enzymatic assays revealed that the EIIANtr protein controls 
the connection of pyruvate to the TCA cycle by downregulating the pyruvate shunt, that 
bypasses malate dehydrogenase in the TCA cycle. Chapter 2 describes the link between 
PTSFru, the transcriptional regulator Cra and its effector Fructose 1-phosphate (F1P) through in 
vitro approaches. Electrophoretic mobility shift assays (EMSA) and Isothermal Titration 
Microcalorimetry (ITC) experiments showed that Cra recognized the palindromic sequence 
TTAAACGTTTCA in the regulatory region of fruBKA operon.  In addition, Cra crystal 
structure, EMSA and ITC experiments point to F1P as the only metabolic effector of this 
bacterial regulator. Finally, in Chapter 3, we showed with in vivo experiments that Cra is a 
repressor of the PTSFru in P. putida. Moreover in this chapter, we demonstrated that Cra is a 
fine-tuning regulator of PTSNtr since the repression exerted by Cra on fruB expression affects the 
phosphorylated/non-phosphorylated PtsN ratio via PTS cross-talk. In summary, we have 
contributed to the understanding of carbon central metabolism and PTS systems in the soil 
bacterium P. putida, which according to our findings in some aspects differ importantly to model 
species such as E. coli or B. subtilis.  
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RESUMEN 
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RESUMEN 
 
La bacteria del suelo Pseudomonas putida es conocida por su versatilidad metabólica y resistencia a 
diversos tipos de estrés. Esto requiere diversos niveles de control para coordinar la expresión 
génica y así mantener la fisiología general de la célula en diversas condiciones. Un importante 
sensor fisiológico es el sistema de transporte fosfoenolpiruvato fosfotransferasa de azúcares 
(PTS), que lleva a cabo la asimilación de hidratos de carbono hacia el metabolismo central, así 
como funciones reguladoras (p.e.   en el fenómeno de represión catabólica). Aparte de los 
sistemas PTS clásicos, muchos procariotas tienen un tipo de sistema PTS que no está 
involucrado en el tráfico de hidratos de carbono, el cual participa en la regulación de algunos 
procesos metabólicos. En P. putida, el sistema PTS de azúcar específico para el transporte de 
fructosa (FruA / EIIBC y FruB / EI-HPR-EIIA) coexiste con el llamado sistema PTS de 
nitrógeno PTSNtr (PtsP / EINTR, PtsO / Npr, y PtsN / EIIANtr). 
 
 En este trabajo se analiza: [i] el flujo del carbono en el metabolismo central de P. putida, así 
como su interacción con el sistema PTSNtr y [ii] el control ejercido por el regulador 
transcripcional Cra sobre los sistemas PTS de esta bacteria. En concreto, en el Capítulo 1 se 
analizó a través de herramientas de fluxómica y metabolómica la utilización de  varias fuentes 
de carbono (PTS y no PTS). Los resultados mostraron que el Entner-Doudoroff (ED) es la vía 
más común para la degradación de azúcares en P. putida. Además, se demostró que la vía del 
ED en P. putida opera en un inusual modo cíclico. Además, en el Capítulo 1 a través de análisis 
de flujos y ensayos enzimáticos se demostró que la proteína EIIANtr controla el desvío del piruvato 
(pyruvate shunt) que controla la conexión entre el piruvato y el ciclo de Krebs.  El Capítulo 2 
describe a través de estudios in vitro la relación entre el sistema PTSFru, el regulador 
transcripcional Cra y su efector (fructosa 1-fosfato; F1P). Ensayos de movilidad electroforética 
(EMSA) y de microcalorimetría de titulación isotérmica (ITC), mostraron que Cra reconoce la 
secuencia palindrómica TTAAACGTTTCA en la región reguladora del operón fruBKA. 
Además, la estructura cristalina del regulador se obtuvo en ausencia y presencia de la F1P. Por 
tanto, todos nuestros resultados apuntan a la F1P como el único efector de este regulador 
transcripcional bacteriano. Por último, en el Capítulo 3, se mostró con experimentos in vivo 
que Cra  es un represor del sistema PTSFru en P. putida. Por otra parte, se observó que  Cra 
controla bajo ciertas condiciones metabólicas el estado de fosforilación de PtsN  a través de 
FruB. 
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En este trabajo hemos contribuido a la comprensión del metabolismo central y los sistemas PTS 
en la bacteria del suelo P. putida los cuales, de acuerdo a nuestros resultados, pueden diferir en 
importantes aspectos a otras bacterias modelo como E. coli o B. subtilis. 
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1. Overview of Pseudomonas putida  
 
1.1. The genus Pseudomonas and its metabolic diversity 
 
Pseudomonas genus was defined by W. Migula in 1894  such as a genus of Gram-negative, 
rod-shaped and polar-flagella cells. This very general definition was accepted for many 
years, until the 60's, when the definition was made more precise thanks to the inclusion 
of morphological and physiological characteristics as a method of bacterial classification 
(Stanier et al, 1966). Thus, in the 60-70's according to the Bergey´s manual of systematic 
bacteriology, Pseudomonas was defined such as cells with diameter usually less than 1 µm, 
length from 1.5 to 5 µm; rod-shaped, curved or straight but no helical; they have not 
appendices and are not surrounded by sheaths. Then, with the development of new 
methodologies  and the inclusion of approaches based on the studies of conservative 
macromolecules many strains were reclassified. In this regard,  DNA/DNA and 
RNAr/DNA hybridization techniques (Doi and Igarashi, 1965; Johnson and Ordal, 
1968; Palleroni et al, 1972; Palleroni et al, 1973) allowed a division of Pseudomonas species, 
which were grouped into five taxonomic groups (RNA-I to RNA-V). Later, with the use 
of 16S rRNA gene sequences (Palleroni et al, 1973) to study bacterial phylogeny and 
taxonomy, the diversity of RNA-I and RNA-V groups was evident which led to the 
clustering of Pseudomonas into the RNA-I group within the subclass of γ-Proteobacteria, 
that is until today the most widely accepted classification (Palleroni, 2003). The current 
affiliation of Pseudomonas genus is:  
 
                                                 Kingdom:    Bacteria 
                Phylum:    Proteobacteria 
                           Class:    Gamma proteobacteria 
        Order:    Pseudomonodales 
       Family:    Pseudomonodaceae 
        Genus:    Pseudomonas 
 
After its discovery, Pseudomonas were isolated from many natural niches and around 148 
species have been reported (Palleroni and Moore, 2004). Of these, just P. aeruginosa 
(Govan and Deretic, 1996), is a opportunistic pathogen to humans (P. mallei and P. 
pseudomallei have been moved to the genus Burkolderia), therefore in general terms most 
Pseudomonas species are innocuous to humans. Moreover, there are phytopathogenic 
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species such as P. syringae (Buell et al, 2003) and plant growth-promoting rhizobacterium 
such as P. fluorescens (Paulsen et al, 2005). The strains are aerobic, with a strictly 
respiratory type of metabolism with oxygen as terminal electron acceptor, although in 
some cases, nitrate can be used as alternative electron aceptor under anaerobic 
conditions (Jensen et al, 2004; Moore et al, 2006). 
 
Pseudomonas are able to colonize various environments, including soil, water, marshes, 
coastal marine habitats, plant rhizosphere and plant and animal tissues (Jensen et al, 
2004). Maybe the most prominent characteristic of Pseudomonas species is its metabolic 
versatility (Clarke, 1982; Stanier et al, 1966). This allows them to use a large amount of 
organic compounds such as carbohydrates, lineal hydrocarbons, aliphatic acids, amines, 
amides, amino acids, alcohols and aromatic compounds. At the beginning of this 
century the sequencing of the entire genome of 6 members of the genus Pseudomonas: P. 
aeruginosa PAO1 (Stover et al, 2000), P. putida KT2440 (Frank et al, 2011; Nelson et al, 
2002), P. syringae pv tomato DC3000 (Buell et al, 2003), P. syringae pv syringae B728a (Feil 
et al, 2005), P. fluorescens Pf-5 (Paulsen et al, 2005)  and P. entomophila (Vodovar et al, 2006), 
has allowed understanding of the unique and versatile adaptive capacity of this genus. It 
was possible possible to see in these sequenced genomes an extensive collection of 
enzymes and metabolic pathways that can degrade a large number of organic 
compounds including xenobiotics. Today, the genome of 38 strains of the genus 
Pseudomonas have been sequenced (nine of them correspond to different species: P. 
aeruginosa, P. putida, P. fluorescens, P. mendocina, P. syringae, P. savastanoi, P. resinovorans, P. 
stutzeri and P. entomophila) so that knowledge about the genus Pseudomonas has increased 
markedly in the last years, being more evident its metabolic versatility. Therefore, due to 
their strong skills for degradation of a great variety of chemical compounds, 
Pseudomonads have great potential for different biotechnological applications, 
particularly in the areas of bioremediation and biocatalysis (Loh and Cao, 2008). 
 
1.2. Description of Pseudomonas putida  
 
The bacterium P. putida belongs to the group of fluorescent Pseudomonas well known for 
producing fluorescent pigments (Meyer, 2000). Strains of P. putida display a wide range 
of metabolic activities, which is indicative of their adaptation to various niches (Jensen et 
al, 2004). P. putida KT2440 (Nelson et al, 2002) is probably the best-characterized 
saprophytic laboratory Pseudomonad, that has retained its ability to survive and 
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function in the environment (Frank et al, 2011; Jimenez et al, 2002). The bacterium is a 
plasmid-free derivative of a toluene-degrading bacterium isolated in Japan by 
Hosahawa in 1963 (Nelson et al, 2002), which was originally designated as Pseudomonas 
arvilla strain mt-2 and then reclassified as P. putida mt-2 (Williams and Murray, 1974). 
 
P. putida KT2440 was the first host vector biosafety system for gene cloning in Gram-
negative soil bacteria (Duque et al, 2007; Stjepandic et al, 2002). This strain has been 
extensively used as a host for cloning and gene expression, and its most prominent 
characteristic is its capability to degrade aromatic compounds  such as toluene or m-
xylene so it is considered as a model organism for biodegradation studies (Jimenez et al, 
2002; Loh et al, 2008). P. putida KT2440 is thus considered as the workhorse for 
Pseudomonas research (Martins dos Santos et al, 2004; Timmis, 2002; Wu et al, 2011).  
 
The genome of strain KT2440 consists of a single circular chromosome of 6,181,863 
bas pairs (bp) whose G+C content varies between 43% and 69%, and has a mean value 
of 61.6% (Duque et al, 2007).  A total of 5420 open reading frames (ORFs) with an 
average length of 998 bp were identified. A putative role assignments could be made for 
3571 ORFs, with another 600 (11.1%) being unique to P. putida (Martins dos Santos et 
al, 2004). A total of 1037 (19.1%) of the ORFs encode conserved hypothetical proteins. 
Comparative genome analysis with the currently completed microbial genomes revealed 
that 4610 ORFs (85%) of the KT2440 genome have homologues in the P. aeruginosa 
PAO1 genome (Stover et al, 2000). 
 
1.3. Carbohydrate metabolism in P. putida 
 
The central pathways of metabolism are responsible for the generation of stored 
biological energy and formation of the metabolic precursors that serve as the starting 
point for biosynthesis of the building blocks that are in turn polymerized to form the 
essential cellular constituents of all living cells (Downs, 2006; Romano and Conway, 
1996). This set of reactions, occurs in all three domains of the live; hence it must have 
been established before divergence of the domains (Romano et al, 1996).  In the 
literature we can find the expression carbon central metabolism, refers to the classic 
metabolic pathways such as those found in yeast or Escherichia coli (Romano et al, 1996), 
and includes the Embden-Meyerhof-Parnas (EMP) pathway, the pentose phosphate  
(PP) pathway, Entner-Doudoroff (ED) pathway and the tricarboxylic acid (TCA) cycle. 
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Interestingly, each of these pathways can be replaced by alternative pathways or can 
operate in abbreviated schemes. In fact, all possible combination of these classic, 
alternative and abbreviated metabolic pathways can be found together in 
microorganisms (Conway, 1992).  
 
Specifically, the genome of P. putida KT2440 contains all the genes encoding enzymes 
that make the three prominent metabolic pathways in bacteria: the ED pathway, the 
EMP pathway and the PP pathway (Fig. 1) with the intriguing exception of the 
glycolytic enzyme 6-phosphofructokinase, Pfk (Velazquez et al, 2004). The key glycolytic 
enzyme Pfk catalyzes the transformation of fructose-6-phosphate (F6P) to fructose 1,6-
bisphosphate (FBP) by transferring a phosphate group from ATP or pyrophosphate, to 
the C1-position (Ronimus and Morgan, 2001). In bacteria, Pfk enzymes are usually 
absent in aerobic organisms but they are very common in anaerobic organisms in which 
is not possible the formation of ATP by oxidative phosphorylation and therefore the 
formation of ATP by EMP pathway is essential. The absence of this enzyme in P. putida 
can explain why this bacterium uses only the ED pathway for degrading glucose and it 
is unable to use the EMP pathway, which has been previously demonstrated through 
experiments of radioactivity with 14C (Vicente and Canovas, 1973) and metabolic flux 
analysis (Fuhrer, 2005). On the other hand, catabolism of fructose could be slightly 
different to hexoses metabolism since this sugar directly enters into EMP pathway via 
FruBKA (Velazquez et al, 2004; Velazquez et al, 2007; Vicente, 1975). In principle, 
fructose could be degraded through the ED pathway and/or EMP pathway (Velazquez 
et al, 2004), however, previous studies showed that this pentose is catabolized primarily 
through the ED pathway (Sawyer et al, 1977). Therefore, it seems that ED route is the 
most important pathway for sugar degradation in upper central metabolism in P. putida. 
The ED pathway was first discovered in 1952 in Pseudomonas saccharophila (Entner and 
Doudoroff, 1952) and several years later  was shown to be present in E. coli (Eisenberg 
and Dobrogosz, 1967). We currently know that the ED pathway is present in all three 
phylogenetic domains, including the most deeply rooted Archaea (Peekhaus and 
Conway, 1998). The wide distribution of the ED pathway suggests that it is of much 
greater importance in Nature than was previously assigned. In fact, an analysis of the 
evolution of the central metabolism suggested that ED pathway is earlier than EMP 
pathway (Romano et al, 1996). The main difference between the ED and EMP 
pathways comes in the characteristics of the metabolites that serve as substrates for aldol 
cleavage (Conway, 1992). For the  ED pathway, the 6-phosphogluconate dehydratase  
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Figure 1. Carbon central metabolism in P. putida KT2440. Representation of 
glucose, fructose, gluconate and succinate metabolism in P. putida KT2440. The EMP 
pathway (red), ED pathway (blue) and TCA cycle (green) are highlighted with different 
colors. Note the absence of any Pfk enzyme in the upper central metabolism. 
Abbreviations: F1P Fructose-1-Phosphate; FBP Fructose-1,6-bisphosphate; F6P 
Fructose-6-Phosphate; G6P Glucose-6-phosphate; 6PG 6-phosphogluconate; 2K3D6P 2-
keto-3-deoxy-6-phosphogluconate; Pyr Pyruvate; GA3P Glyceraldehyde-3-phosphate; 
DHAP Dihydroxyacetone phosphate; PEP Phosphoenolpyruvate; AcCoA Acetyl 
Coenzyme A; Mal Malate; OAA Oxaloacetate; Cit Citrate; 2OG 2-oxoglutarate; Suc 
Succinate; Fum Fumarate; FruBA PTSFru system; FruK 1-Phosphofructokinase; GlK 
Glucokinase; GnuK Glucokinase; Gcd glucose dehydrogenase; Fbp Fructose-1,6-
bisphosphatase; Pgi Glucose-6-phosphate isomerase; Zwf-1 Glucose-6-phosphate 1-
dehydrogenase; Edd Phosphogluconate dehydratase; Eda Keto-hydroxyglutarate-
aldolase/keto-deoxy-phosphogluconate aldolase; Fda fructose-1,6-bisphosphate aldolase; 
TpiA Triosephosphate isomerase; Gap Glyceraldehyde-3-phosphate dehydrogenase; Pgk 
phosphoglycerate kinase; Eno phosphopyruvate hydratase; Pcc phosphoenolpyruvate 
carboxylase; MaeB Malic enzyme; Pyk pyruvate kinase; Mdh malate dehydrogenase; AceE 
Pyruvate dehydrogenase subunit E1; AceF dihydrolipoamide acetyltransferase; LpdA 
lipoamide dehydrogenase; AccC-2 pyruvate carboxylase subunit A; OadA pyruvate 
carboxylase subunit B; FumC fumarate hydratase; SdhABCD succinate dehydrogenase; 
SucA 2-oxoglutarate dehydrogenase E1 component; KgdB; SucC succinyl-CoA synthetase 
subunit beta; SucD succinyl-CoA synthetase subunit alpha; KgdB dihydrolipoamide 
succinyltransferase; AcnA aconitate hydratase; AcnB bifunctional aconitate hydratase 2/2-
methylisocitrate dehydratase; Icd isocitrate dehydrogenase; GltA type II citrate synthase. 
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(Edd), catalyzes a dehydration of 6-phosphogluconate to form  2-keto-3-deoxy-6-
phosphogluconate (2K3D6P), then 2K3D6P aldolase (Eda), catalyzes an aldol cleavage 
to form pyruvate and glyceraldehyde 3-phosphate (GA3P). Finally, the triose phosphates 
intermediates is further metabolized by the glycolytic pathway to provide energy 
through TCA cycle (Peekhaus et al, 1998). 
 
Mutants deficient in activities of the two ED pathway enzymes have been isolated in P. 
putida, P. aeruginosa, E. coli, etc (Lessie and Phibbs, 1984). In Pseudomonas species, mutants 
blocked in the ED pathway were unable to utilize glucose or gluconate.  These 
phenotypic observations are in agreement with the absence of the 6-
phosphofructokinase discussed above.  In contrast, E. coli mutants grow normally on 
glucose and retained the capacity to utilize gluconate via the PP route. That reflects in 
part the large differences between E. coli and Pseudomonas species (Lessie et al, 1984).   
 
Although the catabolism of carbohydrates in P. putida has been studied since the 70`s, 
there are  many  phenomena that depend on carbon source and metabolic pathways 
involved in its degradation that have not been properly explained. Thus, one of the aims 
of this Thesis was to determine at a quantitative level the metabolic steps involved in the 
degradation of carbohydrates in P. putida so establishes the basis for understanding other 
phenomena dependent on carbon source. 
 
2. Transcriptional factors involved in regulation of central carbon 
metabolism of bacteria 
 
2.1. Transcriptional factor vs central metabolism 
 
The genome of E. coli possesses more than 300 potential regulators that can control cell 
activity at the transcriptional level. However, only half of these have been studied and 
experimentally verified (Browning and Busby, 2004). Some of these transcriptional 
factors simultaneously regulate large numbers of genes (global regulators), while others 
control just one or two genes (local regulators). There are seven specific transcriptional 
factors called global regulators  (Crp, Fnr, IHF, Fis, ArcA/ArcB ,NarL and Lrp) since 
they control 50% of all the regulated genes in the cell. On the other hand,  around 60 
transcriptional factors control only a single promoter (Browning et al, 2004). 
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The mechanism of regulation of the transcriptional factors involves the binding of the 
protein to one or more operators in the promoter region, which makes transcription be 
activated or repressed. In fact, some transcription factors works exclusively as activators 
or repressors, while others can function as dual regulators. A computational analysis of 
the model species E. coli suggests that of the 300 potential regulators found in its genome 
35% are activators, 43% repressors and 22% dual regulators (Zhou and Yang, 2006). 
Despite many studies of the use of metabolic pathways and central enzymes, their 
regulation is still poorly understood (Blencke et al, 2003). Nowadays, it is known that 
central metabolism in bacteria is controlled through the interplay of global and local 
regulators, the outcome of which depends on the nature of the carbon and energy 
sources and the specific culture conditions. In past years several works have been 
published that report regulation of gene expression of central metabolic genes due to 
different transcripcional factors. Some of the most important are briefly described 
below: 
[i] the ArcB/ArcA two-component signal transduction system that functions as the  
aerobiosis-sensing device that regulate the activity of catabolic pathways depending of 
the redox conditions. Upon signal perception, ArcB is phosphorylated, and the 
phosphoryl group is subsequently transferred to ArcA (Georgellis et al, 1997). The extent 
of phosphorylation of ArcA determines the expression of operons involved in a wide 
variety of (mostly) catabolic pathways that are operative under different redox growth 
conditions (Bekker et al, 2010); 
[ii] The catabolic repressor Crp that is a global transcriptional regulator that is involved 
in the regulation of an important number of genes (e.g. pts genes in E. coli); it is 
activated by adenylate cyclase (Cya)-synthesized cAMP (Gosset et al, 2004); 
[iii] Fnr is a global regulator that controls transcription of genes whose functions 
facilitate adaptation to growth under O2 limiting conditions (Unden et al, 2002; 
Unden and Schirawski, 1997); 
[iv] the cAMP-independent catabolite repressor-activator Cra which is a dual 
transcriptional regulator that controls the carbon flow in E. coli (Saier and 
Ramseier, 1996) and,  
[v] the global repressor Mlc that controls transcription of genes involved in 
carbohydrate utilization, such as the phosphoenolpyruvate PEP:glucose 
phosphotransferase (PTS) system (Plumbridge, 2002). 
 
As the regulation by Cra in P. putida is studied in this work, there will be a more detailed 
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description of the role that this regulator exerts in bacteria in the next section. 
 
2.2. Regulatory duties of the catabolite repressor/activator (Cra) protein 
in central carbon metabolism of bacteria 
 
The catabolite repressor/activator (Cra) protein (also known as FruR) is a pleiotropic 
regulatory protein that plays a key role in the control of carbon flow in E. coli and 
Salmonella typhimurium (Saier et al, 1996). This factor was first identified as a repressor that 
inhibited expression of the fructose operon of these two bacteria when the sugar was not 
available -thereby the earlier name FruR (Ramseier et al, 1993). Later work, however, 
revealed that the same protein represses genes for many other enzymes of the central 
metabolism (pfkA, pykA, pykF, acnB, edd, eda, mtlADR and gapB; (Bledig et al, 1996; Ow et 
al, 2007; Saier et al, 1996; Sarkar et al, 2008) and activates others (ppsA, fbp, pckA, acnA, 
icd, aceA, and aceB; (Cortay et al, 1994; Negre et al, 1998; Prost et al, 1999; Ramseier et al, 
1996; Saier et al, 1996), suggesting a dual character of Cra as both a transcriptional 
repressor and an activator. Therefore, Cra apparently controls the direction of carbon 
flow in E. coli and consequently influences the rates of utilization of dozens of exogenous 
carbon sources.  
 
From a structural point of view, the Cra protein has been classified as a member of the 
GalR-LacI superfamily of DNA-binding transcriptional regulators (Penin et al, 1997; 
Scarabel et al, 1995). In E. coli, the Cra monomer is organized in two functional 
domains. The N-terminal helix-turn-helix module accounts for the binding of the 
protein to the cognate DNA operator sequence, while the C-terminal portion mediates 
the interactions between subunits and triggers changes in the protein upon effector 
binding (Scarabel et al, 1995). Earlier studies on the Cra proteins of E. coli and S. 
typhimurium suggested that the regulator is a tetramer (see Fig. 2) that recognizes an 
imperfect palindromic DNA sequence to which it binds asymmetrically (Saier et al, 
1996).  
 
It is generally believed that promoters containing a Cra operator upstream of the RNAP 
binding site might become activated by the factor, thereby stimulating transcription of 
downstream genes. In contrast, Cra binding sites overlapping those bound by RNA 
polymerase originate a typical negative regulation scenario (Saier et al, 1996). Whether 
positive or negative, the effects of Cra on transcription can be counteracted in vitro by 
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micromolar concentrations of fructose-1-phosphate (F1P) or millimolar concentrations 
of fructose-1,6-bisphosphate (FBP; Ramseier et al, 1995). In fact, the nature of the 
metabolic effector(s) alleged to make(s) Cra release target DNA sites is intriguing. This is 
because F1P and FBP can be originated by different metabolic routes and produced at 
levels that depend on the consumed carbon source. Furthermore, electronic densities of 
these two chemicals are not alike, making it improbable that the same effector-
recognition pocket can bind both of them. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Model of the sensory transduction pathway for Cra-mediated 
catabolite repression and catabolite activation in E. coli. In this species Cra 
protein binds to the operator as a tetramer, where it can activate or repress the 
transcription. In presence of the catabolic effector (lower panel), the protein change its 
conformation and is unable to bind to the operator, which produces deactivation or 
derepression of the transcription. 
 
 
Conflicting publications on this matter bear witness of such a problem in the relevant 
literature. Gel retardation experiments with a labeled DNA fragment bearing a Cra 
operator (Bledig et al, 1996; Ramseier et al, 1993) could authenticate F1P as one bona fide 
effector, but not FBP. Some studies suggest that the in vitro response of Cra to FBP is due 
to a possible contamination of FBP with F1P (Ramseier et al, 1993). Yet, other authors 
argue that FBP is an authentic effector of Cra (Bledig et al, 1996; Kotte et al, 2010). The 
state of affairs at this point is, therefore, that of uncertainly on the role of FBP as agonist 
INTRODUCTION 
26 
of the Cra regulator (that F1P is one seems to be beyond question). Besides uncertain 
role of the FBP, studies of Cra regulation have been reported just in enterobacteria, 
while in other species such as P. putida the Cra regulation remains unknown. 
 
3. Phosphoenolpyruvate PEP:carbohydrate phosphotransferase system 
(PTS) in bacteria  
 
3.1. Carbohydrate PTS system 
 
The phosphoenolpyruvate PEP:carbohydrate phosphotransferase system (PTS) was 
discovered in E. coli by Kundig, Ghosh, and Roseman as a device that phosphorylates a 
number of carbohydrates (Kundig et al, 1964). Later, it was demonstrated that the PTS 
is a transport system that catalyzes the intake of several sugars and their conversion to 
the respective phosphoesters. The common features of this phosphotransferase system 
included [i] the use of phosphoenolpyruvate (PEP) as the phosphoryl donor for sugar 
phosphorylation and [ii] the presence of three essential catalytic entities, termed enzyme 
I, enzyme II, and HPr (heat-stable, histidine-phosphorylatable protein; Saier and 
Reizer, 1994). Specifically,  enzymes I (EI) and HPr are cytoplasmic energy-coupling 
proteins, which lack sugar specificity, and membranous enzyme II (EII) is specific for 
one or a few sugars. Actually, the enzyme II is a complex that consist of three proteins 
or protein domains, namely, EIIA, EIIB, and EIIC. Phosphoryl relay proceeds 
sequentially from PEP to EI, HPr, EIIA, EIIB, and finally, the incoming sugar, which is 
transported across the membrane via the integral membrane EIIC porter (Fig. 3). 
Currently, we know that PTS proteins are present in a large number of  bacteria where 
we can find transport systems for glucose, fructose, maltose, mannose and many more 
sugars (Deutscher et al, 2006). It is interesting that the most widely distributed PTS 
system (see Fig. 4) is the fructose-specific PTS (PTSFru) or fructose operon. Many 
evolutionarily divergent genera  (e.g., Azospirillum, Fusobacterium, Lactobacillus, Listeria, 
Pseudomonas, Rhodobacter, Streptomyces, etc.) possess the PTSFru system, but they apparently 
cannot phosphorylate other sugars via the PTS. This would suggest that this  PTS 
system is the ancestral and all the other are derived from it (Saier et al, 1996). 
 
The very first function that was asigned to the PTS systems, was its participation in 
sugar transport and phosphorylation. Today, we know that besides sugar reception, 
transport, and phosphorylation, this system in involved in several regulatory roles in the 
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cell including cell division, chemoreception, central metabolism, pathogenesis, flagellar 
motility, the control of 54-dependent transcription of several metabolic genes and others 
(Deutscher et al, 2006; Postma et al, 1993). 
 
 
 
 
 
 
 
 
 
 
Figure 3. PTS systems in bacteria.  The PTS systems are formed by three essential 
enzymes called EI, HPr an EIIA. Enzymes I (EI) and HPr are cytoplasmic proteins, which 
lack sugar specificity, and enzyme II (EII) usually is a complex that consist of three proteins 
or protein domains, namely, EIIA, EIIB, and EIIC. In all cases, PEP acts as phosphoryl 
donor for sugar  phosphorylation. Moreover, many bacteria possess a PTS system that is 
not involved in sugar transport (PTSNtr) which is discussed in the next section. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Presence of PTS systems in bacteria. Many evolutionarily divergent 
genera (but not all) possess the fructose-specific PTS or fructose operon. They may also 
have the genes for phosphorylate other sugars via PTS. It is clear that the PTSFru is the most 
conserved PTS system in bacteria. The y-axis represents the porcentage of species in each 
genera that report the presence of the respective PTS system. The information was 
obtained from KEGG database.  
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3.2. Nitrogen PTS (PTSNtr) system in bacteria 
 
In addition to the carbohydrate PTS, E. coli and many other bacteria contain a parallel 
PTS called nitrogen PTS system (PTSNtr, see Fig. 3). This system is formed by the EINtr 
(PtsP) protein (Rabus et al, 1999), a HPr (Npr or  PtsO)  homologue (Jones et al, 1994; 
Powell et al, 1995) and the EIIANtr (PtsN) protein (Powell et al, 1995). The 
phosphorylation chain starting from PEP through EINtr  NPr  EIIANtr is highly 
specific. Yet, it has been reported in E. coli (Powell et al, 1995; Zimmer et al, 2008) and 
other species (Pfluger and de Lorenzo, 2008) that the system exhibits cross-reactivity 
with the carbohydrate PTS system. A clear difference between the two PTS systems,  is 
that permease components are absent in the nitrogen related set, ruling out its 
participation in sugar intake (Velazquez et al, 2007).  Owing that ptsN and ptsO genes 
form an operon with the rpoN gene (encoding the sigma factor of RNA polymerase, σ54), 
the involvement of PtsN/PtsO proteins with nitrogen regulation has been suggested, 
leading to the designation nitrogen PTS (Powell et al, 1995). Multiple phenotypes 
associated to PTSNtr proteins (specially to PtsN) suggest that the PTSNtr system strongly 
participates in regulation of several metabolic functions in the cell (Cases et al, 2001a; 
Cases et al, 2007; Lee et al, 2007; Luttmann et al, 2009; Pfluger and de Lorenzo, 2007; 
Reizer et al, 1992; Velazquez et al, 2007). For example, in E. coli, the ptsN mutant 
reduced its capabilities to utilize certain amino acids as nitrogen source when glucose 
was the substrate (Powell et al, 1995). Moreover, the ptsN strain showed a mucoidy 
character in the presence of glucose with Arg, His, or Pro which is similar to the 
observations made in a ntrC mutant (Ninfa, 2007). On the other hand, growth 
experiments with leucine-containing peptides indicated that ptsP and ptsO mutants 
tolerate these compounds while wild type strain and ptsN mutant are sensitive to their 
presence (Lee et al, 2005). The resistance of ptsO and ptsP strains was explained by the 
ability of the nonphosphorylated-PtsN to endure the intracellular accumulation of 
leucine which is a potent feedback inhibitor of acetolactate synthase (ilvB), a key enzyme 
for the biosynthesis of valine and isoleucine (Lee et al, 2005). This result (in addition to 
the finding that the expression of the ilvB depends on the presence of 
nonphosphorylated-PtsN) strengthens the idea that the nitrogen PTS links the 
regulation of carbon and nitrogen metabolism (Commichau et al, 2006). Furthermore, it 
has been demonstrated that the dephosphorylated PtsN (but not its phosphorylated 
form), forms a tight complex with TrkA that inhibits the accumulation of high 
intracellular concentrations of K+ (Lee et al, 2007). The high K+ concentration (in the 
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ptsN mutant) produces the sensitivity of E. coli to Leucine or Leucine containing peptides 
(LCPs) by inhibiting the expression and activity of acetolactate synthase (Lee et al, 2007). 
 
Yet, the cases of toxicity of leucine and the regulation of K+ uptake are just two of the 
few that have been elucidated: the majority of the mechanisms behind the multiple 
phenotypes  associated to PTSNtr proteins remain poorly understood. Examples of 
processes controlled directly or indirectly by PTSNtr, which the mechanism remains 
unexplained included: the supression by ptsN and the effects of a lethal σE mutation in 
E. coli (Powell et al, 1995), the effects of PTSNtr proteins in accumulation of  
polyhydroxyalkanoates (PHAs) in P. putida (Velazquez et al, 2007),  the involvement of 
ptsN in the utilization of organic nitrogen sources in P. aeruginosa (Jin et al, 1994),  the 
requirements of ptsP for replication in host cells and thereby for virulence in Legionella 
pneumophila (Edelstein et al, 1999) and others. Moreover, other key questions remain 
unanswered, e.g. where the phosphate goes after EIIANtr or which is the metabolic 
signals that are recognized by the PTSNtr system?. In our laboratory, we are working to 
answer these questions and understand the functions of the PTS in bacteria, specifically 
in the soil bacterium P. putida. Some of our findings in P. putida are summarized in the 
next section. 
 
3.3. PTS systems in P. putida 
 
In P. putida, one sugar-specific PTS for fructose transport (FruA/EIIBC and FruB/EI-
HPr-EIIA) coexists with the PTSNtr (PtsP/EINtr, PtsO/NPr, and PtsN/EIIANtr), which, 
while keeping the core phosphotransfer domains, lacks the EIIBC modules that make 
the connection to sugar intake (Fig. 5, Pfluger et al, 2007; Velazquez et al, 2007). As 
discussed above, the high energy phosphate is derived in both systems from 
phosphoenolpyruvate (PEP) and then transferred from EI via HPr/NPr to the EII 
enzymes (Fig. 5; Postma et al, 1993).  In P. putida, it was shown that the PTSFru and the 
PTSNtr do not represent two completely separated systems, since they do communicate 
under specific conditions with each other in vivo by the exchange of phosphate moieties 
(Fig. 5; Pfluger et al, 2008). This interaction, which was postulated for a long time on the 
basis of in vitro experiments with the purified proteins (Powell et al, 1995), is not restricted 
to the special case of P. putida, where one PTS of each type is present, but was also 
observed in vivo in E. coli (Zimmer et al, 2008) and is probably a common principle. 
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In P. putida, global expression analysis using two-dimensional gel electrophoresis has 
indicated that ptsN affects numerous proteins, comprising 5–9% of all proteins analyzed 
(Cases et al, 2001a). Of these, a small number are regulated by glucose, and, of this small 
set, some are regulated from σ54-dependent promoters. A much larger number of 
proteins regulated by ptsN were unrelated to control by glucose or σ54. Thus, the broad 
conclusion is that ptsN controls numerous genes, most likely by a variety of different 
mechanisms. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. PTS systems in P. putida. In P. putida, one specif sugar PTS for fructose 
transport PTSFru coexists with one PTSNtr. The PTSFru is formed by FruA/EIIBC and 
FruB/EI-HPr-EIIA and FruK while PTSNtr is formed by PtsP/EINtr, PtsO/NPr, and 
PtsN/EIIANtr. In both systems the high-energy phosphate is originated in 
phosphoenolpyruvate (PEP) and then transferred from EI via HPr/NPr to the EII enzymes.  
  
Mutants of P. putida lacking one or more PTSNtr proteins display a number of 
phenotypes (Cases et al, 2001a; Cases et al, 1999; Cases et al, 2001b; Pfluger et al, 2007; 
Pfluger-Grau et al, 2011; Velazquez et al, 2007). For instance, the PTSNtr proteins are 
involved in regulation of accumulation of PHAs, a storage compound accumulated 
mainly under conditions of carbon overflow and nitrogen limitation (Velazquez et al, 
2007). According to the putative sensory function of PTSNtr, mutants in these proteins 
show different growth phenotypes when cultivated on various carbon and nitrogen 
sources (Velazquez et al, 2007). On the other hand, the PTSNtr proteins are involved in 
regulation of the toluene degradation pathway by tuning the activity of the m-xylene 
responsive Pu promoter of the pWW0 plasmid (Cases et al, 1999; Cases et al, 2001b). 
More recently, it was shown that the non-phosphorylated form of PtsN directly 
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downregulates pyruvate dehydrogenase (PDH) activity, an enzymatic complex 
responsible for the decarboxylation of pyruvate to acetyl-CoA, thereby linking glycolysis 
to the TCA cycle (Pfluger-Grau et al, 2011). In the same way as in other bacteria, most 
of the mechanisms by which PTSNtr proteins control some processes remain obscure in 
P. putida. As part of the phenotypes observed in PTSNtr mutants could be explained by 
an effect on central metabolism, one of the aims of this Thesis was to analyze the flow 
distribution in central metabolism in various PTS mutants of P. putida. 
 
 
4. The issue at  stake 
 
To take full advantage of living organisms for biotecnological purposes, we need to 
understand the complex mechanism of life as best as possible.  The machinery of life is 
better understood in some species that have been studied more extensively and that the 
scientific community called as model organisms (such as E. coli). However, other species 
with very interesting features that can be exploited in bioremediation, biocatalysis or as 
cell factories are much less known. This is the case of P. putida, a bacterium that presents 
the same advantages that E. coli in laboratory handling (no pathogenic, genetic tools 
available, etc) but also it offers robustness, remarkable adaptability to different 
environments and a large collection of enzymes in its genome encoding for metabolic 
pathways that are not included in other bacterial species. These characteristics 
distinguish P. putida as an ideal organism as cell factory.  
 
There is extensive evidence that the environmental niche of each bacterium has shaped 
the metabolism, sensory systems, regulators, etc, to co-adapted to requirements and 
lifestyle of each organism. Therefore, to use P. putida efficiently in biotechnological 
process we need to study the performance of its metabolic machinery without 
generalizing the observations made in model organisms. With this idea in mind, we 
have focused on investigating possible regulatory effects of PTS proteins on carbon 
central metabolism in P. putida. To adress this point, we need a proper understanding of 
the carbon central metabolism of this bacterium. To this end, we have investigated the 
regulation exerted on PTS systems by the catabolic repressor/activator (Cra) regulator, 
which is known to control several metabolic genes in Escherichia coli and Salmonella 
typhimurium.  In this context, in this work we have addressed the following objectives. 
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General objetive: 
 
To investigate the regulation of PTS systems (PTSFru and PTSNtr systems)  of P. putida as 
well as its conection with central carbon metabolism.  
 
 
Through the following specific objetives: 
 
1. To analyze the main metabolic routes and carbon flow in central metabolism of P. 
putida. 
 
2. To study the interplay between the PTS systems and carbon central metabolism. 
 
3. To study the regulation exerted by the catabolic repressor/activator (Cra) regulator on 
PTS systems of P. putida. 
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1. General procedures 
 
1.1. Bacterial strains  
Strains of Pseudomonas putida and Escherichia coli used in this study are described in Table 
1, together with their most relevant characteristics. 
 
Table 1. Strains of P. putida and E. coli. 
 
Strain Relevant characteristics Source/Reference 
P. putida strains 
mt-2  P. putida wild type with TOL (pWW0) plasmid  Williams and 
Murray, 1974 
KT2440 Strain derived of P. putida mt-2 without the pWW0 
plasmid 
Nelson et al, 2002 
 
MAD2 TelR, RifR. Variant of P. putida KT2440, with a Pu-
lacZ transcriptional fusion along with the constitutive 
xylR∆A+ allele of the xylR regulator of the pWW0 
plasmid assembled in a mini-Tn5 vector  
Fernandez et al, 1995 
 
MAD2 
fruB::xylE 
TelR, RifR. Derivative of P. putida MAD2 carrying a 
directed chromosomal insertion of the xylE marker in 
fruB, replacing a 1.5 kb internal fragment  
Cases et al, 2001 
MAD2  
ptsO::km 
TelR, RifR, KmR. Derivative of P. putida MAD2 
carrying a directed chromosomal insertion of a Km 
resistance cassette in ptsO 
Cases et al, 2001 
MAD2  
ptsP::km 
TelR, RifR, KmR. Derivative of P. putida MAD2 
carrying a directed chromosomal insertion of a Km 
resistance cassette in ptsP replacing a 249 bp internal 
fragment  
Cases et al, 2001 
 
MAD2  
ptsN::km 
TelR, RifR, KmR. Derivative of P. putida MAD2 
carrying a directed chromosomal insertion of a Km 
resistance cassette in ptsN 
Cases et al, 1999 
 
MAD2 
ptsN::xylE, 
ptsO::km 
TelR, RifR, KmR. Derivative of P. putida MAD2 
carrying a directed chromosomal insertion of a xylE 
marker in ptsN and Km resistance in ptsO 
Cases et al, 2001 
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MAD2 ptsP::km, 
fruB::xylE 
TelR, RifR, KmR. Derivative of P. putida MAD2 
carrying a directed chromosomal insertion of a Km 
resistance cassette in ptsP and a xylE marker in fruB 
Cases et al, 2001 
MAD2 ptsNHA TelR. Derivative of P. putida MAD2 in which His in 
position 68 has been replaced by an Ala (A68) residue 
in the amino acid sequence of PtsN protein 
Pfluger-Grau et al, 
2011 
MAD2 ptsNHE TelR. Derivative of P. putida MAD2 in which His in 
position 68 has been replaced by a Glu (E68) residue 
in the amino acid sequence of PtsN protein 
Pfluger-Grau et al, 
2011 
MAD2  
eda::xylE 
TelR, RifR. Derivative of P. putida MAD2 carrying a 
directed chromosomal insertion of the xylE marker in 
eda   
Velazquez et al, 2004 
KT2440 Δcra Derivative of P. putida KT2440 with a complete 
deletion of cra gene 
This work 
KT2440  
Δcra ΔptsP  
Derivative of P. putida KT2440 with a complete 
deletion of cra and ptsP genes 
This work 
KT2440 ΔptsP Derivative of P. putida KT2440 with a complete 
deletion of ptsP gene 
This work 
KT2440 ΔfruB  Derivative of P. putida KT2440 with a complete 
deletion of fruB gene  
This work 
KT2440 eda::km KmR, RifR.  Derivative of P. putida KT2440 carrying 
a chromosomal insertion of a mini-Tn5 Km in eda 
Duque et al, 2007 
KT2440 
tpiA::km  
KmR. Derivative of P. putida KT2440 carrying a 
chromosomal insertion of a mini-Tn5 Km in tpiA  
V. dos Santos 
KT2440  
zwf-1::km 
KmR, RifR. Derivative of P. putida KT2440 carrying a 
chromosomal insertion of a mini-Tn5 Km in zwf-1 
Duque et al, 2007 
 
KT2440  
pgi::km 
 
KmR, RifR. Derivative of P. putida KT2440 carrying a 
chromosomal insertion of a mini-Tn5 Km in PP1808 
(pgi) 
Duque et al, 2007 
KT2440 
pgi2::km  
KmR, RifR. Derivative of P. putida KT2440 carrying a 
chromosomal insertion of a mini-Tn5 Km in PP4701 
(pgi) 
Duque et al, 2007 
 
KT2440  
edd::km  
KmR, RifR. Derivative of P. putida KT2440 carrying a 
chromosomal insertion of a mini-Tn5 Km in edd 
Duque et al, 2007 
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1.2. Media and culture conditions 
P. putida and E. coli strains were cultured at 30 °C and 37 °C, respectively, in an orbital 
shaker at 170 rpm. The rich medium used to grow all strains of this study was Luria-
Bertani (LB) as described in Sambrook et al. (1989). Cultures on solid medium were 
performed with LB medium supplemented with Bacto Agar (Pronadisa) 1.5% (w/v). 
When needed, we added 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) at 
a concentration of 0.08 mM, and isopropyl-1-thio-β-galactopyranoside (IPTG) to a 
concentration between 0.5 and 1 mM. Moreover, different strains of P. putida were also 
cultivated, when it was appropriate in minimal medium M9 (Miller, 1972), 
supplemented with glucose, fructose or succinate as carbon source (0.2% w/v). 
 
 Concentrated solutions of different carbon sources were sterilized by autoclaving and 
added to the medium aseptically. The solid minimal medium cultures were performed 
by supplementing the M9 medium and carbon source (0.2% w/v) with 1.5% Bacto 
Agar (w/v). Antibiotics were prepared in concentrated solutions (1000x), were sterilized 
by filtration and stored at -20 °C. The final concentrations of each antibiotic were: 
ampicillin (Ap, 150 μg/ml, or 500 μg/ml for P. putida), kanamycin (Km, 50 μg/ml), 
potassium tellurite (Tel, 80 μg/ml) and tetracycline (Tc, 10 μg/ml). 
 
KT2440 
 gnd::km  
KmR, RifR. Derivative of P. putida KT2440 carrying a 
chromosomal insertion of a mini-Tn5 Km in gnd 
 
Duque et al, 2007 
 
E. coli strains 
CC118 Δ(ara-leu), araD, ΔlacX74, galE, galK, phoA, thi1, rpsE, 
rpoB, argE, recA1  
Manoil and 
Beckwith, 1985 
CC118λpir CC118 λpir phage lysogen  Herrero et al, 1990 
DH5α                   
  
F- Φ80 lacZΔMΔ15 (lacZYA-argF), U169, recA1, endA1, 
hsdR17, R-M+, supE44, thil, gyrA, relA1 
Hanahan, 1983 
DH5αλpir DH5α λpir phage lysogen  Lab collection 
W3110 K12, F-, IN (rrnD-rrnE)  Bachmann, 1987 
BL21 (DE3) F– ompT gal dcm lon hsdSB (rB- mB-) λ (DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5])  
Novagen 
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During periods of less than one month, the strains were stored at 4 °C on LB or 
minimal medium agar plates. For long-term preservation, the bacteria were frozen in 
the culture medium corresponding to 20% glycerol (v/v) and kept at -80 °C. Growth in 
liquid medium was followed by turbidometry at 600 nm (OD600) using an Ultrospec-
3000 pro or to 595 nm in a Victor 2 multichannel spectrophotometer (Perkin Elmer). 
 
1.3. Plasmids                 
Table 2 shows the plasmids used in this Thesis and its main features. 
 
Table 2. Plasmids used in this work. 
 
Plasmid Characteristics Reference 
pVLT31 TcR, Broad-host-range plasmid based on lacIq/Ptrc  de Lorenzo 
et al, 1993 
pVLT31pfkA TcR, pVLT31 plasmid with pfkA sequence from E. coli 
W3110 cloned in the polylinker as a 963 bp KpnI-HindIII 
fragment. The cloned sequence included the Ribosomal 
Binding Site (RBS) from pTrc99A vector (AGGAAA) 
This work 
pVLT31ptsN_Etag TcR. The plasmid carries a variant of the ptsN gene with a 
short E-tag epitope added in its C-terminus 
Pfluger and 
de Lorenzo, 
2007a 
pET28a(+)  KmR. The plasmid carries a N-terminal His-
Tag/thrombin/T7-Tag configuration in addition to an 
optional C-terminal His-Tag sequence 
Novagen 
pET28a(+)cra  KmR. pET28a(+) plasmid with cra sequence from P. putida 
KT2440 cloned as NdeI/XhoI fragment 
This work 
pSW ApR, oriRK2, xylS, PmI-sceI Wong and 
Mekalanos, 
2000 
pEMG KmR, oriR6K, lacZα with two flanking I-SceI sites Martínez-
García and 
de Lorenzo, 
submitted 
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pEMGΔcra pEMG bearing a 1000 bp TS1-TS2 EcoRI-BamHI insert 
for cra deletion  
This work 
pEMGΔptsP pEMG bearing a 1600 bp TS1-TS2 BamHI-XbaI insert 
for ptsP deletion 
This work 
pEMGΔfruB pEMG bearing a 1000 bp TS1-TS2 EcoRI-BamHI insert 
for fruB deletion 
This work 
pSEVA221 KmR, oriRK2, oriT. Standard broad-host range cloning 
plasmid  
Lab 
collection 
pUJ9  ApR, oriColE1, promoter probe vector, lacZ fusion  de Lorenzo 
et al, 1990 
pUJ9PfruB Vector derivative from pUJ9 with fruB promoter cloned as 
an 586 bp EcoRI/BamHI fragment 
This work 
pMCH1 KmR, oriRK2, oriT, lacZ. pSEVA221 inserted with a 
EcoRI-HindIII fragment from pUJ9PfruB bearing a PfruB-
lacZ translational fusion 
This work 
pMCH2 KmR, oriRK2, oriT, lacZ. Plasmid derivative from pMCH1 
in which EcoRI-BamHI fragment (fruB promoter, 586 bp) 
was replaced by cra promoter fragment (376 bp) bearing a 
Pcra-lacZ translational fusion 
This work 
 
pMCH3 KmR, oriRK2, oriT, lacZ. pSEVA221 inserted with a 
BamHI-HindIII fragment from pUJ9. This plasmid 
corresponds to the negative control for experiments with 
pMCH1 and pMCH2 plasmids. 
This work 
 
 
1.4. Cell transformation 
Cells of E. coli were made competent for transformation with the RbCl method 
(Sambrook, 1989) or by electroporation (Wirth et al, 1989). For P. putida strains, 
electrocompetent cells were produced by washing them at room temperature with 300 
mM sucrose (Choi et al, 2006). Electroporation was performed with a Gene Pulser/Pulse 
Controller (Bio-Rad) system using the following conditions: 2.5 kV, 25 μF, 200 ohms. 
 
1.5. DNA manipulation methods 
Techniques used for preparation and manipulation of DNA have been described by 
Sambrook et al. (1989). Restriction endonucleases were purchased from New England 
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Biolabs. Digestions were always conducted at 37 °C for 2 h. For DNA ligation, enzymes 
T4 ligase (incubation by 12 h at 16 °C) or Quick Ligase (incubation by 5 min to room 
temperature) were used. In both cases a ratio 3/1 insert/vector was used. All enzymes 
were used according to manufacturer's specifications. The DNA fragments were purified 
using agarose gels, and the commercial kit QIAEX®II Gel Extraction, QIAGEN (Cat. 
# 20021). Genomic DNA from P. putida, used in PCR amplifications was obtained 
according to the protocol described by Murray and Thompson (1980) which uses 
extraction with cetyl trimethyl ammonium bromide (CTAB)/NaCl. Plasmid DNA was 
obtained with alkaline lysis with the QIAprep Spin Miniprep Kit QIAGEN (Cat. # 
27106), according to the manufacturer's protocol. 
 
1.6. Design of oligonucleotides 
Polymerase Chain Reaction (PCR) primers were designed from the DNA sequence of 
interest using the analysis software Ape-A Plasmid Editor v1.12 (Copyright © 2003-
2005, M. Wayne Davis). The hybridization temperature (Tm) in all cases was above 55 
°C. The synthesis was carried out by Sigma-Genosys. All oligonucleotides used are listed 
in Table 3. 
 
Table 3. Synthetic oligonucleotides used in this work for amplification of PCR 
products. The underlined sequences correspond to the restriction enzyme 
introduced in each case 
 
Oligonucleotide Sequence (5´-3’) 
PfkA-F (KpnI) CGCGGGGTACCAGGAAAGATATAATGATTAAGAAAATCGGT 
PfkA-R (HindIII) CGCGGAAGCTTTTAATACAGAAAAAACGCGCAGTC 
Cra-F (NdeI) GGGAATTCCATATGAAACTCAGCGATA TCGCCCGT 
Cra-R (XhoI) CCGGCTCGAGTCAGGCCACTGAGAT 
cra-TS1F (EcoRI) CGGAATTCGGCCTCTTCGTAGCTGCCGGC 
cra-TS1R CAGCCCCGGTAATAACAAGGAAAATTCGACATGCGCCTGAT
CGACACC 
cra-TS2F CGAATTTTCCTTGTTATTACCGGGGCTG 
cra-TS2R (BamHI) CGGGATCCATACACCAGGTCACGTGTTTGCG 
cra/fruB-F TCAGATTAAACGTTTCAGCTGC 
cra/fruB-R GCAGCTGAAACGTTTAATCTGA 
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ptsP-TS1F (BamHI) CGGGATCCCCGCCCCACTCAGCCCCTGG 
ptsP-TS1R ACGGAGTTCGACCCCGAGCCGGGTGATGCTGTTTGTGCCG 
ptsP-TS2F GGCTCGGGGTCGAACTCCGT 
ptsP-TS2R (XbaI) GCTCTAGACCAGGGTGCCATTGAGGTAA 
fruB-TS1F (EcoRI) CGGAATTCCTCCAGATCCGGGAGAATGAAGCC 
fruB-TS1R AGAGTGAGGATCTTGGCCATGACCTTCTCCTTTTGCAGTT 
fruB-TS2F ATGGCCAAGATCCTCACTCT 
fruB-TS2R(BamHI) CGGGATCCCTGTCCAGGACTACCTTGAGGCC 
pSW-F GGACGCTTCGCTGAAAACTA 
psW-R AACGTCGTGACTGGGAAAAC 
PfruB-F (EcoRI) CGGAATTCCGAATTTTCCTTGTTATTACCGGGG 
PfruB-R (BamHI) CGGGATCCGCGGCAATACCAATGGC 
Pcra-F (EcoRI) CGGAATTCGACCTTCTCCTTTTGCAGTTCCCGTTCGGG 
Pcra-R (BamHI) CGGGATCCCTGATGCGCTGCTGTTCAGCCTTG 
 
1.7. Design of P. putida mutants 
Strains Δcra, ΔptsP, ΔcraΔptsP and ΔfruB were constructed using the method developed by 
Martínez-García and de Lorenzo (submitted). Primers cra-TS1F (EcoRI)/ cra-TS1R/ 
cra-TS2F/ cra-TS2R (BamHI)/ fruB-TS1F (EcoRI)/ fruB-TS1R/ fruB-TS2F/ fruB-
TS2R (BamHI)/ ptsP-TS1F (BamHI)/ ptsP-TS1R/ ptsP-TS2F and ptsP-TS2R (XbaI) 
were used (Table 3) to amplify flanking regions (TS1, upstream and TS2, downstream) 
of genes cra, ptsP and fruB respectively. TS1 and TS2 regions of homology of 500-800 bp 
length were amplified with Vent DNA polymerase (Promega) and both fragments (TS1 
and TS2) joined together by overlap extension (SOE)-PCR (Horton et al, 1989). The 
resulting 1.0-1.6-kb segments were purified as EcoRI-BamHI fragments (BamHI-XbaI 
for ptsP), ligated into the pEMG and transformed into E. coli DH5αλpir. Candidate 
clones were confirmed by PCR and sequencing the entire TS1-TS2 insert. The resulting 
pEMGΔcra pEMGΔptsP, pEMGΔfruB vectors were isolated and electroporated in P. 
putida KT2440 (pSW).  
 
The cointegrated KmR clones were grown overnight in a 5 ml tube with LB medium, 
Ap 500 μg/ml and 15 mM 3-methylbenzoate as inducer and plated in LB. The 
individual colonies were restreaked in LB and LB+Km to check the lost of the 
cointegrated plasmid. Kanamycin-sensitive clones were analyzed by colony PCR for 
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identification of cra, ptsP and fruB deleted clones. Finally, pSW plasmid was eliminated 
after three consecutive passes in liquid LB. Elimination of the plasmid was verified in all 
the cases by direct colony PCR amplification, using the primers pair pSW-F and pSW-
R. 
 
1.8. Construction of lacZ-translational fusions 
 For gene expression studies, plasmids were constructed as follows. First, the sequence of 
the regulatoy region of fruB (284 bp before ATG), plus 100 aminoacids of the FruB 
protein was amplified by PCR using PfruB-F (EcoRI) and PfruB-R (BamHI) primers (Table 
3). The 586 bp DNA fragment was digested as EcoRI-BamHI, ligated to the polylinker 
of the pUJ9 and the vector subsequently transformed in E. coli DH5α. Then, the vector 
was isolated, digested with EcoRI-HindIII enzymes, and the DNA band corresponding 
to fragment PfruBlacZ was purified, cloned in the pSEVA221 and transformed in E. coli 
DH5α to obtain the vector pMCH1. This vector corresponds to a translational fusion 
PfruB::lacZ which was electroporated in P. putida KT2440 and its mutant Δcra. 
 
On the other hand, to obtain the Pcra::lacZ translational fusion, the regulatory region of 
cra (284 bp before ATG), plus 30 aminoacids of Cra protein was amplified by PCR 
using Pcra-F (EcoRI) and Pcra-R (BamHI) primers (Table 3). The 376 bp DNA fragment 
was digested as EcoRI-BamHI, ligated to the polylinker of pMCH1 and the vector 
subsequently transformed in E. coli DH5α. This procedure replaced the PfruB promoter 
from pMCH1 by Pcra promoter bearing the pMCH2 vector. Finally, this vector was 
electroporated in P. putida KT2440. 
 
2. Metabolic Flux analysis 
 
2.1. Determination of physiological parameters for metabolic flux analysis 
For determination of physiological parameters, bacteria were grown at 30 °C in 500 ml 
baffled shake flasks with 50 ml synthetic M9 medium with glucose or fructose as C-
source. Cell growth was monitored spectrophotometrically at 600 nm (OD600) and 
glucose or fructose concentrations were determined enzymatically with the glucose (HK) 
assay kit (Sigma-Aldrich) or and the fructose kit (Enzytec) according to the suppliers’ 
manuals, respectively. The following physiological parameters were determined by 
regression analysis during the exponential growth phase in the batch culture, as 
described elsewhere (Sauer et al, 1999): maximum specific growth rate, biomass yield on 
MATERIALS AND METHODS 
47 
glucose (or fructose, respectively), specific glucose (or fructose, respectively) 
consumption. The correlations factors (k) between cellular dry weight (CDW) and 
OD600 were determined from batch cultures of each mutant. Therefore, CDW was 
measured from at least four parallel 10 ml cell suspensions by harvesting the cells by fast 
filtration through pre-weight nitrocellulose filters (0.45 µm), which were subsequently 
washed with 0.9% NaCl and dried at 105 °C for 24 h to a constant weight. 
 
2.2. Metabolic flux ratio analysis by GC-MS 
For labelling, either 100% [1-13C]-glucose (or [1-13C]-fructose, respectively, Sigma-
Aldrich), or a mixture of 20% (wt/wt) [U-13C]-glucose (or [U-13C]-fructose, respectively, 
Sigma-Aldrich) and 80% (wt/wt) natural glucose (or fructose, respectively) were used. 5 
ml cell aliquots were harvested in mid-exponential growth by centrifugation at 1,200 x g 
and 4 °C for 10 min. The pellet was washed twice with 1 ml of 0.9% NaCl, then 
hydrolyzed in 1 ml 6 M HCl for 24 h at 110 °C in sealed 2 ml Eppendorff tubes, and 
desiccated overnight in a heating block at 85 °C under a constant air stream. The 
hydrolysate was dissolved in 30 μl of 99.8% pure dimethyl formamide. For 
derivatization, 20 μl of N-methyl-N-(tert-butyldimethylsilyl)-trifluoroacetamide was 
added and the mixture was incubated at 85 °C for 60 min. The GC-MS-derived mass 
isotope distributions of proteinogenic amino acids was analyzed injecting 1 μl of the 
derivatized sample into the gas chromatograph 6890N (Agilent Technologies) combined 
with the Mass selective Detector model 5973 (Agilent Technologies) and analyzed as 
described previously (Dauner and Sauer, 2000; Fischer and Sauer, 2003). 
 
The corrected mass distributions were related to the in vivo metabolic activities obtained 
with previously described algebraic equations and statistical-data treatment of 
metabolic-flux ratio analysis (Fischer et al, 2003) using the program ratio of Fiat Flux 
software (Zamboni et al, 2005). 
 
2.3. 13C-constrained metabolic net flux analysis  
The metabolic model used for net-flux analysis was based on the master reaction 
network (Fuhrer and Sauer 2005), which included 45 reactions and 33 metabolites. To 
adapt the metabolic reaction network to growth on fructose, it was necessary to modify 
the upper metabolism as follows: fructose is taken up by the PTSFru system and thereby 
activated to F1P, which is then converted to FBP by the activity of the 1-
Phosphofructokinase (Lessie and Phibbs, 1984; Sawyer et al, 1977; Schleissner et al, 
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1997; Van Dijken and Quayle, 1977; Velazquez et al, 2004; Vicente, 1975; Vicente et al, 
1975). Net fluxes were then calculated using [i] the stoichiometric reaction matrix, [ii] 
the METAFoR analysis-derived flux ratios, [iii] physiological data, and [iv] precursor 
requirements for biomass synthesis, as described previously (Zamboni et al, 2005). 
Specifically, the following flux ratios were used: serine derived through the EMP 
pathway, pyruvate derived through the ED pathway, oxaloacetate (OAA) originating 
from pyruvate, PEP originating from OAA, the lower and upper bounds of pyruvate 
originating from malate, and the upper bound of PEP derived through the PP pathway. 
The stoichiometric matrix was then solved with the MATLAB-based program Netto of 
Fiat Flux software (Zamboni et al, 2005) by minimizing the sum of the weighted square 
residuals of the constraints from both metabolite balances and flux ratios to obtain 
estimated net fluxes. 
 
3. Metabolic measurements 
 
3.1. Determination of metabolite concentrations by Liquid 
Chromatography Mass spectrometry (LC-MS) 
For metabolite quantification fresh medium (M9 medium with glucose, fructose or 
succinate) was inoculated to a starting OD600 of 0.05 from a P. putida wild type culture 
grown on the same medium.  The biomass corresponding to 0.5-0.6 mg of cellular dry 
weight (CDW, 4 ml of culture to OD600 = 0.5-0.6) of each of the samples (five 
independent replicates) were separated of its supernatant by fast centrifugation (13 000 x 
g, 30 sec) and the cell pellet frozen in liquid nitrogen until extraction. Then, the samples 
were extracted three times with 0.5 ml 60% (v/v) ethanol buffered with 10 mM 
ammonium acetate pH 7.2 at 78 °C for 1 min as described previously (Buescher et al, 
2010; Fuhrer and Sauer, 2009). After each extraction step, biomass was separated by 
centrifugation for 1 min at 13 000 x g. The three liquid extracts of each sample were 
pooled prior to drying at 120 μbar to complete dryness and then stored at -80 °C until 
resuspension. Prior to analysis, the dry extracts were resuspended in 500 μl of MilliQ 
water. The samples were sealed in 96-well plates for LC-MS analysis. Quality control 
and carry-over checks were included in the analysis series by injection of a mixture of 
standard compounds and water, respectively. Liquid chromatography, mass 
spectrometer conditions and data analysis were carried out as described previously 
(Buescher et al, 2010). 
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3.2. Determination of total ATP 
ATP was measured in wild type and pfkA+ strains using an ATP bioluminiscence kit 
(Proteinkinase, Biaffin GMBH & Co KG). Cultures of P. putida MAD2 (pVLT31) and P. 
putida MAD2 (pVLT31pfkA) were diluted to an OD600 of 0.05 in fresh medium (M9 
medium with glucose or fructose, Tc and IPTG 0.5 mM) and grown at 30 °C until 
exponential phase (OD600 = 0.2-0.5). For ATP extraction, we used the trichloroacetic 
acid protocol (Bagnara and Finch, 1972) which is considered the best method for 
microorganisms. This is because it inactives enzymes that might quickly degrade the 
ATP before measurement (Lundin and Thore, 1975). For this procedure 100 μl of cell 
culture was mixed with 100 μl of a solution of 5% trichloroacetic acid with 4 mM 
EDTA and cooled in ice bath by 15 min (Lundin et al, 1975). Then, samples were 
diluted 20-fold with buffer Tris 20 mM, EDTA 2 mM pH = 7.75 and 50 μl of this 
solution was mixed with 50 μl of bioluminiscence reagent according to manufacturers’ 
instructions.  The bioluminiscence signal was measured in a Victor2 (Perkin Elmer) 
recording spectrophotometer after 10 min of incubation. 
 
4. Expression of enzymes and measurements of their activity 
 
4.1. Expression of 6-phosphofructokinase 
The broad-host-range expression vector pVLT31 was employed to express the protein 
PfkA in the wild type P. putida MAD2 and its eda mutant.  Cultures of P. putida MAD2 
(pVLT31) and P. putida MAD2 (pVLT31pfkA) were diluted to an OD600 of 0.05 in fresh 
medium (LB medium, tetracycline and IPTG 0.5 mM) and then grown at 30 °C until 
exponential phase (OD600 = 0.5-0.6). PfkA expression was monitored under denaturing 
conditions as follows: cells were harvested by centrifugation (2 min, 13 000 x g) such that 
a cell mass equivalent of 1 ml of culture at an OD600 = 1 was adjusted to disperse in 200 
μl of denaturing loading buffer (63 mM Tris HCl, 10% glycerol, 2% SDS, 2% 
mercaptoethanol, 0.0025% Bromophenol Blue, pH 6.8) and boiled at 100 ºC by 5 min. 
10 μl of cell suspensions were directly loaded into the wells of a denaturing 10% 
polyacrylamide SDS-PAGE system.  
 
4.2. Enzymatic assay for 6-phosphofructokinase activity 
For determination of PfkA activity, crude cell extracts of P. putida MAD2 (pVLT31, as 
negative control), E. coli W3110 (as positive control) and P. putida MAD2 (pVLT31pfkA) 
were prepared from pellets of 50 ml cultures. Cells were harvested in the exponential 
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growth phase (OD600 = 0.5-0.6) by centrifugation (15 min, 4000 × g, 4 °C) and the 
sediments resuspended in Phosphate Buffer Solution 1X (PBS, 1% w/v NaCl, 0.025% 
KCl, 0.18% Na2HPO4, 0.03% KH2PO4) such that a cell mass equivalent of 50 ml of 
culture at an OD600 = 0.8 was adjusted to disperse in 2 ml of PBS. Afterwards, cells were 
lysed by sonication in the cold (5 pulses of 30 sec) and spun down for 30 min at 14,000 
× g to collect cell debris. The supernatant was used for protein determination by 
Bradford analysis (Bradford, 1976) and enzymatic assays for 6-phosphofructokinase 
activity. The enzymatic assays were performed according to the protocol described by 
Steinbuchel et al. (1986) by following the decrease in extinction at 340 nm at 25 °C due 
to NADH consumption during 5 minutes in a 200 μl well plate with the use of a Victor2 
(Perkin Elmer) recording spectrophotometer. 
 
4.3. Enzymatic assays for malic enzyme and pyruvate carboxylase 
activities 
Crude cell extracts for in vitro enzyme assays were prepared from pellets of 50 ml 
cultures as before. Enzymatic assays (Geer et al, 1979; Warren and Tipton, 1974) were 
run with a spectrophotometric method and the results expressed in micromols of 
substrate converted per mg protein per min (U/mg protein). NADP-dependent malic 
enzyme and pyruvate carboxylase were assayed basically as described elsewhere (Geer et 
al, 1979; Warren et al, 1974). Briefly, the increase or decrease in extinction at 340 nm at 
25 °C due to NADPH production or NADH consumption was followed for 10 minutes 
in a 200 μl well-plate with the Victor2 multi-tasking plate reader (Perkin Elmer). For the 
malic enzyme assay a volume equivalent to 25 μg of protein in the cells extracts was 
used. The final concentrations in the reaction mix were 67 mM triethanolamine, 3.3 
mM L-malic acid, 0.3 mM β-nicotinamide adenine dinucleotide phosphate and 5.0 mM 
magnesium chloride. For the pyruvate carboxylase assays, a volume equivalent to 75 μg 
of protein in the cells extracts was used and the final concentrations in the reaction mix 
were 134 mM triethanolamine, 5 mM magnesium sulfate, 7 mM pyruvic acid, 0.12% 
(w/v) bovine serum albumin, 0.23 mM β-nicotinamide adenine dinucleotide (reduced 
form), 0.05 mM acetyl coenzyme A, 2.63 units malic dehydrogenase, 1 mM adenosine 
5'-triphosphate, 15 mM potassium bicarbonate, 0.05% (v/v) glycerol, 0.002 mM 
magnesium acetate, 0.001 mM ethylenediaminetetraacetic acid and 0.05 mM Tris-HCl. 
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5. Cloning, expression and purification of Cra 
 
The DNA sequence encoding the Cra protein of P. putida KT2440 (PP0792) was 
amplified from the chromosome of this bacterium with primers Cra-F and Cra-R (see 
Table 3). The resulting PCR product was digested with NdeI/XhoI and cloned into the 
bacterial expression vector pET28a (see Table 2), which adds six histidines to the N-
terminus of the encoded protein. Note that we included a stop codon (TCA) in the Cra-
R primer inmediatly after of XhoI enzyme sequence to avoid that the vector adds His 
residues in the C-terminus. The resulting plasmid (pET28acra) was transformed into the 
specialized host strain E. coli BL21 (DE3). For expression of the His6-tagged protein, the 
transformed strain was grown at 37 °C in LB to OD600 = 0.5 and added with 0.5 mM of 
IPTG, after which the cultures were grown for 3 more hours. Cells were then harvested 
by centrifugation and the pellets frozen at -80 °C until further use.  
 
For purification, cells were thawed, resuspended in 50 mM sodium phosphate buffer pH 
7.0, 200 mM NaCl (1 ml of culture OD600 = 0.5 in 50 μl), and mechanically lysed using 
a French press (Thermo Electron corporation). Cell debris was removed by 
centrifugation (20 000 x g for 30 min at 4 °C) and the native His6-Cra protein isolated to 
apparent homogeneity from the supernatant of the cell lysate using TALON Metal 
Affinity Resin (Clontech) according to manufacturers' instructions. The resin was 
equilibrated with 20 bed volumes of 50 mM sodium phosphate buffer pH 7.0, 200 mM 
NaCl (equilibration buffer 1X). The clarified sample was passed through the column 
and then washed successively with 10 bed volumes of equilibration buffer 1X, 10 bed 
volumes of equilibration buffer 1X plus 5 mM of imidazol, 10 bed volumes of 
equilibration buffer 1X plus 10 mM of imidazol and finally with 10 bed volumes of 
equilibration buffer 1X plus 20 mM of imidazol. The pure protein elution was done 
with equilibration buffer 1X plus 150 mM of imidazol. 
 
The purified protein was kept in the elution buffer at 4 °C until its utilization as 
indicated in each case. On the other hand, Selenium-methionine (Se/Met)-derivatized 
P. putida Cra was purified as before from cells grown in M9 minimal medium in the 
presence of 0.2% glucose, seleno-methionine and other amendments known to inhibit 
methionine biosynthesis (Van Duyne et al, 1993). All buffers for (Se/Met)-Cra 
purification were supplemented with 5 mM dithiothreitol, but the isolation procedures 
were otherwise identical to those employed for the non-derivatized protein. 
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6. Identification and synthesis of the Cra operator 
 
The reference E. coli consensus sequence for Cra binding sites was retrieved from the 
PRODORIC database (Munch et al, 2003). The resulting DNA motif was then searched 
in the genome of P. putida KT2440 by means of the Virtual Footprint software (version 
3.0; Munch et al, 2005).  One of the identified Cra binding site happened to occur 
within the intergenic and divergent promoter region of the cra/fruBKA 
(5’TTAAACGTTTCA3’) gene cluster (P. putida chromosomal coordinates 908211-
915030). This plausible operator was synthesized as part of a 22 bp double-stranded 
DNA fragment and employed in the mobility shift and isothermal microcalorimetry 
(ITC) assays. The 22-bp DNA fragment used for EMSA with the Cra protein was 
prepared by heating an equimolar (50 nmol) mixture of complementary oligonucleotides 
containing the presumed Cra binding site of the cra/fruBKA promoter region (primers 
cra/fruB-F and cra/fruB-R in Table 3) in 1 ml of TE buffer at 95 °C for 10 min and then 
keeping the annealed product chilled on ice until further use. 
 
7. Non-radioactive electrophoretic mobility shift assays (EMSA) 
 
The Cra-DNA binding reaction was assembled in a final volume of 20 μl containing 2 
μl of TGED binding buffer 10X (final concentrations: 10 mM Tris-HCl pH 8.0, 5% 
vol/vol glycerol, 0.1 mM EDTA, 1 mM dithiothreitol, 20 μg/ml of poly (dI-dC), 200 
μg/ml of bovine serum albumin, 0.75 μM of the Cra-site containing DNA fragment and 
increasing amounts of the pure Cra. Mixtures were incubated for 15 min at 30 °C and 
electrophoresed in a non-denaturing 10% (w/v) polyacrylamide: bisacrylamide gel in 
Tris-glycine buffer 1X pH 8.9. Finally, the gels were stained with ethidium bromide and 
visualized using a Gel Doc XR (Bio-Rad). In the experiments for identification of 
potential effectors, Cra was incubated with the DNA fragment in the presence of 1 mM 
of each of the following compounds: fructose (Fluka, 99% purity), fructose-1-phosphate 
(F1P, Sigma, 100%), fructose-1,6-bisphosphate (FBP, Sigma, 98%), fructose-6-
phosphate (F6P, Sigma, 98%), glucose-6-phosphate (G6P, Sigma, 100% purity) and the 
samples  run in a gel and analyzed as described before. 
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8. Isothermal Titration Microcalorimetry (ITC) 
 
ITC experiments were performed on a VP microcalorimeter (MicroCal, Northampton, 
MA, USA) at 25 °C. Prior to experiments, Cra was thoroughly dialyzed in 25 mM Tris-
HCl, 50 mM NaCl, 1 mM DTT, pH 8.0. After dialysis, protein solution was filtered 
through a 0.45 μm filter and its concentration was determined by UV absorption 
spectroscopy using and extinction coefficient of 1.217 x 105 cm M-1 at 280 nm 
(Gasteiger et al, 2005). Effectors were prepared by diluting pure powdered products in 
filtered dialysis buffer so that the ligand and protein solvent were the same. Each 
titration involved a single 1.6 μl injection and a series of 4.8 μl injections of 250 μM of 
each of the effectors into a 7.5 μM protein solution. For DNA binding studies, the 22-bp 
DNA fragment used in EMSA experiments (see above) was dialyzed so that the DNA 
and protein solvent were the same. In this case, the assays consisted of the injection of 
4.8 μl aliquots of 60 μM DNA into a protein solution of 10 μM. The mean enthalpies 
measured from injection of the ligands into the buffer were subtracted from raw titration 
data prior to data fitting using the one binding site model of the MicroCal version of the 
ORIGIN software. From the curves thus fitted, the parameters ΔH (reaction enthalpy), 
KA (binding constant, KA = 1/KD), and n (reaction stoichiometry) were determined. 
From the values of KA and ΔH, the change in free energy (ΔG) and in entropy (ΔS) were 
calculated with the equation: ΔG = -RT lnKA = ΔH - TΔS, where R is the universal 
molar gas constant and T is the absolute temperature. 
 
9. Analysis of Cra oligomerization state 
 
Analytical ultracentrifugation experiments were performed in a Beckman Optima XL-A 
analytical ultracentrifuge with a UV-visible absorbance detection system. Sedimentation 
velocity measurements were carried out an An50Ti eight-hole rotor in phosphate buffer 
with 150 mM Imidazol, 200 mM NaCl, pH 7.0  (elution buffer in protein purification) 
at 45000 rpm, with 400 ml of protein solution (0.5, 1, and 1.3 mg/ml) in each cell, using 
double sector Epon-charcoal centrepieces. Differential sedimentation coefficient 
distributions c(s) were calculated by least squares boundary modelling of sedimentation 
velocity data using the program SEDFIT (Schuck, 2000, 2004). From this analysis, the 
experimental sedimentation coefficients (s) were corrected for solvent composition and 
temperature to obtain the corresponding standard s-values (s20,W, standard solvent 
conditions: pure water at 20 °C) using the SEDNTERP program (Lebowitz et al, 2002). 
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Partial specific volume of 0.7312 mlg-1 at 20 °C was calculated from the amino acid 
composition (Laue et al, 1992).  
 
Sedimentation equilibrium experiments were performed at 20 °C by centrifugation of 
80 ml samples of Cra at 11000, 13000 and 19000 rpm in the Optima XL-A 
ultracentrifuge. Conservation of mass in the cell was verified in all the experiments. 
After the equilibrium scans a high-speed centrifugation run (45000 rpm) was done to 
estimate the corresponding baseline offsets. Weight-average buoyant molecular weights 
were determined by fitting a single species model to the experimental data using the 
Hetero-Analysis program (Cole, 2004). The absolute molecular weight of Cra potein 
was determined using the partial specific volume  (0.7312 ml g-1) and the solvent density 
(1.0207 mg/ml). In addition, the oligomerization form of P. putida Cra was confirmed by 
size-exclusion chromatography. To this end, a protein solution of 1.0 mg/ml was run 
through a Superdex 200 column (Amersham Biosciences) in 25 mM Tris-HCl, 50 mM 
NaCl, pH 8.0. The molecular weight markers were run under the same conditions. 
Proteins in the eluted fractions were monitored by SDS-PAGE.  
 
10. Cra X-Ray structure 
 
10.1. Cra crystallization 
 The affinity-purified His-tagged Cra protein was concentrated to 15 mg/ml for its 
crystallization.  During concentration, the sample buffer was diluted approximately 50 
times against 25 mM Tris pH 8.0, 50 mM NaCl and 1 mM DTT. This procedure 
allowed a high concentration of the protein and avoided amorphous precipitation while 
simultaneously clearing the samples of the potentially disturbing imidazol left after 
eluting the protein from the metallo-affinity column. Crystals of the native Cra protein 
were then generated from a 15 mg/ml protein sample by the sitting-drop vapor-
diffusion method. Drops were prepared by mixing 150 nl of protein with 150 nl of 
crystallization solution and equilibrated against 100 μL of the crystallization solution in 
Greiner plates.  Crystals appeared after two days in drops prepared with a solution 
containing 15% (w/v) of PEG8000, 0.2 M sodium acetate and 0.1 M MES buffer, pH 
6.5. Seleno-methionine (Se/Met)-derivatized Cra protein was crystallized using identical 
conditions. The resulting crystals were dialyzed against the same solution supplemented 
with 20% glycerol before cryofreezing in liquid nitrogen (see below). For the ligand 
binding experiments, native Cra protein crystals were soaked for 4 to 7 hours in the 
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cryofreezing solution containing 1 mM of each tested candidate effectors (F1P, FBP, 
F6P, G6P and fructose).  
 
10.2. Data collection and structure resolution of Cra  
Datasets from the native, effector-less Cra protein, its (Se/Met)-derivatized variant and 
the ligand-containing complexes F1P and FBP were collected at the European 
Synchrotron Radiation Facility (ESRF, Grenoble) at beamlines ID14-1, ID23-1 and 
ID14-2 (crystals soaked with the F6P, G6P and fructose did not show any diffraction). 
The crystals, which belonged to the space group P21, contained two Cra molecules in 
the asymmetric unit and a solvent content around 43%. Diffraction data was processed 
with XDS (Kabsch, 1993) and scaled with SCALA (Collaborative computational project 
number 4, 1994). The structure of the protein without effector was solved first by the 
SAD method using the Autorickshaw Server (Panjikar et al, 2005) and diffraction data 
extending up to 2.5 Å resolution.   
 
Structure resolution and phasing in the Server was carried out by SHELX programs 
(Sheldrick, 2002). The initial model built by RESOLVE (Terwilliger, 2000) gave R-
factor/R-free values of 22% and 28% respectively.  The model was manually adjusted 
using Coot (Emsley et al, 2010) and refined using PHENIX 1.6-289 (Adams et al, 2010) 
with data up to 2.0 Å resolution to a final R-factor and R-free of 18.4 and 21.8, 
respectively. Crystal structures of the Cra protein in complex with the F1P and FBP 
were determined by the molecular replacement method using the effector-less structure 
and the PHASER program (McCoy et al, 2007), followed by refinement with PHENIX 
1.6-289 (Adams et al, 2010). The structure of the Cra protein prepared by crystal 
soaking with FBP gave an electron density map in the effector-binding site, which was 
indistinguishable from the Cra-F1P complex and therefore has not been included 
separately (not shown).  All residues are in the most favored region (91.7%) or the 
additional allowed regions (7.9%) of the Ramachandran plot, except the effector-
binding Asp148 that lies in a disallowed region in all structures. 
 
11. Measurements of β-Galactosidase activity 
 
 For measuring promoter activity, we used the protocol described by Miller (1972). For 
that, pre-inocula of each strain were grown in mineral minimum medium with fructose, 
glucose or succinate as carbon source. The cultures were diluted to an optical density at 
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600 nm of approximately 0.05 in fresh medium and then grown at 30 °C until 
exponential phase (OD600 = 0.3-0.6). 1 ml of each sample was collected and promoter 
activity was measured by assaying the amount of β-galactosidase in cells made 
permeable with chloroform and sodium dodecyl sulfate. All the enzymatic 
measurements were performed at least with six biological replicates. 
 
12. Measurements of β-Galactosidase activity with the Galacton-Light 
PlusTM system (Applied Biosystems) 
 
 Low β-Galactosidase activity was measured with the extremely sensitive Galacton-Light 
PlusTM system (Applied Biosystems). This protocol quantifies low levels of galactosidase, 
and it is based on a chemiluminescent substrate of the enzyme (Galacton-Plus®, 
Tropix).  In this case, 500 μl of cells (OD600 = 0.3-0.6) were separated of its supernatant 
by centrifugation (14000 x g, 2 min, room temperature) and the cell pellet resuspended 
in 200 μl of lysis buffer (100 mM potassium phosphate pH 7.8, 0.2% Triton X-100). 
The lysis mixture was subjected to two freeze-thaw cycles and finally centrifuged 1 min 
14000 x g at room temperature to eliminate the cell debris. 20 μl of lysed supernatant 
were then incubated for 30 min with 80 μl of reaction buffer (100 mM sodium 
phosphate, pH 8.0, 1 mM MgCl2, 1X Galacton-Plus®). These reactions were run in 
triplicate in 96-well plates and recorded in a luminometer for 30 sec immediately after 
the addition of 125 μl of a light emission accelerator (Accelerator-II Sapphire-IITM) 
following the instructions of the commercial supplier. 
 
13. Sample preparation and processing for native PAGE and western 
blotting 
 
To obtain samples for analysis of PtsN phosphorylation in the native PAGE system, 
preinocula of P. putida KT2440, and mutants, Δcra, ΔptsP, ΔcraΔptsP, containing the 
plasmid pVLT31ptsN_Etag were grown in M9 medium with fructose, glucose or 
succinate with tetracycline and IPTG 0.5 mM. The cultures were diluted to an OD600 of 
0.05 in fresh medium and then grown at 30 °C until exponential phase (OD600 = 0.4-
0.6). The cells were then harvested by centrifugation (2 min, 14000 x g, 4 °C) and the 
pellets resuspended in a non-denaturing loading buffer (10% glycerol, 40 mM glycine, 5 
mM Tris, pH 8.9, and 0.005% w/v bromphenol blue) such that a cell mass equivalent 
of 1 ml of culture at an OD600 of 1.0 was adjusted to disperse in 200 μl of the native 
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loading buffer. 10 μl of such intact cell suspensions were directly loaded into the wells of 
the non-denaturing gel system (Pfluger et al, 2007a; Pfluger et al, 2007b) as was described 
previously. The non-denaturing gel electrophoresis system consisted of a 10% 
polyacrylamide gel [10% v/v acrylamide/bis-acrylamide solution (29:1) polymerized 
with 0.05% v/v TEMED and 0.05% ammonium persulfate in 1X running buffer (200 
mM glycine, 25 mM Tris, pH = 8.9)] and casted in a mini-Protean gel box (Bio-Rad). 
Electrophoresis was carried out with a fixed current of 12.5 mA/gel (8.5 cm, W x H) at 
4 ºC for 35 min. The proteins were transferred onto a polyvinylidene difluoride 
membrane (Immobilon-P, Millipore) using a semidry transfer apparatus (Bio-Rad) as 
was described previously (Jurado et al. 2002). The anti-E-tag monoclonal antibody 
(MAb)-peroxidase (POD) conjugate (Amersham Pharmacia Biotech) was applied for 
luminescent detection of the PtsN-E-tag fusion proteins (Jurado et al. 2002). 
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CHAPTER 1 
 
Central carbon metabolism and its interplay with PTS systems 
in P. putida* 
 
*  Manuscripts in preparation: 
Max Chavarría, Tobias Fuhrer, Danilo Perez, Javier Tamames, Uwe Sauer & Víctor de 
Lorenzo. (2011) An atypical metabolic cycle formed by Embden-Meyerhoff-Parnas and Entner-
Doudoroff enzymes empowers Pseudomonas putida to endure environmental stress.  
Max Chavarría, Roelco J. Kleijn, Uwe Sauer, Víctor de Lorenzo & Katharina Pfluger-Grau. 
(2011) The regulatory duties of the phosphotransferase system (PTSNtr) on Central carbon 
Metabolism of Pseudomonas putida. 
________________________________ 
 
1. Central carbon metabolism in P. putida 
 
1.1. Pathways involved in glucose and fructose degradation 
Due to comprehensive reasons, the central carbon metabolism (see Fig. 1) was divided 
in this Thesis into the upper metabolism, comprising the degradation of the internalized 
sugar to C3 components via the ED pathway, the PP pathway, or the EMP pathway, 
and the lower metabolism, formed by the PEP-Pyr-OAA node and the TCA cycle. By 
evaluating the first module (upper metabolism), we can obtain information about 
metabolic steps, which bacteria use to degrade the main sugars. This is not trivial as 
different microorganisms use diverse catabolic pathways for sugar consumption, which 
reflects the phylogeny and evolution of each bacterium. Regarding the carbon source, 
major differences in the upper metabolism can be observed as represented by the net 
fluxes (Fig. 6). These are relative values and represent the estimated fluxes normalized to 
the amount of carbon source taken up. When P. putida was grown on glucose, 96% of 
this carbon source was degraded via the ED pathway to pyruvate, only about 4% was 
degraded via the PP pathway and no activity of EMP pathway was observed (Fig. 6). 
When cells were grown on fructose, the ED pathway was still the major carbon 
degradation pathway, with 52% of the fructose being degraded via this pathway. 
However, about 34% of the internalized fructose is degraded via the energetically more 
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favourable EMP pathway. The rest is degraded via the PP pathway.  
 
 
 
 
 
 
 
 
 
 
Figure 6. Pathway activity for catabolism of (a) glucose and (b) fructose in P. 
putida. % activity in y-axis are represented by the net fluxes calculated by metabolic flux 
analysis of P. putida MAD2 strain. 
 
Therefore, metabolic flux analysis of sugar catabolism in the environmental bacterium 
P. putida showed that the ED pathway is the most prevalent route in the upper central 
metabolism. Using radioactivity experiments with 14-C in P. putida, P. aeruginosa, and P. 
stutzeri Sawyer et al. (1977)  reported similar results regarding the pathways involved in 
degradation of glucose and fructose.  
 
1.2. ED pathway is essential for glucose catabolism in P. putida 
Following our studies about the carbon central metabolism, we investigated whether P. 
putida was able to grow with glucose as substrate using a metabolic pathway distinct 
from ED pathway. This would allow us to understand the importance of the ED 
pathway in the physiology and regulation of other processes. Therefore, we set to study 
the physiological and metabolic impact of redirecting the metabolism of this bacterium 
from the ED pathway towards EMP pathway. Using a metabolic engineering approach, 
we expressed the PfkA enzyme (the missing metabolic enzyme of EMP pathway in P. 
putida) from E. coli in a wild type P. putida strain as well as its eda mutant (mutant unable 
to use the ED pathway). The enzyme was successfully expressed and remained active in 
cell extracts of P. putida (Figs. 7a and 7b). However, growth experiments in which 
glucose was the only substrate revealed that the eda pfkA+ strain was unable to grow on 
this carbon source suggesting that the PfkA enzyme cannot completely switch the 
carbon flux into EMP pathway (Fig. 7c). This key observation suggests that the ED 
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pathway is essential for glucose degradation in P. putida. Futhermore, it suggests that a 
functional EMP pathway cannot be established in the metabolic network of P. putida to 
replace the ED pathway for glucose degradation simply by overexpressing PfkA from E. 
coli. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Expression of the PfkA enzyme in P. putida. (a) SDS gel stained with 
Coomassie showing the expression of E. coli PfkA (34.8 KDa) in P. putida. Lane1- MAD2 
(pVLT31); Lane 2- MAD2 (pVLT31pfkA) –IPTG; Lane 3- MAD2 (pVLT31pfkA) +IPTG. 
(b) Enzymatic assays for 6-phosphofructokinase in E. coli W3110 (green), MAD2 (pVLT31) 
(red) and MAD2 (pVLT31pfkA) +IPTG (blue). PfkA enzyme was successfully expressed and 
remained active in cell extracts of P. putida. (c) Growth experiments with glucose as the only 
substrate revealed that eda pfkA+ strain is unable to grow in this carbon source and therefore 
the PfkA enzyme cannot switch the carbon flux into EMP pathway. 
 
Surprisingly, the expression of PfkA in the wild type strain had a strong negative effect 
in bacterial growth (Fig. 8). Growth comparison of wild type and pfkA+ showed that the 
cell growth decreased dramatically with the PfkA expression in all substrates tested 
(glucose, fructose, and succinate; Fig. 8). The negative effect of the PfkA in P. putida is 
intriguing because based on current metabolic models (Nogales et al, 2008; Puchalka et 
al, 2008), it is accepted that this enzyme should cooperate at least partially to the 
degradation of hexoses, increasing the metabolic efficiency to catabolize these carbon 
sources (Baart et al, 2010). The negative impact on growth can be ordered as follows: 
fructose > glucose ≈ succinate. The effect in fructose-grown cells is particularly dramatic 
(Fig. 8c).  
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Figure 8. Growth experiments of P. putida MAD2 (pVLT31, red) and MAD2 
(pVLT31pfkA) strains in absence (blue) and presence (green) of IPTG with (a) 
succinate (b) glucose and (c) fructose as the only carbon substrate.  Growth 
experiments were performed in liquid (left panel) and solid (right panel) media. These 
experiments showed that when PfkA was expressed in P. putida (pfkA+ in presence of IPTG) 
the cell growth was reduced in all the tested carbon sources.  The impact on growth can be 
ordered as follows: fructose > glucose ≈ succinate where the effect in fructose-grown cells is 
the most drastic.  
 
Knock-in of pfkA in P. putida apparently unbalances the metabolic network thus affecting 
the primary biological functions involved in biomass production. Since these 
observations cannot be explained using existing metabolic models for P. putida, we 
examined in depth the upper central metabolism in this bacterium through a 
metabolomic approach. 
 
1.3. Metabolomic analyses suggest a cyclic operation of the ED pathway in 
P. putida  
In order to better understand the central metabolism in P. putida, we quantified 
concentrations of key metabolites when the bacterium was grown on three different 
carbon sources (Fig. 9): glucose, fructose, (glycolytic conditions) and succinate 
RESULTS, CHAPTER 1 
65 
(gluconeogenic conditions). In glucose we observed the highest concentrations of glucose 
6-phosphate (G6P) and 6-phosphogluconate (6PG), 1167 ± 128 and 2300 ± 1178 μM 
respectively, as expected from metabolic models. This evidence indicates that P. putida 
channels the glucose directly to G6P (del Castillo et al, 2007), which is transformed to 
6PG through glucose-6-phosphate dehydrogenase (Zwf). Subsequently this product is 
catabolized by ED pathway via the Eda/Edd enzymes (Fuhrer et al, 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Concentrations of intracellular metabolites in P. putida wild type 
measured by HPLC-MS on succinate (green column), glucose (yellow column) 
and fructose (red column) cultures. Metabolome data showed that in all the 
conditions, metabolites of upper metabolism are produced in micromolar concentrations. 
The metabolic measurements support the occurrence of a cyclic ED pathway, where triose 
phosphates are recycled to FBP/F6P/G6P/6PG. Metabolite concentrations were expressed 
in micromols in the intracellular volume. 
 
Alternatively, other authors (Schleissner et al, 1997) have suggested that glucose could be 
converted extracellularly to gluconate and degraded through the ED pathway. Our 
current results cannot distinguish which of these convergent pheripheral pathways is 
preferred for glucose uptake in this bacterium. In any case, G6P and 6PG 
concentrations indicate the preference of the ED pathway in glucose degradation over 
EMP pathway, which is in agreement with our results obtained through metabolic flux 
analysis. According to the literature, Zwf/Edd/Eda enzymes carry out irreversible 
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reactions (Conway, 1992) for C6 sugar conversion to pyruvate (Pyr) and glyceraldehyde 
3-phosphate (GA3P). After these biochemical steps, most P. putida metabolic models 
(Nogales et al, 2008; Puchalka et al, 2008) consider that triose phosphates are mainly 
directed towards the TCA cycle (lower metabolism, Fig. 1) in order to produce ATP, 
amino acids and other building blocks necessary for the synthesis of macromolecules.  
However, our metabolomic analysis in combination with enzymatic activity information 
provide a new vision of central metabolism in P. putida, since it can be deduced that an 
important fraction of triose phosphates are recycled to DHAP/FBP/F6P/G6P via the 
gluconeogenic enzymes glyceraldehyde 3-phosphate dehydrogenase (Gap), triose 
phosphate isomerase (TpiA), fructose bisphosphate aldolase (Fda), fructose-1,6-
bisphosphatase (Fbp) and glucose phosphate isomerase (Pgi). The quantification of 
significant concentrations of DHAP, FBP, and F6P in glucose (3107 ± 1002, 275 ± 31 
and 77 ± 8 μM respectively; Fig. 9) allows us to entertain about the presence of an 
operative cycle in the metabolic core formed by the enzymes Gap, TpiA, Fda, Fbp, Pgi, 
Zwf, Pgl, Edd, and Eda, which are capable of recycling triose phosphates to 
phosphorylate hexoses. The possibility that these metabolites (DHAP, FBP and F6P) 
would be formed from the EMP pathway is discarded by the absence of any 6-
phosphofructokinase as discussed in the Introduction.  
 
Metabolic data in fructose and succinate allowed us to come to similar conclusions 
about the direction of the carbon flux in the central metabolism of P. putida. In fructose 
as substrate we observed the highest levels of FBP (Fig. 9). This value is consistent with 
the pheripheral pathway reported for this carbon source in P. putida; involving the 
phosphoenolpyruvate PEP:phosphotransferase system, PTSFru system (Velazquez et al, 
2007), encoded by fruBKA where the fructose is phosphorylated to F1P and subsequently 
diphosphorylated to FBP. On the other hand, the presence of significant FBP levels 
when using glucose and succinate as substrates suggest that this compound is generated 
by Fda via the proposed cyclic ED pathway. 
According to current metabolic models (Nogales et al, 2008; Puchalka et al, 2008), 
fructose can be degraded through EMP pathway since this sugar enters this pathway 
directly to FBP by the action of FruBKA and consequently does not require 6-
phosphofructokinase.  However, the detected levels on fructose of F6P (44 ± 7 µM), 
G6P (887 ± 188 µM), and 6PG (1425 ± 8 µM) suggest that this substrate is degraded 
mainly through the ED pathway, which is consistent with our fluxomic data and 
previous reports (Van Dijken and Quayle, 1977). The preference of P. putida to use the 
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ED pathway for fructose metabolization is intriguing since that option is energetically 
less efficient than EMP pathway. Alas, when grown on fructose as carbon source, 
metabolomic data cannot distinguish whether the concentrations of DHAP are 
produced by glycolytic activity or the proposed cyclic ED pathway. On the other hand, 
the measured levels on succinate of FBP (60 ± 24 µM), F6P (76 ± 8 µM), G6P (710 ± 
169 µM), and 6PG (440 ± 86 µM) indicates that bacteria can reconstruct the entire 
metabolic network in gluconeogenic conditions, thus synthesizing the compounds of the 
upper metabolism. Quantification of these metabolites on succinate shows how important 
it is for the cell the formation of the intermediaries from upper metabolism in P. putida. 
 
1.4. A cyclic ED pathway is needed under glycolytic and gluconeogenic 
conditions 
The occurrence of a cyclic ED pathway in P. putida is strongly suggested by metabolomic 
data; however an open question is how essential is the operativity of this cycle for the 
bacterium under different metabolic conditions. In order to answer this standing 
question we tested the growth in different substrates (glucose, fructose, and succinate) of 
different P. putida mutants bearing inactivated versions of enzymes belonging to the 
proposed cyclic ED pathway, namely Eda, Edd, Zwf-1, Pgi, Gnd, and TpiA (Fig. 10). 
 
 
 
 
 
 
 
 
 
Figure 10. Growth experiments of P. putida wild type, pgi (PP1808), pgi 
(PP4701), tpiA, eda, edd, gnd and zwf-1 mutants on (a) glucose, (b) fructose 
and (c) succinate as the only carbon source. Experiments illustrate how the 
formation of the cyclic ED pathway is physiologically important for cells in glycolytic and 
gluconeogenic conditions.  
 
The results showed that the tpiA mutant was unable to grow in all tested conditions, 
which suggested that the recycling of triose phosphates to hexoses is physiologically 
important for the cell in all conditions. On the other hand, zwf-1 strain grew in all the 
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carbon sources but this result would be explained by the existence of two other glucose 
6-phosphate dehydrogenase encoding genes, zwf-2 (PP4042) and zwf-3 (PP5351) in P. 
putida which can be functionally redundant. A similar situation occurs in mutants of 
glucose 6-phophate isomerase (PP1808 and PP4701) since both enzymes can 
complement its activity respectively. Assessing the real effect of blocking the operation of 
the cyclic ED by zwf and pgi products is hampered by the gene redundancy. 
 
On the other hand, eda mutant is unable to grow on fructose and glucose but it grows 
normally on succinate. A detailed analysis of carbon flux based on gene annotation and 
reversibility reported for each reaction indicates that the eda mutant is able to generate 
the whole set of metabolites constituting the cycle in succinate. GA3P, DHAP, FBP, 
F6P, G6P and 6PG are produced by gluconeogenic activity as was shown for the wild 
type strain (Fig. 9). It should be noted that the eda mutant is unable to transform the 
2K3D6P to GA3P and Pyr to complete the ED cycle. We think that in eda mutant this 
reaction is not essential since GA3P and Pyr are supplied through gluconeogenic 
activity. Particulary, the absence of growth in fructose is interesting in this mutant. P. 
putida could degrade this pentose using the EMP pathway. However, the bacterium is 
unable to grow. One explanation for this observation was given by Vicente and 
Canovas (1973). They suggested that the eda mutant accumulates 2K3D6P at levels that 
could become toxic on fructose as carbon source. The edd mutant can support this 
hypothesis since it is unable to grow in glucose, but is able to grow well in fructose and 
succinate. It seems that in absence of any accumulation of 2K3D6P, the EMP pathway 
can be used by P. putida for fructose degradation. 
 
Finally, we included a gnd mutant in the growth experiments, which can provide 
information about the carbon flux through the pentoses pathway via G6P. This mutant 
was able to grow in all the conditions tested, which indicates that this reaction is not 
essential for growth. These experiments with gnd mutant (Fig. 10) correlate well with our 
fluxomic (Fig. 6) and metabolomic (Fig. 9) data, since they show that the input to the PP 
pathway through 6PG is low. While our results can ensure that the production of PP 
metabolites via 6PG is low, we can not exclude that part of the demand of C5 
metabolites is produced via GA3P and F6P. 
 
It was not possible to evaluate the phenotype of mutants in other genes encoding 
enzymes of the cycle such as pgl, fda or fbp since they are not available. It should be 
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noted that several attempts to obtain an fbp mutant in P. putida were unsuccessful 
probably indicating an essential role for viability, as it has been suggested for P. aeruginosa 
(Banerjee, 1989). On the other hand, previous studies in P. aeruginosa have showed that a 
mutant lacking Fda is able to grow on fructose but not on other carbon sources such as 
glucose, gluconate or succinate (Banerjee et al, 1985). In this case, the way in which the 
fructose enters to the central metabolism in the cell allows the fda mutant to form all 
metabolites constituting the cyclic ED.  Taken together, all the results about the growth 
on different c-sources, it can be concluded that biosynthesis of the metabolites of the 
cycle:  DHAP, FBP, F6P and G6P is essential for P. putida. 
 
1.5. PfkA expression produces a futile cycle in central metabolism that 
wastes ATP 
 In light of metabolomics and growth data of P. putida mutants we could argue that upper 
metabolism in P. putida is carried out cyclically. With this idea in mind, we can interpret 
the drastic reduction in the biomass formation when PfkA enzyme was expressed in this 
bacterium. PfkA expression catalyzes the opossite reaction (F6PFBP) than the innate 
carbon flow (FBPF6P) in the cyclic ED pathway, which gives rise to a futile cycle in 
the central metabolism. As mentioned above, it seems that the more drastic effect on 
growth is observed with fructose as carbon source, which can be explained by the 
proximity of the futile cycle to the imput of the fructose into central metabolism 
(Fructose  FBP via FruBKA). This futile cycle is also produced on glucose and 
succinate, but the impact on growth is lower because it does not affect the early 
metabolic steps for these carbon sources. To demonstrate the existence of a futile cycle 
between the FBP and PfkA we determined the concentrations of ATP in the wt and 
pfkA+ strains on glucose and fructose (Fig. 11).  As can be observed, the expression of 
PfkA decreased the pool of ATP in the cell, what is consistent with a waste of ATP by 
the proposed futile cycle. 
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Figure 11. Determination of ATP in P. putida MAD2 in absence and presence 
of PfkA enzyme. Experiments were performed in P. putida MAD2 (pVLT31); MAD2 
(pVLT31pfkA) in absence of presence of IPTG 0.5 mM with fructose (orange columns) and 
glucose (green columns) as carbon source. Expression of PfkA enzyme reduces the ATP 
pool in P. putida. ATP concentrations were normalized to Cellular Dry Weight (CDW) and 
expressed in nmols of ATP per milligram of CDW. 
 
2. The regulatory duties of the PTSNtr system on the central carbon 
metabolism of P. putida 
 
As it was mentioned in the Introduction, P. putida KT2440 possesses, like many other 
bacteria one branch of the phosphotransferase system that is not related to sugar 
transport, but fulfils various regulatory functions. Recently, we showed that the non-
phosphorylated form of one of its proteins, PtsN, directly downregulates the pyruvate 
dehydrogenase (PDH) activity, an enzymatic complex responsible for the 
decarboxylation of pyruvate to acetyl-CoA, thereby linking glycolysis to the TCA cycle 
(Pfluger-Grau et al, 2011). On this background, we set out to clarify a possible regulatory 
role of the PTSNtr in the central carbon metabolism in this bacterium, as some of the 
phenotypes described above could be consistent with an alteration in the central 
metabolism (Velazquez et al, 2007). To this end, we analyzed the metabolic fluxes of 
isogenic strains bearing non-polar directed mutations in each of the corresponding pts 
genes.  
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2.1. Physiological parameters for growth on different carbon sources  
In order to analyze the influence of the PTSNtr on the central carbon metabolism we 
compared the metabolic fluxes of cells grown on a non-PTS sugar (glucose) to cells 
grown on a PTS sugar (fructose) in several pts mutants. As a first step, the physiological 
parameters of the two growth conditions were determined in P. putida MAD2 and PTS 
mutants (Table 4 and 5) in batch cultures.  
 
Table 4. Growth physiology in glucose 
 
 
Strain 
Maximum specific 
growth rate (µ) [h-1] 
Biomass yield on 
glucose (YX/G) 
[gCDW/gglucose] 
Specific glucose 
consumption rate (qglc) 
[mmolglc/gbiomassh] 
MAD2 0.25 ± 0.01 0.28 ± 0.03 4.79 ± 0.38 
fruB 0.30 ± 0.02 0.29 ± 0.04 4.75 ± 0.43 
ptsO 0.30 ± 0.01 0.32 ± 0.02 4.86 ± 0.32 
ptsP 0.32 ± 0.03 0.29 ± 0.01 4.90 ±0.43 
ptsN 0.23 ± 0.01 0.25 ± 0.04 4.20 ± 0.25 
ptsN/ptsO 0.21 ± 0.01 0.31 ± 0.03 4.10 ± 0.11 
ptsP/fruB 0.27 ± 0.02 0.31 ± 0.02 4.38 ± 0.10 
 
Table 5. Growth physiology in fructose 
 
 
Strain 
Maximum specific 
growth rate (µ) [h-1] 
Biomass yield on 
fructose (YX/F) 
[gCDW/gfructose] 
Specific fructose 
consumption rate (qFrc) 
[mmolFrc/gbiomassh] 
MAD2 0.15 ± 0.05 0.47 ± 0.01 0.85± 0.04 
fruB -- -- -- 
ptsO 0.12 ± 0.03 0.55 ± 0.01 0.96 ± 0.03 
ptsP 0.13 ±  0.02 0.47 ± 0.03 0.80 ± 0.03 
ptsN 0.09 ± 0.04 0.49 ± 0.09 0.87 ± 0.02 
ptsN/ptsO 0.11 ± 0.03 0.45 ± 0.01 0.90  ± 0.01 
ptsP/FruB -- -- -- 
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We observed 60% reduced growth rate in wild type cells grown on fructose compared to 
growth on glucose. The final biomass concentration reached however, was comparable 
between the two growth conditions (1.9 ± 0.09 mg/ml culture on glucose and 1.8 ± 0.08 
mg/ml culture on fructose). The lower growth rate observed with fructose comes along 
with a lower rate of fructose uptake into the cells. Cells grown on fructose internalized 
0.75 mmol fructose per g biomass per hour, whereas cells grown of glucose consumed 
the sugar more than 6 fold faster (4.79 mmol glucose per g biomass per hour). However, 
growth on fructose seems to be energetically more efficient as reflected by the biomass 
yield per g sugar consumed. Whereas cells grown on glucose reached 0.28 g CDW 
(cellular dry weight) per g glucose consumed, cells grown on fructose have a 1.6-fold 
higher yield (0.47 g CDW/g fructose). Thus, taken together, the non-PTS sugar is 
degraded more rapidly, but less efficiently than the PTS sugar, a phenomenon that 
suggests differences in the metabolic fluxes in the central carbon metabolism.  
 
2.2. Metabolic flux analysis of PTS mutants 
Analysis of the flux ratios of the upper metabolism (Fig. 12, serine derived from the 
EMP pathway and pyruvate derived from the ED pathway) revealed that mutation of 
any of the pts genes had no significant influence on the upper pathway, of course with 
the exception of fruB mutations, as these mutants are no longer able to grow on fructose 
(Velazquez et al, 2007). 
 
An interesting picture emerges by analyzing the fluxes around the PEP-Pyr-OAA node 
in the pts mutants (oxaloacetate derived from pyruvate and pyruvate derived from 
malate). The first striking result is that the only mutation that seems to have a significant 
influence on the fluxes of the central carbon metabolism is the disruption of ptsN, as seen 
with the ptsN or the ptsN/ptsO mutant. Therefore, the following analysis is focused these 
mutants. Both mutants showed higher fluxes in the reactions of the pyruvate shunt (see 
Figs. 13 and 14, from malate to pyruvate to OAA), independent of the carbon source 
used. This can be seen in both the flux ratios (Fig. 12) and even better in the net fluxes 
(Figs. 13 and 14). 
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                                                       Glucose                 Fructose 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Metabolic flux ratios obtained by METAFoR analysis of 
experiments with 100% [1-13C]glucose (or 100% [1-13C]fructose), 20% [U-
13C]glucose (or 20% [U-13C]fructose), and 80% naturally labelled glucose (or 
fructose). The data represent the flux ratios (fraction of total pool) for all the pts mutants 
grown on either glucose (blue) or fructose (red) as carbon source. Flux ratios are shown for 
serine derived from the EMP pathway, pyruvate derived from the ED pathway, 
oxaloacetate derived from pyruvate, pyruvate derived from malate (upper and lower bond), 
and phosphoenolpyruvate derived from oxaloacetate. For fruB and double mutant fruB/ptsP 
no values are shown growing on fructose, as fruB mutants are unable to grow on fructose. 
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Figure 13. Metabolic net fluxes in the P. putida MAD2 reference strain, ptsN 
and ptsN/ptsO mutants on glucose as carbon source. Flux values were normalized 
to the specific glucose uptake rate (shown in the green box). Values shown represent the 
mean of two independent experiments and the errors indicate their standard deviation. For 
clarity reasons only the fluxes for the ptsN and the ptsN/ptsO mutants are shown. Metabolic 
net fluxes for ptsO, and ptsP mutants were omitted, as they do not differ significantly in 
respect to wild type strain. Note the increased net fluxes for ptsN and ptsN/ptsO mutants in 
the pyruvate shunt (yellow boxes). 
 
The presentation of the data as net fluxes allows an easy and reliable comparison 
between various strains grown under the same conditions, because data are normalized 
to hexose/pentose consumption rates. For the sake of clarity we present in Fig. 13 and 
14 only the values for the wild type strain, the ptsN and the ptsN/ptsO mutants. The flux 
from pyruvate to OAA catalyzed by the pyruvate carboxylase increased in the ptsN 
mutant 1.2-fold (1.4-fold for ptsN/ptsO mutant) on glucose and 1.4-fold (1.5-fold for 
ptsN/ptsO mutant) on fructose. The flux from malate to pyruvate catalyzed by the malic 
enzyme increased in the ptsN mutant 1.6-fold (2.3-fold for ptsN/ptsO mutant) on glucose 
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and 1.5-fold (1.7-fold for ptsN/ptsO mutant) on fructose. Thus, the loss of the PtsN 
protein leads on average to a 1.6-fold increase in the carbon fluxes of the reactions of 
the pyruvate shunt, independently of the carbon source used.  Statistical analysis (t-test) 
showed that differences between the wild type strain and mutants ptsN, ptsN/ptsO are all 
significant at a confidence level of 95% with the exception of the differences observed in 
the single ptsN mutant on glucose. However, similarly to the double mutant ptsN/ptsO on 
glucose, the single mutant ptsN is the only strain where these fluxes are higher than wild 
type strain.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Metabolic net fluxes in the P. putida MAD2 reference strain, ptsN 
and ptsN/ptsO mutants on fructose as carbon source. Flux values were 
normalized to the specific fructose uptake rate (shown in the green box). Values shown 
represent the mean of two independent experiments and the errors indicate their standard 
deviation. For the sake of clarity only the fluxes for the ptsN and the ptsN/ptsO mutants are 
shown. Metabolic net fluxes for ptsO, and ptsP mutants were omitted, as they do not differ 
significantly in respect to wild type strain. Note the increased net fluxes for ptsN and 
ptsN/ptsO mutants in the pyruvate shunt (yellow boxes).  
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The fluxomic analysis revealed significantly higher fluxes in the reactions of the 
pyruvate shunt, which bypasses malate dehydrogenase in the TCA cycle. The pyruvate 
shunt is a metabolic futile cycle and it comprises the reactions from malate to pyruvate 
catalized by the malic enzyme and from pyruvate to oxaloacetate by the pyruvate 
carboxylase. In the P. putida chromosome the malic enzyme is encoded by maeB 
(PP_5085) and the pyruvate carboxylase by accC-2 (PP_5347) and oadA (PP_5346). Some 
bacteria, e.g. P. aeruginosa, possess two malic enzymes that differ in cofactor preference 
(NAD+ or NADP+-dependent; Eyzaguirre et al, 1973). In P. putida however, we could 
only find one gene encoding a putative malic enzyme and obtained measurable 
enzymatic values only assaying the NADP-dependent but not the NAD-dependent 
activity (at least in vitro, Fig 15). Therefore, P. putida seems to have only one malic 
enzyme encoded by maeB (PP_5085). As a next step, we analyzed whether the higher 
fluxes in the ptsN mutants in the shunt can be traced to higher activities of the 
corresponding enzymes. Thus, cell free extracts of P. putida MAD2, ptsN and ptsN/ptsO 
were prepared from cultures grown on glucose or fructose, respectively, and assayed for 
activity of the pyruvate shunt enzymes (Fig. 16).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Enzymatic assay for NADP dependent-malic enzyme (blue) and 
NAD dependent malic enzyme (green) in P. putida wild type strain. As can be 
observed, enzyme activity was obtained only when the cofactor was NADP which suggests 
that the enzyme MaeB (PP_5085)  is NADP-dependent. A blank of the assay (red) was 
performed with all the components of the enzymatic reaction but lacking proteins.  
 
The activity of the malic enzyme was about 1.4-fold higher in PtsN-less cell extracts with 
no apparent influence of the presence/absence of PtsO and independent of the carbon 
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source. These data reflect well the estimated fluxes. When measuring the specific activity 
of the pyruvate carboxylase, a similar result was obtained (Fig. 16b). In cell extracts of P. 
putida ptsN and ptsN/ptsO the enzyme showed higher activity as compared to the wild 
type, and again, this was independent of the carbon source and the presence of PtsO.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Enzyme activities in crude cell extracts for pyruvate shunt enzymes 
(a) malic enzyme and (b) pyruvate carboxylase of the P. putida MAD2 
reference strain, ptsN and ptsN/ptsO mutants. The enzymatic activities were 
measured on glucose and fructose as carbon source and the data are show in Units per 
milligram of protein (U/mg protein). Given values represent the mean of three independent 
experiments and the error bars indicate their standard deviation. 
 
In a next step, we wondered whether the regulation exerted by PtsN on the pyruvate 
shunt depend of its phosphoprylation state. To clarify this issue we analyzed the malic 
enzyme activity  in two P. putida MAD2 strains altogether isogenic to the wild-type but 
bearing each an allele of ptsN with changes in the triplet corresponding to the 
phosphorylable position H68 of the EIIANtr protein (Pfluger-Grau et al, 2011). In one 
case (ptsNHA), the encoded product had a HisxAla substitution that prevented any 
phosphorylation and thus locked PtsN in a form devoid of any phospho-histidine 
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(Pfluger and de Lorenzo, 2007). In the other case (ptsNHE), the same H68 codon was 
changed from His to Glu. The addition of a negative charge in the position formerly 
occupied by a phosphorylable histidine is generally considered to lock the protein in a 
form that resembles the phosphorylated species (Wittekind et al, 1989). The difference is 
that such a charge cannot be transferred further to another destination. This genetic 
approach allows to differentiate the effects of PtsN owing to its phosphorylation state. 
The results are shown in Fig. 17. No significant differences in enzyme activity were 
observed between the wild type and mutants ptsNHA, ptsNHE, suggesting that the 
regulation exerted by PtsN occurs independently of its phosphorylation state.  
 
   
 
 
 
 
 
 
 
 
Figure 17. Malic enzyme activity in crude cell extracts of the P. putida MAD2 
reference strain, ptsN, ptsN/ptsO, ptsNHA and ptsNHE mutants. The 
enzymatic activities were measured on glucose and fructose as carbon source and the data 
are show in Units per milligram of protein (U/mg protein). Given values represent the 
mean of three independent experiments and the error bars indicate the standard deviation 
of these independent experiments. 
 
Thus, PtsN seems to downpregulate the activity of the pyruvate shunt enzymes 
regardless of its phosphorylation state, in a process that depends only on the 
presence/absence of the protein. Whether this phenomenon is based on direct 
interactions between the participating proteins or is a secondary result of carbon flux 
redistribution cannot be answered with the present data and will be the subject of 
further investigations. 
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CHAPTER 2 
 
The Catabolite repressor activator (Cra) regulator from 
Pseudomonas putida and its interplay with the PTSFru system: in 
vitro studies* 
 
 
* This chapter was published as: 
Max Chavarría, César Santiago, Raúl Platero, Tino Krell, José M. Casasnovas & Víctor de 
Lorenzo. Fructose 1-Phosphate is the preferred effector of the metabolic regulator Cra of 
Pseudomonas putida.    J. Biol. Chem. (2011) 286, 9351-9359. 
________________________________ 
 
 
1. Identification, cloning and purification of the Cra protein of P.  putida 
 
The genome of P. putida bears an ORF for a protein (PP0792) of 331 amino acid 
residues (coordinates 909206-908211) and 38.4 KDa MW that shares 74% similarity 
and 48% identity with the E. coli Cra protein (Fig. 18). This identity goes up to 70% in 
the predicted DNA binding domain of the proteins, suggesting that the target genomic 
sequences ought to be similar (if not identical) as well. All this criteria qualifies PP0792 
as a bona fide orthologue of the reference enterobacterial counterpart. Yet, unlike E. coli 
and S. typhimurium, the craP. putida variant maps adjacent and divergently oriented to the 
fruBKA operon (Figs. 19 and 21). 
 
This gene cluster encodes proteins for phosphorylation and transport of fructose 
(Velazquez et al, 2007) through the phosphoenol pyruvate phosphotransferase 
carbohydrate system of P. putida (Velazquez et al, 2007; PTSFru). Because of this 
proximity, PP0792 was formerly annotated as FruR, not as Cra (Nelson et al, 2002). To 
ensure the functional assignment, the craP. putida sequence was amplified, added with a 
metallo-affinity His6-tag and the protein purified to apparent homogeneity as explained 
in the Materials and Methods section (Fig. 20).  
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Figure 18. Alignment of Cra proteins from E. coli, S. typhimurium and P. 
putida KT2440. The P. putida Cra protein has 74% similarity and 48% identity with the 
E. coli counterpart. Identity increases to 70% in the predicted DNA binding domain of the 
proteins. The DNA binding module is located in the N-terminal side and it is formed by the 
first 57 aminoacids of the proteins (indicated with a black line). Amino acids that form the 
effector-binding pocket are marked with black boxes. Note that 85% of the amino acids 
that form the pocket of the P. putida protein are identical, and 100% of them are similar in 
respect to those of E. coli and S. typhimurium. The only changes are the Phe220 (Tyr in E. coli) 
and Tyr 248 (Phe in E. coli). The alignment and the conservation score were performed 
with PRALINE software (Simossis and Heringa, 2005). The scoring ranks (consistency 
values) from 0 for the least conserved alignment position, up to 10 for the most conserved 
alignment position. 
 
RESULTS, CHAPTER 2 
81 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. Organization of the fructose operon in bacteria.  Comparison of 
genomic organization of the fructose operon revealed differences between species, e.g. 
position and orientation of the fruBKA operon with respect to the regulator Cra (FruR). 
Duplicate fru genes are not infrequent. Note similarities in the organization of the operon of 
E. coli and S. typhimurium, and their difference in respect to Pseudomonas. Color code: fruB in 
green, fruA in red, fruK in yellow and cra (fruR) in blue. Other genes found in or adjacent to 
the fru operon are shown as empty boxes. 
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Figure 20. Expression and purification of the Cra protein of P. putida. (a) 
Expression test. A high expression level of Cra (38.4 KDa) from the expression vector 
was triggered by the addition of 0.5 mM of isopropyl-β-D-thiogalactoside (IPTG) followed 
by induction for a further 3 h. (b) Solubility test. Cell pellets were resuspended in 
50 mM sodium phosphate buffer pH 7.0, 200 mM and mechanically lysed using a French 
press. Then, cell debris were removed by centrifugation. Note that the majority of Cra 
protein remains in the soluble phase. T = total proteins (before lysis); S = soluble phase; I = 
insoluble phase (cell debris). (c) Protein purification. The native His6-Cra protein 
isolated from the lysis supernatant was purified using a TALON Metal Affinity Resin 
(Clontech). The pure protein elution was done with equilibration buffer 1X plus 150 mM of 
Imidazol as was described in materials and methods section. FT = Flow through. 
 
2. Analysis of the regulatory region of fructose operon of P. putida 
 
Analysis of the intergenic region (Fig. 21b) revealed the presence of a motif (5’-
TTAAACGTTTCA-3’) with a high score to the consensus binding site for the Cra 
regulator of E. coli and S. typhimurium (Fig. 21a; Negre et al, 1996; Ramseier et al, 1993; 
Shimada et al, 2005). To examine whether such a sequence was in fact the operator of 
CraP. putida, a 22 bp double-stranded DNA fragment containing the candidate target was 
synthesized and employed in the mobility shift assay shown in Figure 22.  
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Figure 21. E. coli Cra binding consensus sequence and regulatory region of 
the fructose operon of P. putida. (a) The E. coli consensus sequence for Cra binding 
site was retrieved from the PRODORIC database (Munch et al, 2003). This sequence forms 
an incomplete palindrome in which the left half-site is considerably better conserved than 
the right half-site. (b) The regulatory region of the fruBKA operon in P. putida was analyzed 
and one single operator was identified as shown. The sequence TTAAACGTTTCA (in 
red) corresponds to the palindromic Cra-binding motif, whereas the black boxes show the 
putative -35/-10 promoter region upstream of the fruBKA operon.  
 
The results indicated the formation of one specific complex between the DNA and the 
CraP. putida, the abundance of which increased with Cra concentration (Fig. 22a). The 
molar ratio at which the DNA band disappeared entirely from the gel grossly 
corresponded to DNA:Cra 1:2. These results verified the interaction of the protein with 
its predicted binding site within the cra/fruBKA promoter region and laid the basis for 
determination of key parameters as explained below. 
 
3. The Cra regulator of P. putida is a dimeric protein 
 
The oligomerization state of the purified CraP. putida was determined by means of 
analytical ultracentrifugation experiments. The sedimentation profile (Fig. 23a) showed 
the occurrence of one main species to 3.9S with S20,W of 4.8 ± 0.1 (frictional ratio f/f0 = 
1.35), which accounted for 88-94% of the observed molecules and which was 
compatible with a dimeric form of the protein. The sedimentation equilibrium results 
(data not shown) predicted a mass value of 72.4 ± 6.0 KDa, which was slightly lower 
than the theoretical mass for the dimeric form of the protein. But taken together, the 
velocity and equilibrium sedimentation results indicated that Cra existed mainly as a 
dimer in solution at the concentrations used. The protein oligomerization state was 
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confirmed by size-exclusion chromatography (Fig. 23b), in which one main peak of 
approximately 60-80 KDa (i.e. a dimer) was followed by much less abundant species, 
tailing between the 21-50 KDa markers (i.e., a monomer). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. Non-radioactive electrophoretic mobility shift assays (EMSA) of 
Cra and its binding site in the intergenic cra/fruBKA region of P. putida. (a) 
EMSA experiment with increasing concentrations of pure Cra protein. Molar ratios 
DNA:Cra were 1:0 (lane 1), 1:0.5 (lane 2); 1:1 (lane 3), 1:2 (lane 4), 1:4 (lane 5) and 1:8 (lane 
6). (b) Cra effector identification. DNA (0.75 µM) was incubated with pure protein (1.5 
µM) in the presence of 1 mM of different metabolites: F1P (lane 3), FBP (lane 4), F6P (lane 
5), G6P (lane 6) and fructose (lane 7). Lanes 1 and 2 correspond to DNA in the absence and 
presence of Cra respectively, without any added metabolite. Note that only F1P prevents 
the binding of the protein to DNA. 
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Figure 23. Oligomerization state of the Cra protein of P. putida. (a) Distribution 
of sedimentation coefficient population c(s) against s, obtained by sedimentation velocity 
experiments. The experiments were performed with 0.5, 1 and 1.3 mg/ml of pure Cra 
protein. The sedimentation profile was dominated by a species of 3.9S, accounting for 88-
94% of the observed molecules, followed by a small peak at 2.4S (2.3-8.9%). The 
predominant species with sedimentation coefficient of 3.9S, was corrected to S20,w, using the 
viscosity value of the solution (measured in a viscometer Anton Paar AMVn). The corrected 
sedimentation coefficient was 4.8S which is compatible with a globular dimer of the protein. 
Equilibrium sedimentation experiments predicted that the dominant peak has a molecular 
mass of 72.4 ± 6.0 KDa. (b) Gel filtration. The oligomerization form of P. putida Cra was 
confirmed by size-exclusion chromatography as shown. The main peak of 60-80 KDa is 
consistent with a dimeric species, while the minor tail of 21-50 KDa surely corresponds to 
residual monomeric species. The chromatogram shows the superposition of two differents 
runs: Cra alone (red line) and standard proteins used as weight marker (black line). The 
proteins in the elution fractions were monitored by SDS-PAGE (not shown). Molecular 
weight markers were run under the same conditions. 1: chymotrypsin (21 KDa), 2: albumin 
(50 KDa), 3: BSA (70 KDa), 4: Ab (170 KDa), 5: Dextran. 
 
4. Cra strongly binds its single operator in the cra/fruBKA region of P. 
putida 
 
The interaction parameters of the CraP. putida protein with the operator DNA found 
within the fruBKA promoter segment (Fig. 21b) were examined by means of isothermal 
titration microcalorimetry. The corresponding results are shown in Fig. 24a.  
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Figure 24. ITC assays with Cra, effectors and DNA. The upper panels plot raw 
data from representative ITC experiments, while the lower panels show the fitted curves of 
the same results, but integrated and corrected for dilution. (a) Titration of Cra protein with 
DNA in absence and presence of F1P. Positive peaks represent an endothermic event. Note 
that no interaction between Cra and the DNA is detected in the presence of F1P. (b-d) 
Titration of Cra protein with FBP, G6P, fructose, glucose and F1P. Note that only the 
titration with F1P produces a heat change in the experiment. In all the cases, F1P was 
added after each titration as positive control. Negative peaks are indicative of an 
exothermic event. The sigmoidal shape of the binding curve allows determination of the 
protein-effector stoichiometry, which corresponds to the molar ratio (x-axis in lower panel) 
at the point of inflexion of the curve. In this case, such molar ratio was 1:1; indicating that 
one molecule (calculated: 1.06 ± 0.06 molecules) of F1P interacts with one molecule of Cra 
monomer.  
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Note that in the upper panel peaks go upwards, which indicates that the binding of Cra 
to DNA is an endothermic process (∆H = 7.66 ± 0.09 kcal/mol). Since enthalpy 
changes are unfavorable, binding ought to be entirely entropy-driven (T∆S = 17.68 ± 
0.15 kcal/mol, ∆G = -10.02 ± 0.10 kcal/mol). This situation is not infrequent, as the 
binding of proteins to DNA is often endothermic but also fostered by the positive 
entropic effect of the displacement of DNA-bound water molecules (Krell et al, 2007). 
Subsequent calculations allowed us to determine a protein-DNA dissociation constant 
(KD) of 26.3 ± 3.1 nM that reflects a very strong interaction and which likely enables 
CraP. putida to exert a considerable repression on expression of the fruBKA genes. 
 
5. Surveying metabolic intermediates as CraP. putida effector candidates 
 
In order to shed light on the nature of Cra effector(s), DNA samples were incubated 
with pure Cra protein in the presence of different metabolites and submitted to EMSA 
experiments as before -except for the addition of candidate molecules to the binding 
mixtures prior to loading the gel. The chemical species that were listed as possible Cra 
inducers able to release its strong binding to DNA included fructose, F1P, FBP, F6P, 
and G6P. The EMSA experiments shown in Fig. 22b (lanes 3-7) indicated that only F1P 
was able to prevent binding of the repressor to the fruBKA regulatory region (Fig. 21b) 
confirming this metabolite as the effector of Cra. These experiments, however, did not 
altogether rule out that other small molecules could interact with the target protein with 
a weaker strength unable to withstand the conditions of the EMSA test. Furthermore, 
the gel of Fig. 22b revealed the persistence of a fraction of the Cra-DNA complex that 
did form even in the presence of F1P (Fig. 22b, lane 3). To clarify these ambiguities, we 
again resorted to the ITC technology described before. First, we ran isothermal titration 
experiments with purified Cra and the various candidate effectors as the interaction 
partners (Figs. 24b-d). The results shown in Fig. 23b indicated that binding of F1P to 
Cra was both enthalpy-driven (∆H = -5.94 ± 0.39 kcal/mol) and entropy-driven (T∆S = 
3.16 ± 0.4 kcal/mol), producing a total free energy change (∆G) of -9.10 ± 0.06 
kcal/mol. Favourable (negative) enthalpy changes can be attributed to bond formation 
between F1P and amino acids in the cognate binding site, whereas favorable (positive) 
entropy changes are generally caused by the ligand-induced release into the medium of 
otherwise bound water, thereby increasing the disorder (entropy) of the system. Further 
calculations revealed not only an apparent stoichiometry of 1.06 ± 0.06 molecules of 
F1P per Cra monomer, but also demonstrated a high protein-effector affinity (KD = 209 
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± 20 nM). It is noteworthy that this affinity value is significantly higher than the 
corresponding figures for other transcriptional regulators of the GalR-LacI family. For 
instance, the KD of IPTG binding to LacI is 2.8 µM (Wilson et al, 2005), that of 2-
ketogluconate to PtxS, 15 µM (Daddaoua et al, 2010), and so on. ITC experiments also 
demonstrated without a doubt that Cra had no affinity, even residual for other 
metabolites. Specifically, the test run with FBP as a Cra effector-to-be (Fig. 24b) did not 
produce the slightest indication of interaction. The same was true for other candidate 
effectors e.g. G6P, glucose and fructose (Figs. 24c and 24d), indicating that the repressor 
is highly selective for F1P. Finally, to clarify whether some residual Cra-DNA complex 
could still be formed in the presence of F1P, a mixture of Cra and F1P was incubated 
with the same target DNA employed above for the repressor-operator binding 
experiments. The resulting ITC curves (Fig. 24a) confirmed that the Cra-F1P complex 
was altogether unable to bind DNA. This set of data rules out that high concentrations 
of FBP formed intracellularly during certain physiological conditions could act as a 
physiological effector of Cra. Instead, the effects of FBP as an inducer of this repressor 
reported in the literature (Bledig et al, 1996; Kotte et al, 2010) could be the result of its 
chemical or enzymatic conversion into F1P.  
 
6. Cra crystallization and structure resolution 
 
While the results above confirmed the nature of F1P as Cra effector, they did not 
discount that the effector-binding site of the repressor could accommodate other thus far 
unidentified metabolites. To shed light on this possibility, we set out to determine the 
tridimensional structure of such a pocket in both the effector-less and the effector-bound 
Cra structure by X-ray crystallography.  The protein was crystallized as described in 
Materials and methods. SDS-PAGE of extensively washed crystals showed a single, 
sharp band of ~30 kDa for the crystallized sample, smaller than the theoretical size of 
38 kDa. This suggested precise excision of an ~8 kDa fragment from the main protein 
body during the crystallization process (see below). MALDI-TOFF analysis of the 
truncated protein produced a predominant peak of 30.4 kDa, confirming the previous 
data (Fig. 25). 
 
Proteolytic removal of non structured or unstable polypeptides often help the 
crystallization of the rest of the protein core (Wernimont and Edwards, 2009). This 
appeared to be our case, because the occurrence of such a cleavage during the 
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concentration and crystallization of Cra was ultimately beneficial: crystals were obtained 
that belonged to the P21 space group, contained two Cra molecules in the asymmetric 
unit and did diffract to a resolution of 2 Å (see Table 6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25. MALDI-TOFF analysis of Cra crystals. Mass spectrometry analysis of the 
truncated protein produced a predominant peak of 30.4 kDa. This suggested precise 
excision of an ~8 kDa fragment from the main protein body during the crystallization 
process. 
 
The structure of the Cra protein was determined for both the effector-free and the F1P-
bound forms, in which last case crystals were soaked in a solution containing 1 mM 
concentration of the metabolite (see Materials and Methods). The corresponding 3D 
architectures are shown in Fig. 26a. Note that the dimers of the effector-less Cra and its 
F1P-bound counterpart were very similar, with a root mean square deviation (rmsd) of 
0.48 Å for 270 residues. Note also that expectedly the crystal structure lacks the leading 
N-terminal 59 amino acid residues. As mentioned above, this deletion is irrelevant (if 
not beneficial) for our purpose, because the missing segment includes the DNA-binding 
domain and a short linker, but leaves intact the effector-binding site of the protein. 
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Table 6. Data Collection and Refinement Statistics of Se-Met derivatized protein and 
Cra with its effector. 
 
Data collection Se/Met Cra Cra/F1P 
Space group P21 P21 
Wavelength 0.97925 (peak) 0.933 
Cell dimensions     
    a, b, c (Å) 37.3, 118.5, 61.8 37.7, 120.2, 61.8 
    a, b, g  (°) 90, 107.1, 90 90, 107.4, 90 
Resolution (Å) 59-2.0 60-2.3 
Highest resolution bin 2.1-2.0 2.42-2.3 
No. of unique reflections 34595 (5011) 23340 (3381) 
Multiplicity 7.4 (7.4) 3.4 (3.4) 
Completeness (%) 99.8 (99.8) 99.8 (100) 
Rsym or Rmerge 8.3 (40) 5.0 (35.8) 
I / s(I) 5.6 (1.7) 12.6 (2.2) 
B-factor Wilson (Å2) 28 42 
Refinement statistics   
Resolution (Å) 15.0-2.0 15.0-2.3 
Rwork / Rfree 18.4/21.8 18.4/22.1 
Reflections (Rfree) 66122 (3320) 22057 (1130) 
No. of atoms   
    Protein 4193 4186 
    Ligand 12 32 
    Water 175 107 
B-factors   
    Protein A/B 41/40 50/51 
    Ligand C/D 37/58 30/34 
    Water 41 41 
R.m.s deviations   
    Bond lengths (Å) 0.003 0.003 
    Bond angles (°) 0.71 0.843 
Ramachandran plota 91.7/7.9/0/0.4 87.9/11.5/0.2/0.4 
*Highest-resolution shell is shown in parentheses. aPercentage of residues in most favored regions, allowed 
regions, generously allowed regions and disfavored regions, respectively. 
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Figure 26. Crystal structure of Cra in complex with F1P. (a) Ribbon 
representation of the crystal structure of the regulatory subdomain of Cra in complex with 
its ligand F1P. β-strands are colored in magenta, helixes in cyan, 310 helixes in red and 
loops in orange. F1P is shown with sticks representation and the carbons in yellow, 
phosphorus in orange and oxygens in red.  The N and C terminus are marked with lower 
case letters and the secondary structure elements with upper case. The N-regulatory 
subdomain consists of strand A (63 to 68), helix I (74 to 89), strand B (93 to 98), helix II (103 
to 115), strand C (120-123), helix III (133 to 139), strand D (144 to 147), strand E (157 to 
164), helix X (293 to 310), and strand K (316 to 320). The C-regulatory subdomain is 
composed of helix IV (163 to 175), strand F (181to 187), helix V (192 to 204), strand G (211 
to 217), helix VI (222 to 236), strand H (242 to 245), helix VII (239 to 248), helix VIII (263 
to 265), strand I (269 to 273), helix IX (277 to 280), strand J (286 to 290) and strand L (323 
to 325). (b) Stereo view of the superimposed regulatory domains of Cra from P. putida 
colored in red and from E. coli (PDB accession code: 2IKS) in blue. A lateral view of a Cα 
representation of the structures is shown. 
 
As shown in Figure 26a, both Cra monomers are related by a pseudo two-fold axis and 
share an interface surface of 1700 Å2 per monomer. The N-terminal regulatory 
subdomain (N-RSD) comprising residues from Thr63 to Ser161 and from His293 to 
Val320, specifically α helices I and II and β strand B (Fig. 26a), contributes most of the 
interactions to form the dimer: residues from this region are implicated in 12 salt 
bridges and 80% of the hydrogen bonds between domains. In contrast, the C-terminal 
regulatory subdomain (C-RSD; residues Asp163-Ala290 and Tre323-Lys325) 
contributes only with 6 hydrogen bonds to the interaction through helices VII and IX 
(Fig. 26a). Structural comparisons using the DALI server (Holm and Rosenstrom, 2010) 
gave a top solution with a Z score of 33 and a sequence identity of 44% with the 
fructose repressor (Cra/FruR) of E. coli deposited in the RCSB database (PDB 
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accession code: 2IKS), but not yet published. Structural comparison is shown in Fig. 
26b. The folds observed in both proteins were close to the domain organization of 
other members of the family such as LacI (Lewis et al, 1996) and PurR (Schumacher et 
al, 1994). These were defined by a central parallel β-sheet formed by six β strands (A-E 
and K) surrounded by four α helices (I-III and X) for N-RSD, and a parallel β sheet 
composed of four β strands (G-I), an antiparallel β sheet with two β strands (J and L) 
with four α helices (IV-VII) and two 310 helices (VIII and IX) for C-RSD.  
 
7. Geometry of the Cra inducer-binding pocket 
 
The F1P molecule could be coherently fitted in the electronic density maps obtained 
after refinement of the structures determined for the crystal soaked in F1P (Fig. 27). 
Yet, an attempt was made to generate an additional complex between FBP (instead of 
F1P) and Cra by soaking effector-less protein crystals in a 1 mM solution of this 
metabolite as above. The structures obtained from crystals exposed to F1P and FBP 
were virtually identical, with a rmsd for their superposition in the range of 0.45 Å. But 
once the structure of the putative FBP-Cra complex was inspected, it was found that 
the molecule occupying the effector site was no other than F1P. These results suggested 
that it was the residual F1P present in the nominally 98% pure FBP preparation (see 
Materials and Methods) what the protein recognized as sole interaction partner. That 
such selective binding to F1P happens even in the presence of large excess of FBP 
confirms the very high affinity for the first, consistently detected with the other 
procedures described above.  
 
The cavity where F1P molecules bind Cra is formed by portions of the N-RSD and C-
RSD subdomains (Fig. 26a), at the inter-module cleft. Incubation of Cra native crystals 
with 1 mM F1P for one hour was enough to obtain an equimolecular 1:1 association of 
the ligand to each domain present in the asymmetric unit of the crystals. The F1P 
molecule fitted to perfection the electron density map of the cognate protein cavity 
determined in the absence of the effector (Fig. 27b). The F1P molecule has a solvent 
accessible area of 372 Å2, which is completely buried by contacts with the interacting 
protein residues and solvent molecules.  
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Fig. 27. Detail of the interaction between Cra and F1P. (a) Stick representation of 
F1P and FBP with the same code color as in Fig. 26a. (b) Drawing of the Cra effector 
binding with a bound F1P molecule coordinated to residues of the binding pocket. The 
electron density map (Fo-Fc) determined in the absence of the F1P molecule is represented 
as a green mesh at a 3.5 σ contour level. Protein residues are shown with carbons in grey, 
oxygens in red and nitrogens in blue. Hydrogen bonds are represented as dashed red lines 
and water molecules are shown as red spheres. (c) Ligplot scheme of the F1P interaction 
with Cra (Wallace et al, 1995). The color code is as in panel b. Carbon atoms are colored in 
black and atoms involved in hydrophobic interactions are represented by red arcs with 
spokes radiating towards the interacting atom. 
 
Interactions occur with polar and aromatic residues in that cavity through direct 
hydrogen bonds with residues Tyr76, Ser75, Asn73 and Asp148 of the N-terminal 
regulatory subdomain (N-RSD), as well as Arg149, Arg197, Ser247 and Tyr248 of the 
C-terminal regulatory subdomain (C-RSD; Figs. 27b and 27c). Moreover, two residues 
(Gln291 and Gln322) of the hinge regions connecting both domains contribute with two 
extra direct hydrogen bonds to the interactions. In addition, water-mediated hydrogen 
bonds connect F1P with Asn73 and Asp101 of N-RSD and Asp275 and Gln291 of C-
RSD. Hydrophobic interactions also play a role in the strong affinity and specificity of 
Cra for F1P. These involve the furanose ring of the effector, which sits between the side 
chains of Tyr76 (part of Ser75 and Asp148) and Phe220. These amino acids provide not 
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less than 5 interactions that trap the sugar ring between two hydrophobic surfaces. The 
dense constellation of interactions between F1P and Cra shown in Fig. 27 creates a 
degree of specificity that is unlikely to be matched with any other known metabolite of 
either E. coli or P. putida. Moreover, modeling of the FBP molecule (Fig. 28) based on the 
bound F1P ligand showed that the addition of one phosphate at the Fru C6 would 
locate this chemical group at ~3.5 and 2.0 Å of Asp70 and Asp101 respectively, and 
quite close (< 3 Å) to Pro69, i.e a non-favorable environment for the second phosphate 
group. This features may explain the lack of FBP binding. The Asp and Pro residues are 
conserved in E. coli Cra protein suggesting the same architecture for the inducer-binding 
pocket. The lack of diffraction observed with crystal soaked with other ligands may 
indicate extensive unspecific interactions with the protein, which can alter the molecule 
packing in the crystals, thereby impeding crystal diffraction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 28. Modeling of binding of FBP to Cra inducer-binding pocket. The model 
based on F1P binding showed that residues near to the binding pocket would produce a 
non-favorable environment for the second phosphate Group at the Fru C6. 
 
In conclusion, we showed that Cra binds to the regulatory region of the fructose operon 
in P. putida. Moreover, we have also extensively characterized the regulator and its 
effector. In the next Chapter we will show the regulation exerted by Cra on PTSFru by 
means of in vivo experiments and we examine whether the regulatory effects  can be 
extended to the PTSNtr through the cross talk between both systems. 
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CHAPTER 3 
 
Regulation of the catabolite repressor activator (Cra) protein on 
PTS  systems of Pseudomonas putida: in vivo studies* 
 
 
*Manuscript in preparation 
Max Chavarría, Tobias Fuhrer, Uwe Sauer, Katharina Pfluger-Grau and Víctor de 
Lorenzo. (2011). Regulation of Cra on the PTS systems and the central carbon metabolism from 
Pseudomonas putida.  
________________________________ 
 
1. Cra expression in P. putida 
 
In order to examine whether the carbon source affects the expression of the regulator, 
we started by measuring the activity of the Cra promoter. In first instance, expression of 
cra promoter was evaluated using the classical β-galactosidase protocol (Miller, 1972), 
however, values less than 50 U Miller were obtained (not shown). This result is coherent 
since it is known that the expression of many transcriptional factors is generally very 
low. Therefore, to properly measure the activity of Cra promoter, we resorted to the 
highly sensitive β-Galacto-Light PlusTM system (Applied Biosystems). Analysis of Cra 
promoter activity in mid-exponential phase revealed that the regulator is expressed in all 
the tested conditions (fructose, glucose and succinate), expression on fructose being 
slightly lower (Fig. 29). That less Cra protein is produced on fructose it is coherent, since 
the effector of the regulator (F1P) is produced via PTSFru system in this condition, so in 
the presence of this metabolite most of Cra molecules are unattached to  the DNA 
(catabolic derepression). Therefore, regulatory functions of the protein are deactivated 
in this condition and additional synthesis of the regulator is not required.  
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Figure 29. Activity of cra promoter in P. putida KT2440 as measured by 
translational fusions to lacZ gene in plasmid pMCH2. Cra promoter activity  
measurements in wild type strain (purple) revealed that the regulator is expressed similarly 
at low levels in glycolitic and gluconeogenic conditions. The regulador seems to be 
produced in lower amounts on fructose than glucose and succinate. A schematic diagram is 
shown of the cra′-′lacZ gene fusion fragment in plasmid pMCH2. The negative control 
corresponds to P. putida KT2440 electroporated with pMCH3 (empty vector, red). 
 
2. Expression and activity of the fructose operon in P. putida 
 
2.1. Expression levels of fructose operon in different conditions 
Expression of the fructose operon in P. putida KT2440 was measured with a fruB′-′lacZ  
translational fusion in plasmid pMCH1 using the classical β-galactosidase protocol in 
different conditions (fructose, glucose and succinate, Fig. 30). As expected the highest 
levels of expression were obtained on fructose as carbon source.  Surprisingly, on 
glucose the activity level albert low was 10 times higher than on succinate (23 ± 8 vs 2 ± 
1 U Miller). This interesting observation will be studied in depth in the next section. It 
should be noted that in vivo metabolic measurements of FBP and F1P (Fig. 31) were 
consistent with our gene expression data since the highest levels of both metabolites 
were obtained on fructose as carbon source (FructoseF1PFBP via fruBKA). As was 
mentioned in Chapter 1 the presence of significant FBP levels on glucose and succinate 
can be explained by the presence of the discussed cyclic ED pathway. On the other 
hand, presence of low amounts of F1P on glucose and succinate (see Fig. 31) is 
intriguing since to the best of our knowledge, there are not known enzymes for 
producing F1P during growth on other carbon source than fructose.  
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Figure 30.  fruBKA promoter activity in P. putida as measured by 
translational fusions to lacZ gene in plasmid pMCH1.  As expected the highest  
PTSFru activity levels were measured on fructose as carbon source (545 ± 56 U Miller). On 
the other hand, PTSFru system expression was very low on glucose (23 ± 8 U Miller) and 
succinate (2 ± 1 U Miller). A schematic diagram is shown of the fruB′-′lacZ gene fusion 
fragment in plasmid pMCH1. The negative control corresponds to P. putida KT2440 
electroporated with pMCH3  (empty vector, red). 
 
 
 
 
 
 
 
 
 
 
 
Figure 31.  In vivo concentrations of F1P and FBP in P. putida.  F1P and FBP 
were measured in P. putida by HPLC-MS on succinate (black), glucose (orange) and fructose 
(purple). Highest levels of F1P and FBP were detected on fructose where PTSFru is active.  
Fructose intake is performed by FruAB to produce F1P and then this compound is 
transformed to FBP by FruK. 
 
But, for the most part, the results of gene expression and metabolic data allow us to 
conclude that the PTSFru system is expressed only on fructose where the extracellular 
sugar is phosphorylated to F1P and subsequently phosphorylated again to generate FBP. 
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2.2. Activity of PTSFru system on glucose as carbon source is due to 
inherent fructose contamination on glucose preparations 
From β-galactosidase activity measurements a higher activity of the fructose operon 
promoter on glucose (23 ± 8 U Miller) was noticeable with respect to succinate (2 ± 1 U 
miller). This observation was reproducible not only with the Miller protocol (Fig. 30) but 
also with the protocol based on chemiobioluminescence (Fig. 32b). This higher activity 
of fructose operon could explain previous observations made in our laboratory 
suggesting that FruB is active during growth on glucose and is able to phosphorylate 
PtsN in this condition (for details see section 4 in this Chapter). The notion that FruB 
can phosphorylate to PtsN  on glucose is quite surprising and not trivial. We hypothesize 
two possible explanations for this phenomenon: [i] that glucose preparations could be 
contaminated with small amounts of fructose that can activate the system or [ii] that 
that the glycolitic activity in P. putida may be enough to derepress fruB expression, i.e., 
that FBP or other glycolytic metabolite could be transformed to F1P by an unknown 
enzyme. To adress these possibilities, first we constructed a fruB mutant, which is unable 
to transport fructose as carbon source (Fig. 32a). If fructose is present in the medium as 
a contaminant the sugar is unable to enter the cell in this mutant. We measured the 
expression of the operon in fruB strain as well in wild type strain with the β-Galacto-
Light PlusTM system (Fig. 32b) which is more reliable for measuring low amounts of β-
galactosidase. 
 
As can be observed in Figure 32b, promoter activity decreased in the ΔfruB strain to 
same levels on glucose as the wild strain on succinate, suggesting that the higher activity 
of the fruBKA operon on glucose with respect to succinate is due to the contamination of 
this sugar with fructose. However, it is still surprising that small amounts of fructose in 
presence of a preferential carbon source such as glucose may increase ten times the 
promoter activity in respect to the baseline. To clarify this observation we measured the 
promoter activity on glucose (10 mM, 99.5% purity, SIGMA) with increasing 
concentrations of fructose in the culture medium (0, 10 μM and 100 μM). These very 
low concentrations of fructose are equivalent to mixtures of glucose:fructose of  99.9:0.1 
and 99:1 respectively.  
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Figure 32.  Growth and fructose operon promoter activity of P. putida fruB 
mutant.  (a) Growth of P. putida KT2440 (purple) and ΔfruB mutante (orange) in 
minimum medium with fructose as the only carbon source. (b) Expression of fructose 
operon in wild type strain and ΔfruB mutant on succinate (green) and glucose (purple) as 
carbon sources. Experiments were performed with β-Galacto-Light PlusTM system. A 
schematic diagram is shown of the fruB′-′lacZ gene fusion fragment in plasmid pMCH1. 
The negative control corresponds to P. putida KT2440 electroporated with pMCH3 plasmid 
(empty vector). 
 
 
Results (Fig. 33) showed clearly that very low concentrations of fructose in the medium 
are enough to activate the expression of the fructose operon. Therefore, the small 
quantities of F1P that are produced due to fructose contamination are recognized by 
Cra, leading to slight derepression of the system. This observation is consistent with our 
in vitro studies of Chapter 2 in which we demonstrated the high affinity of the regulator 
by F1P. In contrast, the activity of the fructose operon promoter in fruB strain remains 
unchanged, due to the inability of the strain to internalize fructose and increase the 
intracellular concentrations of F1P. 
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Figure 33.  Activity of fructose operon promoter in P. putida KT2440 (purple) 
and fruB mutant (green) on glucose 10 mM (0.2%) with increasing 
concentrations of fructose. Experiments were performed with the β-Galacto-Light 
PlusTM system. Note that the activity of the fructose operon in ΔfruB strain is not 
significantly altered by the addition of fructose in the medium. A schematic diagram is 
shown of the fruB′-′lacZ gene fusion fragment in plasmid pMCH1. The negative control 
corresponds to P. putida KT2440 electroporated with pMCH3 plasmid (empty vector, red). 
 
 
3.  In vivo regulation of fructose operon by Cra protein 
 
In a next step for understanding in depth the regulation of the PTSFru system in P. putida 
we monitored the fruBKA promoter activity in several conditions in a strain in which the 
regulator Cra has been deleted (Δcra). The results are shown in the Figure 34, where it 
can be observed that in all the carbon sources the activity of the fructose operon in the 
mutant was higher that in the wild type strain. It is even possible to observe these 
differences in solid medium (Fig. 34b). These observations verified  that Cra is a 
repressor of the fructose operon in P. putida. The promoter activity data revealed that 
the derepression on succinate is very strong: lacZ  activity increased two hundred times 
in the cra mutant with respect to wild type strain, while on glucose the promoter activity 
in the cra mutant was increased only 6 times. It is plausible that when P. putida grows on 
glucose as the sole carbon source the PTSFru system is repressed by another thus far 
unknown factor that is expressed mainly in glycolytic conditions. On the other hand, on 
RESULTS, CHAPTER 3 
101 
fructose, the activity of the promoter in the mutant was only 1.4 times higher with 
respect to the wild type strain. This is an expected result since F1P is generated in this 
carbon source (see Figure 31). Therefore, in this conditions most (but not all) molecules 
of Cra are linked to the effector thereby making the PTSFru system to be derepressed in 
the wild type strain since the regulator is unable to bind to the operator. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34.  Activity of fructose operon promoter in P. putida KT2440 (purple) 
and cra mutant (green). (a) Experiments in liquid medium showed that deletion of the 
transcriptional regulator Cra derepress the activity of fructose operon in all the tested 
conditions. A schematic diagram is shown of the fruB′-′lacZ gene fusion fragment in plasmid 
pMCH1. The negative control corresponds to P. putida KT2440 electroporated with 
pMCH3 plasmid (empty vector, red). (b) Experiments in solid medium with the carbon 
sources indicated and Xgal displayed the same behavior that liquid experiments. 
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4. Cra regulates indirectly the phosphorylation state of PtsN 
 
Under certain metabolic conditions an in vivo cross talk between the two PTS systems 
found in P. putida can be observed (Pfluger and de Lorenzo, 2008), so that the FruB 
protein can transfer the phosphoryl group to proteins PtsO or PtsN. With these previous 
observations, we wondered whether the nitrogen PTS system can be regulated indirectly 
via the PTSFru system by Cra. To address this question we monitored the 
phosphorylation state of the protein PtsN in the wild type strain, and the mutants Δcra, 
ΔptsP and ΔcraΔptsP using the protocol developed in our laboratory previously (Pfluger 
and de Lorenzo, 2007) and described in Materials and Methods. ΔptsP and ΔcraΔptsP 
strains were used since the phosphorylation cascade of the nitrogen PTS system is 
interrupted in these mutants, this allows us to monitor the ratio PtsN/PtsN∼P under 
conditions where the phosphate would be transferred to the PtsN protein only by FruB 
(see Figure 35).  
 
 
 
 
 
 
 
 
 
 
Figure. 35. Monitoring non-phosphorylated vs. phosphorylated PtsN share in 
P. putida cells grown in different carbon sources. Cells were grown at 30 ºC in 
mineral M9 medium amended with 0.2% (w/v) of fructose, glucose or succinate and 
analyzed in a native PAGE system. Results from duplicate experiments are shown for each 
of the mutants indicated transformed with pVLTptsN_Etag. The position of each of the 
PtsN protein species is marked to the right side.  
 
Our results (Fig. 35) showed that the PtsN/PtsN∼P ratio in wild type strain and Δcra 
mutant was identical in all the tested conditions. We concluded, that the regulatory 
effect of Cra on PtsN via FruB can not be determined properly (at least with this 
method) in these strains because most of the phosphate of PtsN comes from PtsP/PtsO. 
In contrast, the phosphorylation state of PtsN in strains which have blocked the 
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phosphorylation cascade in PTSNtr system (ΔptsP and ΔcraΔptsP) accredit the regulation 
of Cra on the fruB expression, whose encoged products transfer phosphate to PtsN. As 
can be seen in the Figure 35, differences in the phosphorylation of PtsN on fructose 
were not observed between the single and double mutants (lines 5, 6 vs 7, 8), since the 
amount of FruB is enough in both strains in this condition to phosphorylate PtsN. This 
observation is in agreement with our results of gene expression (Fig. 34). On the other 
hand, on glucose (Figure 35) was observed in the ΔptsP mutant (lines 5, 6) a distribution 
~50:50 of phosphorylated/dephosphorylated protein, while in the ΔcraΔptsP mutant 
(lines 7, 8) was observed that virtually all protein is found in phosphorylated form. The 
50% of PtsN~P in ΔptsP is in agreement with the conclusions of the section 2.2 of this 
Chapter re.,  fruB expression on glucose due to the contamination of the carbon source 
with fructose. Thus, the amount of FruB expressed on glucose was sufficient to 
phosphorylate partially to PtsN. As expected, when the PTSFru system was derepressed 
(ΔcraΔptsP, lines 7, 8) the amount of FruB increases and therefore PtsN appears only in 
phosphorylate form. Similar conclusions about the regulation of Cra and its effect on 
PtsN could be achieved on succinate. In this carbon source, changes in the 
phosphorylation state are more dramatic because, as shown in the Figure 35, the whole 
protein remains in the dephosphorylated form in the ptsP mutant (lines 5, 6) while 
deletion of the regulator (ΔcraΔptsP) derepressed the system and the whole protein is 
found in the phosphorylated form. According to data on phosphorylation levels, we 
conclude that Cra modulates the phosphorylation state of PtsN and thus, Cra would be 
considered as a fine tuning regulator of PTSNtr system in P. putida. 
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1. Analysis of glucose and fructose catabolism in P. putida 
 
The measured distribution of catabolic fluxes for glucose and fructose fits well with 
qualitative observations made in various Laboratories since the late 1970s, on glucose, 
fructose, and gluconate metabolism in P. putida (del Castillo et al, 2007; Lessie and 
Phibbs, 1984; Sawyer et al, 1977; Vicente and Canovas, 1973a, b). Glucose is almost 
exclusively metabolized through the ED pathway, and only a very small fraction of 
about 4% enters into the PP pathway. In the ED pathway, glucose gets phosphorylated 
to glucose-6-phosphate, which is then converted into 6-phosphogluconate and 
eventually into 2-dehydro-3-deoxygluconate phosphate. This intermediate is then split 
into pyruvate and glyceraldehyde-3-phosphate, which next is either transformed to 
other C3 metabolites or feedbacks to C6 compounds through the cyclic mode of ED 
pathway. Glucose can also join the ED route by its direct conversion into gluconate and 
subsequent phosphorylation to 6-phosphogluconate (del Castillo et al, 2007; Lessie et al, 
1984). In P. putida, it has been reported that glucose is metabolized through three initial 
pathways that converge at the level of 6-phosphogluconate and that its simultaneous 
operation is necessary to achieve maximal growth rates (del Castillo et al, 2007). Using 
our fluxomic data no prediction can be made about the early steps of glucose 
metabolism, as in the metabolic model, which laid the basis for the whole analysis, does 
not differentiate between these initial steps of glucose consumption. 
 
 Our data on glucose showed that this substrate necessarily employed almost exclusively 
via the ED pathway because 6-phosphofructokinase is missing in this bacterium 
(Velazquez et al, 2004). Fructose, in contrast, is degraded to about ∼34% via the EMP 
pathway and ∼52% via the ED pathway (Fig. 6). These data correlate well with the 
prediction of radiolabelling experiments with [1-14C]-fructose (Sawyer et al, 1977). 
Fructose is taken up and phosphorylated by the activity of the components of the PTSFru 
to fructose-1-phosphate with the concomitant conversion of PEP to pyruvate. F1P is 
eventually converted to fructose-1,6-bisphosphate, which now either enters the ED 
pathway through the activity of the Fbp or follows the thermodynamically more 
favourable EMP pathway. In the EMP pathway, FBP is cleaved to produce 
glyceraldehyde-3-phosphate and dihydroxyacetone phosphate, which are then 
channelled via PEP to produce pyruvate and acetyl-CoA, that end in the TCA cycle 
(Fig. 1). A small fraction of ∼11% of the fructose initially taken up is metabolized 
through the PP pathway. Thermodynamically, the preference of P. putida by the ED 
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pathway over EMP pathway for degrading fructose is not obvious. We think, that 
utilization of the ED pathway could provide physiological advantages to P. putida to 
withstand oxidative stress, since more equivalents of NADPH per molecule of sugar 
degraded are produced through this step with respect to the classical EMP pathway. 
This idea is not without experimental evidence since in E. coli, the ED pathway has been 
related with other functions apart from sugar catabolism such as participation in SOS 
response and resistance to UV radiation (Peekhaus and Conway, 1998). 
 
From an evolutionary standpoint, the ED pathway is the oldest (Conway, 1992; 
Peekhaus et al, 1998) and most conserved metabolic route. Based on the usual niche of 
P. putida, it would be reasonable to consider that this bacterium has kept the ED 
pathway as its main device for carbohydrate degradation because [i] it provides 
additional resistance to environmental stress and [ii] in aerobic conditions (the usual P. 
putida niche), the utilization of EMP pathway does not endow any advantage, since the 
necessary ATP for carrying out the biological functions can be produced abundantly 
through oxidative phosphorylation in the TCA cycle. 
 
Apart from differences in the fluxes of the upper pathway between glucose and fructose 
consumption, changes in the fluxes around the PEP-Pyr-OAA node could also be 
observed. On fructose, fluxes from PEP to pyruvate, fluxes of the pyruvate shunt formed 
by malic enzyme and pyruvate carboxylase (pyruvate from malate and oxaloacetate 
from pyruvate), and gluconeogenesis (PEP from OAA) were higher than in glucose. On 
glucose, ∼83% of the carbon flux from the TCA cycle proceeds via the malate 
dehydrogenase, and only ∼17% is channelled through the malic enzyme. On fructose, 
∼42% of the carbon flux is directed via the malic enzyme, bypassing the malate 
dehydrogenase (see Fig. 13, 14). Thus, our data suggest that the activity of the pyruvate 
shunt is higher in cells grown on fructose than on glucose. In bacteria, this shunt has to 
be seen in the overall context of the PEP-Pyr-OAA node as a switch point for carbon 
flux distribution of the central metabolism. The node is essential but flexible, in order to 
adjust the carbon flow to the energetic and anabolic demands in given conditions. Its 
enzymes are allosterically controlled, i.e. positively and/or negatively regulated by a 
variety of metabolites of the central metabolism and may be subjected to substrate 
inhibition (Sauer and Eikmanns, 2005). It has been proposed that the pyruvate shunt 
(see Fig. 1 malatepyruvateOAA) can be used to supply oxaloacetate for 
gluconeogenesis and production of amino acids (Diesterhaft and Freese, 1973). In this 
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shunt, one ATP is used and thus more energy is required than in the direct conversion 
of malate to oxalacetate via malate dehydrogenase. For this reason, it is believed that the 
pyruvate shunt is used mainly for the production of oxaloacetate, while malate 
dehydrogenase functions primarily to provide energy via the citric acid cycle (Diesterhaft 
et al, 1973). Moreover, the pyruvate shunt may be a mechanism to remove excess 
carbon in P. putida (del Castillo et al, 2007).  Taking together this information and our 
data, we entertain that the cell adjusts the extension of the pyruvate shunt depending of 
the carbon source (glucose vs fructose) so it can meet the energetic and anabolic 
demands in each growth condition.  
 
Other differences in the metabolic fluxes of P. putida observed with glucose vs. fructose as 
a sole carbon source can be explained by the activity of the PTSFru system, which is 
responsible for additional conversion of PEP to pyruvate in the process of fructose 
uptake, increasing this flux, and for fructose degradation via the EMP pathway. As was 
mentioned, degradation of fructose via the EMP pathway is thermodynamically more 
favourable than degradation via the ED pathway. It is estimated that one molecule ATP 
is gained per molecule fructose degraded through the EMP pathway compared to 
degradation following the ED pathway (Van Dijken and Quayle, 1977). This might 
contribute to the higher biomass yield per molecule of fructose observed in P. putida (see 
Tables 4 and 5). Furthermore, as only one molecule of PEP is produced per molecule of 
hexose via the ED pathway, the PEP supply is emptied during catabolism of hexoses to 
pyruvate in the presence of a functional PTS for sugar uptake (Van Dijken et al, 1977). 
Therefore, degradation of fructose through the EMP pathway is not only energetically 
more favourable in terms of ATP yield, but also leads to the generation of two molecules 
of PEP per molecule of fructose, refilling the PEP pool. The approximately two-fold 
higher flux from OAA to PEP on fructose might also be a consequence of the need to 
refill the PEP pool for the biosynthetic purposes such as synthesis of aromatic amino 
acids, or cell wall polymers. In conclusion, the metabolic flux analysis demonstrates that 
differences in the catabolism of glucose and fructose in P. putida are not just limited to 
the upper metabolism (ED vs EMP pathways), but also to the lower metabolism 
(pyruvate shunt, TCA cycle). On the other hand, our results clearly show that the 
PTSNtr proteins do not have any modulating effect on the three main degradation 
pathways for hexoses (ED, EMP, PP pathways). 
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2. Central metabolism in P. putida is run through an atypical version of 
the ED pathway 
 
ED metabolism is far more widely distributed in Nature than has been recognized, and 
the enzymes of this pathway are highly conserved (Conway, 1992; Peekhaus et al, 1998). 
Previously, it has been accepted that the ED pathway operates in several different 
modes. However, for many organisms the operational mode is not known because there 
is insufficient biochemical and regulatory data available. Nevertheless, an examination 
of the literature reveals predictable patterns of association of certain microbial lifestyles 
with specific modes of ED metabolism (Conway, 1992). In several bacterial genera, 
(including enterobacteria) the ED pathway operates in a linear fashion (Conway, 1992). 
Microorganisms as Rhodobacter capsulata and E. coli are examples of species that work with 
a linear ED pathway, which, in some cases, is only induced for growing on particular 
carbon sources. On the other hand, the operation of a cyclic ED pathway has been 
previously suggested for several Pseudomonads species (Conway, 1992) although most of 
the studies (if not all) have been focused on P. aeruginosa. While some reviews (Conway, 
1992; Portais and Delort, 2002) mentione that there is substantial evidence of the operation of 
a cyclic ED pathway, a closer examination of the literature reveals that the hypothesis of 
the existence of the cycle in Pseudomonas has been based only on growth experiments 
with mutants deficient in enzymes of the upper central metabolism. 
 
Our results shown in Chapter 1 demonstrate that the ED pathway operates in a cyclic 
mode in P. putida (see Fig. 36), which provides a new vision of the central metabolism of 
this bacterium. Given the limited number of articles that have been published about it, 
the occurrence of the cyclic ED pathway has not been taken into consideration in most 
studies of central metabolism in P. putida, including the two existing metabolic models 
that were developed recently (Nogales et al, 2008; Puchalka et al, 2008). Thus, our work 
clarifies the flow of carbon into the central metabolism of this bacterium and we 
advocate to consider these new features in future  P. putida models/studies.  In this cyclic 
version of the ED pathway, the triose phosphates are recycled to 
DHAP/FBP/F6P/G6P via the gluconeogenic enzymes TpiA, Fda, Fbp and Pgi.  
Moreover, our data indicate that the cyclic ED is carried out in both glycolytic and 
gluconeogenic conditions, suggesting that this cycle is constitutive in this bacterium and 
not only inducible by certain carbon sources. The ocurrence of a cyclic version of the 
ED pathway is compatible with the results obtained by flux analysis and discussed 
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above, as the biochemical network used is only able to differentiate between the 
degradation routes (ED, EMP or PP pathways) but can not  distinguish the mode in 
which each works (cyclic, linear, etc).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36. Proposed layout of central carbon metabolism in P. putida. In this 
picture we indicate the occurrence of a cyclic version of the ED pathway, where GA3P can 
be recycled to FBP or degraded for energy production to the TCA cycle. Color codes: cyclic 
ED pathway in blue, EMP pathway in red, PP pathway in purple, TCA cycle in green.  
 
The occurrence of the cyclic ED pathway in fructose is difficult to explain because 
according to the flux analysis, 34% of this substrate is degraded through EMP pathway. 
We have two possible hypotheses about it:  
 
[i] The Fda enzyme could operate in both directions simultaneously, contributing 
partially to the cyclic ED (DHAP + GA3P  FBP) and the degradation of the substrate 
through glycolysis (FBP  DHAP + GA3P). A simultaneous double functionality for 
Fda has been reported in vivo for S. cerevisiae (Navas et al, 1993), E. coli (Shulman et al, 
1979), Corynebacterium melasssecola (Rollin et al, 1995) and Lactococcus lactis (Neves et al, 
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1999). The occurrence of metabolite cycling, where opposite processes operate 
simultaneously, may seem disconcerting, mainly given the tight regulation of 
metabolism usually assumed to provide coherent partitioning of resources over the 
various energetic and biosynthetic requirements. However, there are evidences that 
these phenomena could take place in the cell (Portais et al, 2002). Evidently, its presence 
may significantly affect the carbon, energetic and redox status of the cell, therefore, the 
double direction in the performance of an enzyme may itself play regulatory funtions 
(Portais et al, 2002).  
 
[ii] The Fda enzyme may operate in a stochastic regime. It might be reasonable to think 
that at any given time, some cells can grown under a mode (cyclic ED) and others at a 
different regimen (EMP pathway).  
 
Our data cannot discern whether this is a stochastic phenomenon or reflects double 
functionality of the Fda enzyme. 
 
The existence of the cyclic ED pathway explains also the poor growth in glycolytic and 
gluconeogenic carbon sources when the PfkA was expressed in a wild type strain. This is 
because the enzyme catalyzes a reaction that opposes the innate carbon flux in this 
bacterium. Thus, expression of PfkA in this species produces a futile cycle in the central 
metabolism that wastes the ATP needed for other biological functions such as biomass 
formation. In past years, Steinbuchel et al. (1986) demonstrated that it is possible to 
convert Alcaligenes eutrophus (a naturally 6-phosphofructokinase deficient organism with 
ED pathway in cyclic mode) to EMP metabolism by expression of PfkA. We do not have 
an easy explanation for their results. Perhaps expression and regulation of Fbp/Fda is 
different between organisms, and maybe in the case of A. eutrophus the futile cycle is not 
established. Therefore, it seems that the central metabolism in P. putida cannot 
redirected entirely to EMP pathway by PfkA knock-in such as in the case of A. eutrophus 
even in the case where the cyclic ED pathway is inactivated.  New strategies are 
currently being developed in our laboratory to engineer P. putida into a bacterium that 
uses only the EMP pathway to break down sugars. This will allow us to better 
understand the importance of the ED pathway in P. putida. 
 
Growth experiments with mutants of different enzymes of the cyclic ED pathway 
indicate that the recycling of triose phosphates to hexoses on glucose and succinate is 
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essential for the cell. These results indicate that the importance of the upper metabolism 
lies in the ability to generate certain metabolites that form the cycle, specifically DHAP, 
FBP, F6P and G6P. On the other hand, the production of some of these metabolites on 
fructose is partially supplied by EMP pathway and sufficient for bacterial growth, as can 
be deduced from the behavior of the edd strain.  Taken together all the experiments on 
fructose (growth, PfkA expression, metabolome) suggest that the cyclic ED pathway 
really occurs in cells growing in this sugar, but seems not to be essential. 
 
Why the ED pathway works in P. putida in a cyclical fashion? In P. aeruginosa the cyclic 
ED pathway seems to support the formation of the polysaccharide precursor F6P in 
several metabolic conditions (Conway, 1992). However, we think that the function of 
the cycle is not only to supply DHAP, FBP, F6P and G6P for macromolecular 
biosynthesis, but also to play a role in the optimization of NADPH synthesis for 
sustaining anabolic demands and resistance to oxidative stress. As was mentioned above, 
in the linear ED pathway, one NADPH molecule is generated per molecule of glucose-
6-phosphate entering the process. In the cyclic version, the yield of NADPH can 
increase up to 2-fold depending on the extent of recycling (Portais et al, 2002). 
Therefore,  its presence could be  particularly relevant in organisms where PP pathway 
activity is low as is the case of P. putida (see Figs. 6 and 9). A high number of antioxidant 
enzymes are coupled to NADPH as a redox cofactor. Therefore functional defense 
mechanisms against oxidative stress depends upon the availability of NADPH. We 
hypothesized that the cyclic ED pathway might protect against oxidative stress to P. 
putida due to the enhanced cellular production of this molecule. As a sidelight, our 
results show how different the central metabolism between bacterial species can be. 
Model species such as E. coli or B. subtilis are not entirely representative of global 
microbial metabolism and their generalization can lead to significant errors.  
 
3. PtsN is a fine tuning regulator of carbon central metabolism 
 
In this Thesis, we analyzed the metabolic fluxes in the central carbon metabolism of 
isogenic PTS mutant strains of P. putida (Chapter 1) growing on a PTS sugar (fructose) 
or on a non-PTS sugar (glucose). Two main conclusions regarding the influence of PTS 
proteins could be drawn from those data: [i] that the PTS mutants did not affect the 
carbon flux distribution of the pathways implicated in the upper metabolism (EDP, 
EMP and PPP) with the exception of fruB mutants which are unable to transport 
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fructose in the cell, and [ii] that PtsN is involved in the regulation of the pyruvate shunt 
in the central metabolism, irrespective of the carbon source used and of its 
phosphorylation state.  
 
The regulation of PtsN on pyruvate shunt was observed on first instance through flux 
analysis (see Figs. 13 and 14), and then confirmed with enzymatic assays (Fig. 16). In 
both approaches, a higher activity of the malic enzyme and pyruvate carboxylase were 
observed in the ptsN mutant, as well as in the ptsN/ptsO mutant with respect to the wild 
type strain suggesting a repressor role of PtsN on the pyruvate shunt. Moreover, our 
results suggest that the regulatory influence is not dependent of the phosphorylation 
status of the protein, as: 
 
[i] No effects on the metabolic fluxes were observed in a ptsP/fruB mutant (see Fig. 12). 
This strain lacks both EI components of the PTS and therefore does not support 
phosphorylation of PtsN, thus EIIANtr would not be phosphorylated under any 
condition (Pfluger and de Lorenzo, 2008),  and 
 
[ii] No changes in malic enzyme activity were observed in ptsNHA and ptsNHE mutants 
(see Fig. 17). These strains contain a ptsN allele with changes in the triplet corresponding 
to the phosphorylable position H68 of PtsN (ptsNHA HisxAla and ptsNHE HisxGlu). 
These genetic modifications generate that ptsNHA strain has in any time the PtsN 
protein in dephosphorylated form whereas ptsNHE strain has this protein in a state that 
resembles to the phosphorylated species. The fact that no changes were observed in 
malic enzyme activity in a scenario where the PtsN is fully phosphorylated or 
dephosphorylated suggest that the observed effect of PtsN can be traced down to the 
sole presence/absence of the protein irrespective of its phosphorylation state. 
 
While most studies suggest that the dephosphorylated form of PtsN is responsible for its 
regulatory functions (Begley and Jacobson, 1994; Lee et al, 2005; Luttmann et al, 2009; 
Pfluger-Grau et al, 2011; Segura and Espin, 1998), the fact that the PtsN protein 
regulates the activity of an enzyme independently of their state of phosphorylation is not 
new. Recently Choi et al. (2010) reported in Salmonella a direct protein-protein 
interaction between EIIANtr and the response regulator SsrB, a component required for 
Salmonella virulence. This work showed with in vivo and in vitro experiments that  EIIANtr 
interact with SsrB and it performs its regulatory function in a fashion entirely 
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independent of the phosphorylation state. On the other hand, other studies have 
reported regulatory functions of PtsN that depends on the phosphorylated form (Cases et 
al, 1999; Hayden and Ades, 2008). With these premises, the simplest interpretation is 
that the state of phosphorylation is one of the features that PtsN uses to carry out its 
multiple regulatory functions. Therefore, we believe that the various phenotypes 
observed in PtsN mutants may be due to any of the following: [i] the phosphorylation 
state, [ii] the amount of protein expressed and, [iii] the ability of PtsN to interact with 
other macromolecules to form protein complexes. 
 
Perhaps, the two forms of EIIANtr (phosphorylated and nonphosphorylated) have 
specialized in controling different sets of proteins, so the regulatory functions are carried 
out through several/different mechanisms. According to the literature (Lee et al, 2007; 
Choi et al, 2010; Pfluger-Grau et al, 2011) it seems clear that one of these mechanisms is 
through direct protein-protein interaction suggesting that PtsN may have a role in 
scaffolding multiprotein complexes. 
 
Our experiments do not allow to deduce whether this regulation is due to direct protein-
protein interaction of PtsN with the pyruvate shunt enzymes or by a secondary effect 
due to altered intracellular metabolite composition. For instance, it is known that in 
Bacillus subtilis acetyl-CoA has an inducing effect on the activity of the pyruvate 
carboxylase (Diesterhaft et al, 1973). However, in other bacteria, as e.g. in Pseudomonas 
citronellosis, Methanobacterium thermautotrophicum, and Clostridium glutamicum, no dependence 
on the presence of acetyl-CoA has been observed on Pyruvate carboxylase (Attwood, 
1995; Jitrapakdee and Wallace, 1999). Recently, it was shown that the non-
phosphorylated form of PtsN binds to the AceE component of PDH in vitro, 
downregulating its activity (Pfluger-Grau et al, 2011). Therefore, a ptsN mutant should 
have higher fluxes towards acetyl-CoA, if not even higher amounts of this metabolite. 
Analyzing the metabolic net fluxes only a slight increase is predicted for the reaction 
catalyzed by the PDH complex in the ptsN mutants (see Figs. 13, 14). However, 
measurements of the PDH activity in cell free extracts of P. putida wild type and ptsN 
mutant showed ~2-fold higher activity of the enzyme complex in the absence of PtsN 
(Pfluger-Grau et al, 2011). Thus, we cannot exclude that the higher activity of the 
pyruvate carboxylase is at least to some extend an effect of its induction by acetyl-CoA.  
 
Even when we cannot provide a detailed functional mechanism, we have evidence that 
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the pyruvate shunt is induced in the absence of PtsN. As mentioned above, the pyruvate 
shunt has been related with the production of additional amounts of OAA for 
gluconeogenesis, amino acids biosynthesis (aspartate, isoleucine, threonine), and energy 
production via the citric acid cycle (Diesterhaft et al, 1973). The fact that PtsN repress 
the pyruvate shunt (and therefore modulates the pool of oxaloaceate) indicates that PtsN 
would indirectly regulate the biosynthesis of amino acids. 
 
Although the observed differences in ptsN+/ptsN- strains in the fluxes and enzymatic 
assays are somewhat low, small changes in central metabolic reactions can lead to 
significant changes in other regulatory processes. Therefore, considering the robustness 
of the central metabolism it is very remarkable that PtsN can regulate its activity. We 
are just at the beginning of understanding some of the signals and regulatory devices 
orchestrating the metabolic flux distribution through the pyruvate shunt node and 
thereby guiding the carbon flow to the different metabolic modules.  
 
In summary, we produced evidence that PtsN is one player in the complex machinery 
that is responsible for carbon flux distribution in the central metabolism of P. putida.  
Our data suggest a role of PtsN in the fine-tuning of the central carbon metabolism 
helping to adjust the metabolic fluxes to satisfy the anabolic and energetic demands of 
overall cell physiology.  
 
4. F1P is the one and only effector of the transcriptional regulator Cra 
from bacteria 
 
The catabolite repressor/activator (Cra) protein is a global sensor and regulator of 
carbon fluxes through the central metabolic pathways of Gram-negative bacteria, but 
the actual effector (or effectors) that signal such fluxes to the protein has never been 
unambiguously determined. This bit of information is decisive for setting reliable 
connections between the central fluxes for catabolism/anabolism of carbohydrates 
(which are reported by FBP levels; Ramseier et al, 1993), and the metabolic and non-
metabolic transcriptome (Kotte et al, 2010). In this Thesis, the Cra protein of P. putida 
was purified and characterized, and its tridimensional structure determined.  
 
Analytical ultracentrifugation, gel filtration and mobility shift assays showed that the 
effector-free Cra is a dimer which binds an operator DNA sequence in the promoter 
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region of the fruBKA cluster. The observation that Cra protein of P. putida occurs 
predominantly in a dimeric form is a feature that differs from the same regulator of E. 
coli, known to be a tetramer (Alberti et al, 1993; Chakerian et al, 1991; Chen and 
Matthews, 1992). However, this divergence is understandable, because the leucine mini-
zipper that causes tetramerization of proteins of the LacI family through their the 
carboxyl-terminal regions is conserved in E. coli Cra (Cortay et al, 1994) but not in the P. 
putida counterpart (Fig. 37). 
 
On the other hand, the Cra binding site in the fruBKA promoter region of E. coli 
contains two nearby operators O1 (TGAAACGTTTCA) and O2 
(TGAATCGTTTCA), which could accommodate the cognate repressor tetramer 
(Ramseier et al, 1993). In contrast, the same region of the P. putida genome has only one 
Cra site (Fig. 21b). A plausible consequence of this is that the affinity of the Cra dimer 
for the single site in the fruBKA promoter region of P. putida ought to be high to 
compensate the more extended range of interactions of the tetramer/two-operator 
scenario of the same regulatory device in E. coli.  
 
 
 
 
 
Figure 37. Alignment of the C-terminal amino acid sequence of regulators Cra 
(E. coli), LacI (E. coli) and Cra (P. putida). Note that the E. coli tetrameric regulators 
Cra and LacI contain a leucine mini-zipper, which seems to be required to tetramerization. 
This mini-zipper is absent in the P. putida Cra protein.  
 
One of our main results is that F1P (but not FBP) is the only metabolic effector of the 
bacterial regulator Cra. Thermodynamic parameters of the F1P-Cra-DNA interaction 
calculated by isothermal titration calorimetry revealed that the factor associates tightly 
to the DNA sequence 5’-TTAAACGTTTCA-3’ (KD = 26.3 ± 3.1 nM) and that F1P 
binds the protein with an apparent stoichiometry of 1.06 ± 0.06 molecules per Cra 
monomer and a KD of 209 ± 20 nM. Other effectors like FBP, believed so far to be one 
metabolic partner of Cra, did not display any affinity for the regulator. Moreover, the 
structure of Cra and its co-crystal with F1P at 2Å resolution implies that any small 
molecule other than F1P can hardly match the geometry of the effector pocket. The 
extensive contacts of F1P with Cra lead to a high affinity binding interaction (KD ~ 200 
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nM).  Since the residues that hold the 13 molecular interactions shaping the pocket for 
F1P binding are faithfully preserved in the same protein of E. coli and S. typhimurium 
(Figs. 18, and 27), we can assume that the same conclusion holds true for the 
enterobacterial Cra protein as well. Superimposition of protein structures reveal the 
tightening of the effector binding site of Cra from P. putida in respect to the E. coli 
counterpart due to the presence of glycerol (introduced in the crystallization process) in 
the corresponding pocket. But otherwise the architecture of the sites is identical. The 
extensive similarity between the proteins of P. putida and E. coli suggest that they could 
also share the same structural transmission pathway to regulate its function, which is 
likely to be identical to that of known members of the family (Schumacher et al, 1995; 
Schumacher et al, 1994). Our results thus point to F1P as the one and only metabolic 
effector of the bacterial regulator Cra. 
 
That F1P could ultimately be the only effector of Cra opens new questions, because 
current metabolic models entertain F1P appearance only as a result of fructose 
phoshorylation by the PTS system (Nogales et al, 2008; Puchalka et al, 2008; Sawyer et al, 
1977). To the best of our knowledge, there are not known enzymes for producing F1P 
during growth on glucose or other carbon source other than fructose. But, since Cra 
controls expression of various glucose catabolism genes (Ow et al, 2007) there must be 
alternative ways of producing F1P as a descriptor of glycolytic/gluoconeogenic activity 
(Kotte et al, 2010). One way or the other, it is likely that the first regulatory duty of Cra 
was that of a repressor of fructose metabolism which was later co-opted as a global 
regulator (Saier and Ramseier, 1996).   
 
5. Cra is a transcriptional repressor of PTSFru system in P. putida 
 
In vitro experiments performed with the regulator, the operator, and F1P produced 
evidence that CraP.putida represses expression of the fructose-related phosphoenolpyruvate 
phosphotransferase carbohydrate system of P. putida (PTSFru) in a fashion (predictably) 
dependent on F1P binding (Fig. 38). This observation was examined in depth through in 
vivo experiments (Chapter 3). First, by measuring the promoter activity and metabolite 
concentrations we monitored the expression of the fructose operon in a wild type strain 
in different carbon sources, which revealed (as expected) that fructose operon is 
expressed only in presence of fructose and maintained low levels on glucose and 
succinate. Moreover, we demostrated that the higher basal fruBKA levels on glucose with 
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respect to succinate was due to the contamination of glucose preparations. The presence 
of a small amount of fructose in the glucose could be due to [i] impurities in glucose 
powder (Sigma, 99.5% purity) and/or [ii]  the Lobry de Bruyn-van Ekenstein (1895) 
rearrangement of glucose into fructose in stock glucose solutions prepared in the 
laboratory (20% glucose in water, pH = 4). The rearrangement of glucose takes place 
primarily in alkaline solution, although some rearrangement occurs in the presence of 
salts and slightly acid conditions. The mechanism which has generally been accepted to 
account for this reaction involves the assumption of an intermediary enediol. Ohno et al. 
(1961) reported that this isomerization of glucose to fructose could occur at a pH greater 
than 4.0 which can explain the inevitable presence of a small amount of fructose in 
glucose solutions regardless of its nominal purity.  
 
Activity of PfruBKA promoter in the cra strain, revealed that [i] the regulator is a very 
strong  repressor of  PTSFru system in P. putida and  [ii] the operon expression is 
controled enterely by F1P levels as was suggested by in vitro experiments. These claims 
are represented in Fig. 38.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38. Mechanism of repression/derepression of PTSFru system by Cra 
protein in P. putida. (a) In absence of F1P, the protein binds tightly as a dimer to a 
single operator in the regulatory region, which inhibits transcription. (b) In fructose as 
carbon source, F1P is produced, which binds with high affinity to the regulator. The 
binding of the protein with the effector change its conformation causing the release of the 
protein and the derepression of the fructose operon. 
 
In absence of F1P, the free protein binds tightly as a dimer to the single operator in the 
regulatory region of fructose operon, which inhibits its transcription. On the other 
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hand, when fructose is the carbon source, F1P is produced, which binds with high 
affinity to the regulator. That prevents the binding of Cra to the DNA leading to the 
derepression of the system. 
 
6. Cra modulates the phosphorylation state of PtsN in P. putida 
 
Analysis of the phosphorylation state of EIIANtr in cra and ptsP mutants showed that the 
regulation exerted by Cra on fruB is transferred to the nitrogen PTS system through the 
cross-talk reported in this bacterium. All our phosphorylation data correlate well with 
the gene expression results of fruB. Changes in phosphorylation of PtsN produced by the 
deletion of Cra were visualized only under conditions where PtsP was inactivated. This 
clearly suggests that most of the phosphate of PtsN is obtained via PtsP/PtsO (this is 
based on the observation that cra mutant showed similar phosphorylation than the 
reference strain). Therefore, we hypothetize, that Cra provides a fine tunning regulation 
on  PTSNtr system, so that it can perform small variations/settings in the ratio of 
phosphorylated/dephosphorylated PtsN. It has been reported previously,  that a large 
number of phenotypes associated to PtsN depend on its phosphorylation state. Thus, it 
could be that Cra indirectly modulates other processes including polyhydroxyalkanoate 
(PHA) accumulation (Velazquez et al, 2007), C-source repression of m-xylene catabolism 
(Cases et al, 1999), biofilm formation (Pflüger-Grau, data not published) and swimming 
(Pflüger-Grau, data not published), since some of them depend on the phosphorylation 
state.  
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The work described throughout this Thesis has given rise to the following conclusions: 
 
 
1. Carbon central metabolism in P. putida is carried out through an cyclic version of the Entner-
Doudoroff pathway. Differences between the metabolism of P. putida and other species such 
as E. coli, indicate a clear specialization of  central metabolism as a result of habitat and 
nutritional requirements of each species.  
 
 
2. PTSNtr system plays regulatory functions on carbon central metabolism of P. putida. This 
regulation can be traced mainly to the protein EIIANtr (PtsN), which controls the 
connection of pyruvate to the TCA cycle by downregulating the pyruvate shunt, that 
bypasses malate dehydrogenase in the TCA cycle.  
 
 
3. F1P is the one and only effector of the transcriptional regulator Cra from bacteria. In this work, we 
have studied the Cra protein of P. putida, however, we consider that all our observations 
about the effector can be generalized to other species as E. coli and S. typhimurium 
because of the high similarity in the sequence and three-dimensional structure of the 
effector binding site. Thus, our results suggest that F1P is the only effector of the 
bacterial regulator Cra. 
 
 
4. Cra is a transcriptional repressor of PTSFru system in P. putida. In vitro and in vivo experiments 
demonstrated that Cra is very strong repressor of fructose operon, where the whole 
process is controlled by the intracellular concentrations of F1P. 
 
 
5. Cra is a modulator of the PTSNtr system in P. putida. The regulation exerted by Cra on 
fructose operon modulates the phosphorylation state of PtsN under certain metabolic 
conditions.
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El trabajo descrito a lo largo de esta Tesis ha dado lugar a las siguientes conclusiones: 
 
 
1. El metabolismo central en P. putida se lleva a cabo a través de una versión cíclica de la ruta Entner-
Doudoroff. Las diferencias entre el metabolismo central de P. putida y otras especies tales 
como E. coli, indican una clara especialización de la maquinaria metabólica como 
resultado del hábitat y las necesidades nutricionales de cada especie. 
 
 
2. El Sistema PTSNtr desempeña funciones regulatorias sobre el metabolismo central de P. putida. Esta 
regulación es llevada a cabo por la proteína EIIANtr (PtsN), donde hemos demostrado 
que esta proteína controla la conexión entre el piruvato y el ciclo de Krebs reprimiendo 
la actividad del desvío del piruvato (pyruvate shunt). 
 
 
3. La F1P es el único efector del regulador transcripcional bacteriano Cra. En este trabajo, hemos 
estudiado la proteína Cra de P. putida, sin embargo, consideramos que todas nuestras 
observaciones sobre su efector pueden ser generalizadas a otras especies como E. coli y S. 
typhimurium, debido a la alta similitud en la secuencia y estructura tridimensional del sitio 
de unión en las proteínas Cra de estas especies. Por lo tanto, nuestros resultados indican 
que F1P es el único efector del regulador bacteriano Cra. 
 
 
4. Cra es un represor transcripcional del sistema PTSFru de P. putida. Experimentos in vitro e in vivo 
demostraron que Cra es un represor muy fuerte del operón de la fructosa, donde el 
proceso de expresión está controlado enteramente por las concentraciones intracelulares 
de F1P. 
 
 
5. Cra es un modulador del sistema PTSNtr de P. putida. La regulación ejercida por Cra sobre el 
operón fructosa modula el estado de fosforilación de la proteína PtsN bajo ciertas 
condiciones metabólicas. 
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Table 7. Identified Cra boxes in P. putida. 
Gene Name/Acc Sequence ATG-Distance Location 
FruB (GE00180219) TGAAACGTTTAA 116 intergenic 
Gap-1 (GE00180435) TGAAACGGTTTT 52 intergenic 
Edd (GE00180436) TGAAACGGTTTT 202 intergenic 
HisA (GE00179724) TGAAGCGTTTTC 204 coding region 
PP0300 (GE00179732 TGAATGGCTTCA 163 coding region 
AccB (GE00179987) TGAAACGTTTCT 54 intergenic 
PP0711 (GE00180137) TGAAGCGATTCT 167 coding region 
FruR (GE00180218) TGAAACGTTTAA 158 intergenic 
PP0891 (GE00180317) TGAAGCGGTTAT 329 coding region 
PP1181 (GE00180606) TGAACCGTTTTT 150 intergenic 
RuvA (GE00180641) TGAAGCGCTTAC 102 coding region 
Mqo-2 (GE00180676) TGAATCGTTTTT 203 intergenic 
OprB-2 (GE00180868) TGAAGCGTTTCA 90 intergenic 
SugE (GE00181123) TGAATCGTTTTC 181 intergenic 
PP1868 (GE00181288) TGAATCGATAAT 297 intergenic 
PP2061 (GE00181476) TGAATCGTTTGC 227 coding region 
PP2267 (GE00181681) TGAATCGCTTCG 225 intergenic 
PP2425 (GE00181838) TGAATCGTTTCA 151 intergenic 
PP2426 (GE00181839) TGAATCGTTTCA 20 intergenic 
PP2533 (GE00181943) TGAATCGGTTCC 248 coding region 
PP2828 (GE00182237) TGAATGGTTTTT 289 intergenic 
PP2868 (GE00182277) TGAATCGCTTCT 71 coding region 
PP3443 (GE00182846) TGAATCGTTTCA 42 coding region 
PP3754 (GE00183149) TGAATCGCTTTC 175 coding region 
PP3768 (GE00183163) TGAAACGTTTAT 4 intergenic 
PP3769 (GE00183164) TGAAACGTTTAT 129 intergenic 
PP3783 (GE00183178) TGAAGCGCTTAT 111 coding region 
FliA (GE00183721) TGAACCGTTTCC 311 coding region 
RadA (GE00184018) TGAAGCGTTTAA 118 intergenic 
MscL (GE00184019) TGAAGCGTTTAA 48 intergenic 
PP4658 (GE00184032) TGAAACGCTTTT 110 intergenic 
IlvB (GE00184054) TGAAGCGATTTT 326 intergenic 
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DapB (GE00184098) TGAAGCGCTTCT 28 coding region 
ProA (GE00184181) TGAATGGCTTAA 254 intergenic 
PP4812 (GE00184182) TGAATGGCTTAA 41 intergenic 
PP4948 (GE00184316) TGAAACGTTTCC 250 intergenic 
NtrB (GE00184413) TGAAACGTTTAA 185 intergenic 
GltB (GE00184442) TGAAGCGTTTCA 228 intergenic 
PP5330 (GE00184696) TGAATCGTTTAC 297 intergenic 
PP5331 (GE00184697) TGAATCGTTTAC 54 intergenic 
PP5404 (GE00184769) TGAATCGATTGA 14 coding region 
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Summary of the thesis in Spanish by sections 
 
I. RESUMEN 
 
La bacteria del suelo Pseudomonas putida es conocida por su versatilidad metabólica y 
resistencia a diversos tipos de estrés. Esto requiere diversos niveles de control para 
coordinar la expresión génica y así mantener la fisiología general de la célula en diversas 
condiciones. Un importante sensor fisiológico es el sistema de transporte 
fosfoenolpiruvato fosfotransferasa de azúcares (PTS), que lleva a cabo la asimilación de 
hidratos de carbono hacia el metabolismo central, así como funciones reguladoras (p.e.   
en el fenómeno de represión catabólica). Aparte de los sistemas PTS clásicos, muchos 
procariotas tienen un tipo de sistema PTS que no está involucrado en el tráfico de 
hidratos de carbono, el cual participa en la regulación de algunos procesos metabólicos. 
En P. putida, el sistema PTS de azúcar específico para el transporte de fructosa (FruA / 
EIIBC y FruB / EI-HPR-EIIA) coexiste con el llamado sistema PTS de nitrógeno 
PTSNtr (PtsP / EINTR, PtsO / Npr, y PtsN / EIIANtr). 
 
 En este trabajo se analiza: [i] el flujo del carbono en el metabolismo central de P. putida, 
así como su interacción con el sistema PTSNtr y [ii] el control ejercido por el regulador 
transcripcional Cra sobre los sistemas PTS de esta bacteria. En concreto, en el 
Capítulo 1 se analizó a través de herramientas de fluxómica y metabolómica la 
utilización de  varias fuentes de carbono (PTS y no PTS). Los resultados mostraron que 
el Entner-Doudoroff (ED) es la vía más común para la degradación de azúcares en P. 
putida. Además, se demostró que la vía del ED en P. putida opera en un inusual modo 
cíclico. Además, en el Capítulo 1 a través de análisis de flujos y ensayos enzimáticos se 
demostró que la proteína EIIANtr controla el desvío del piruvato (pyruvate shunt) que controla 
la conexión entre el piruvato y el ciclo de Krebs.  El Capítulo 2 describe a través de 
estudios in vitro la relación entre el sistema PTSFru, el regulador transcripcional Cra y su 
efector (fructosa 1-fosfato; F1P). Ensayos de movilidad electroforética (EMSA) y de 
microcalorimetría de titulación isotérmica (ITC), mostraron que Cra reconoce la 
secuencia palindrómica TTAAACGTTTCA en la región reguladora del operón fruBKA. 
Además, la estructura cristalina del regulador se obtuvo en ausencia y presencia de la 
F1P. Por tanto, todos nuestros resultados apuntan a la F1P como el único efector de este 
regulador transcripcional bacteriano. Por último, en el Capítulo 3, se mostró con 
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experimentos in vivo que Cra  es un represor del sistema PTSFru en P. putida. Por otra 
parte, se observó que  Cra controla bajo ciertas condiciones metabólicas el estado de 
fosforilación de PtsN  a través de FruB. 
 
En este trabajo hemos contribuido a la comprensión del metabolismo central y los 
sistemas PTS en la bacteria del suelo P. putida los cuales, de acuerdo a nuestros 
resultados, pueden diferir en importantes aspectos a otras bacterias modelo como E. coli 
o B. subtilis. 
 
II. INTRODUCCIÓN 
 
1. Descripción de Pseudomonas putida 
 
P. putida pertenece al grupo de Pseudomonas fluorescentes bien conocidas por la 
producción de pigmentos fluorescentes (Meyer, 2000). Las cepas de P. putida presentan 
una amplia gama de actividades metabólicas, lo cual es indicativo de su adaptación a 
diferentes nichos (Jensen et al, 2004). P. putida KT2440 (Nelson et al, 2002) es 
probablemente la cepa saprofítica de laboratorio, que mejor ha conservado su 
capacidad para sobrevivir y funcionar en el ambiente (Frank et al, 2011; Jiménez et al, 
2002). Esta bacteria es derivada de la bacteria aislada en Japón por Hosahawa en 1963 
(Nelson et al, 2002), que fue designada originalmente como Pseudomonas arvilla mt-2 y que  
se reclasificó como P. putida mt-2 (Williams y Murray, 1974). P. putida KT2440 fue el 
primer sistema huésped seguro para la clonación de genes de bacterias del suelo Gram-
negativas (Duque et al, 2007; Stjepandic et al, 2002).  Esta cepa se ha utilizado 
ampliamente como huésped para la clonación y expresión de genes, y su característica 
más prominente es su capacidad para degradar compuestos aromáticos como el tolueno 
o el m-xileno por lo que se considera como un organismo modelo para estudios de 
biodegradación (Jiménez et al, 2002; Loh et al, 2008). Por tanto, P. putida KT2440 es 
considerada como el caballo de batalla para la investigación en Pseudomonas (Martins dos 
Santos et al, 2004; Timmis, 2002; Wu et al, 2011). 
 
2. Metabolismo de carbohidratos en P. putida 
 
El genoma de P. putida KT2440 contiene todos los genes que codifican las enzimas que 
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forman las tres vías metabólicas de degradación de carbohidratos más importantes en 
bacterias: la ruta del Entner-Doudoroff (ED), la ruta de Embden-Meyerhof-Parnas 
(EMP) y la ruta de las pentosas (PP, Fig. 1) con la excepción de la enzima glicolítica 6-
fosfofructoquinasa, PFK (Velázquez et al, 2004).  La ausencia de esta enzima en P. putida 
explica por qué esta bacteria utiliza sólo la ruta de ED para catabolizar la glucosa lo 
cual ha sido previamente demostrado a través de experimentos de radiactividad con 14C 
(Vicente y Cánovas, 1973) y análisis de flujos metabólicos (Fuhrer, 2005). Por otra parte, 
el catabolismo de la fructosa difiere ligeramente del metabolismo de hexosas ya que este 
azúcar entra directamente a la ruta de EMP a través de las proteínas FruBKA 
(Velázquez et al, 2004; Velázquez et al, 2007; Vicente, 1975). En principio, la fructosa 
puede ser degradada a través del paso ED y/o el paso EMP (Velázquez et al, 2004), sin 
embargo, estudios previos demostraron que la fructosa es catabolizada principalmente a 
través de la vía ED (Sawyer et al, 1977). Por lo tanto, parece que la ruta de ED es la vía 
más importante para la degradación de azúcares en el metabolismo central de P. putida. 
 
3. Regulación de la proteína Cra sobre el metabolismo central 
 
La proteína Cra (también conocida como FruR) es un regulador pleitrópico que 
desempeña un papel clave en el control del flujo de carbono en E. coli y Salmonella 
typhimurium (Saier et al, 1996). En primera instancia, este factor transcripcional fue 
identificado como un represor que inhibe la expresión del operón de la fructosa (PTSFru) 
cuando el azúcar no estaba disponible,  por lo que fue llamado FruR (Ramseier et al, 
1993). Más tarde se demostró que la misma proteína reprime genes que codifican a 
otras enzimas del metabolismo central (pfkA, pyka, pykF, edd, eda, mtlADR y gapB; Bledig et 
al, 1996; Ay et al, 2007; Saier et al, 1996; Sarkar et al, 2008) y activa otros (ppsA, fbp icd, 
pckA, aceA y aceB; Cortay et al, 1994; Negre et al, 1998; Ramseier et al, 1996; Saier et al, 
1996), lo que sugiere un carácter dual de Cra (represor y activador transcripcional).  Por 
lo tanto, Cra aparentemente controla la dirección del flujo de carbono en E. coli y por lo 
tanto afecta la utilización de varias fuentes de carbono. 
 
 Ya sea positivo o negativo, los efectos de Cra en la transcripción se pueden 
contrarrestar in vitro por concentraciones micromolares de fructosa-1-fosfato (F1P) o 
concentraciones milimolares de fructosa-1,6-bisfosfato (FBP; Ramseier et al, 1995). De 
hecho, la naturaleza de los efectores metabólicos de este regulador transcripcional es 
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intrigante. Esto se debe a que F1P y FBP pueden ser originados por diferentes rutas 
metabólicas y son producidos a diferentes niveles dependiendo de la fuente de carbono. 
Además, las densidades electrónicas de estas dos sustancias químicas son distintas, por lo 
que es improbable que el mismo sitio de unión de la proteína reconozca ambos 
metabolitos. En la literatura se pueden encontrar puntos de vista contradictorios acerca 
de la naturaleza de los efectores de Cra. Experimentos de retardo con radioactividad 
(EMSA) indican claramente que la F1P es un efector de Cra pero no autentican lo 
mismo de la FBP. Algunos estudios sugieren que la respuesta in vitro de Cra hacia la FBP 
se debe a una posible contaminación de este metabolito con (Ramseier et al 993) F1P. 
Sin embargo, otros autores sostienen que FBP es un auténtico efector de Cra (Bledig et 
al, 1996; Kotte et al, 2010). Por tanto, en estos momentos el papel de la FBP como 
agonista del regulador Cra es incierto (F1P esta fuera de toda duda). Además de la 
función incierta de la FBP, los estudios de la regulación ejercida por Cra se han 
realizado sólo en enterobacterias, mientras que en otras especies como P. putida sus 
funciones siguen siendo desconocidas. 
 
4. Sistemas PTS en P. putida 
 
En P. putida, un sistema de fosfotransferasas (PTS) para el transporte de fructosa 
(FruA/EIIBC y FruB/EI-HPr-EIIA) coexiste con un sistema de fosfotransferasas alterno 
denominado sistema PTS de nitrógeno (PTSNtr; PtsP/EINtr, PtsO/NPr, y PtsN/EIIANtr). 
En ambos sistemas el fosfato de alta energía se deriva de fosfoenolpiruvato (PEP) y luego 
es trasferido de EI a través de HPr/NPr a las enzimas EII (fig. 5; Postma et al, 1993). En 
P. putida, se demostró que PTSFru y PTSNtr no representan dos sistemas completamente 
separados, ya que se comunican en determinadas condiciones in vivo por el intercambio 
de grupos fosfato (fig. 5; Pfluger et al, 2008). 
 
Mutantes de P. putida en una o más proteínas PTSNtr muestran numerosos fenotipos 
(Cases et al, 2001a; Cases et al, 1999; Cases et al, 2001b; Pfluger et al, 2007; Pfluger-Grau 
et al, 2011; Velázquez et al, 2007). Por ejemplo, se ha observado que las proteínas PTSNtr 
están involucradas en la regulación de la acumulación de polihidroxialcanoatos (PHAs) 
y de la actividad de la ruta de degradación del tolueno. Además, mutantes en estas 
proteínas muestran diferentes velocidades de crecimiento cuando se cultivan en distintas 
mezclas de fuentes de carbono/nitrógeno (Velázquez et al, 2007). Más recientemente, se 
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demostró que la forma no fosforilada de PtsN directamente reprime la actividad de la 
piruvato deshidrogenasa (PDH), un complejo enzimático responsable de la 
descarboxilación del piruvato a acetil-CoA. De la misma manera que en otras bacterias, 
la mayoría de los mecanismos por los cuales las proteínas PTSNtr controlan algunos 
procesos permanecen inciertos en P. putida.  
 
III. OBJETIVOS 
 
Objetivo general 
 
Investigar la regulación de los sistemas PTS (sistemas PTSFru y PTSNtr) de P. putida, así 
como su conexión con el metabolismo central. 
 
A través de los siguientes objetivos específicos: 
 
1. Analizar las principales rutas metabólicas y el flujo del carbono en el metabolismo 
central de P. putida. 
 
2. Estudiar la interacción entre los sistemas de PTS y el metabolismo central de P. putida. 
 
3. Estudiar la regulación ejercida por la proteína Cra sobre los sistemas PTS de P. putida. 
 
IV. RESULTADOS Y DISCUSIÓN 
 
1. Capítulo I: Metabolismo central y su interacción con los sistemas PTS de 
P. putida 
 
El metabolismo central es el responsable de la generación de energía y los precursores 
necesarios para la biosíntesis de los componentes esenciales para la vida. Ensayos 
enzimáticos y de análisis de flujos metabólicos del catabolismo de azúcares en P. putida 
demostraron que la ruta de Entner-Doudoroff (ED) es la vía más frecuente para la 
degradación de carbohidratos en el metabolismo central de esta bacteria. Además, el 
genoma de P. putida revela la ausencia de la enzima 6-fosfofructoquinasa (PFK) lo que 
hace que la glucólisis no sea funcional en esta bacteria. En un esfuerzo por activar la 
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glucólisis y redirigir el flujo del carbono en P. putida, se expresó el gen pfkA de E. coli en la 
cepa salvaje P. putida y en un mutante que no puede utilizar la vía ED (eda-). La enzima 
PfkA fue expresada exitosamente, pero no fue capaz de redirigir el flujo del carbono del 
paso de ED hacia la glucólisis. Sorprendentemente, la presencia de esta enzima fue 
perjudicial para el crecimiento bacteriano y la producción de biomasa, tanto en fuentes 
de carbono glicolíticas como gluconeogénicas. Para examinar este hecho, hemos 
analizado en profundidad el metabolismo central de P. putida a través de la medición de 
las concentraciones intracelulares de varios compuestos del metabolismo central en 
diferentes fuentes de carbono (glucosa, fructosa y succinato). En todos los sustratos se 
encontraron concentraciones micromolares de dihidroxiacetona fosfato (DHAP), 
fructosa 1,6-bisfosfato (FBP), fructosa 6-fosfato (F6P), glucosa 6-fosfato (G6P) y 6-
fosfogluconato (6PG). Teniendo en cuenta los actuales modelos metabólicos y genes que 
codifican a las enzimas anotadas en el metabolismo central de P. putida, el modelo 
metabólico que mejor explica nuestros resultados es que la ruta de ED funciona en un 
modo cíclico, de tal forma que las triosas fosfato son recicladas a hexosas 
(DHAPFBPF6PG6P6PG) a través de las enzimas gluconeogénicas TpiA, Fda, 
Fbp, Pgi, Zwf, Pgl, Edd y Eda.  
 
Experimentos de crecimiento con mutantes de genes que codifican a las enzimas que 
forman la vía cíclica de ED sugieren que la ocurrencia del mismo es vital para la célula. 
La operación de un ED cíclico en P. putida explica el escaso crecimiento de la cepa 
salvaje cuando la enzima PfkA es expresada ya que esta se opone al flujo innato del 
carbono. Por tanto, estos resultados podrían explicar la ausencia de cualquier Pfk en 
Pseudomonas y sugieren que la expresión de esta enzima en esta especie genera un ciclo 
fútil en el metabolismo central que produce un desbalance en el metabolismo central y 
consume el ATP necesario para otras funciones biológicas y la formación de biomasa. 
 
Con el fin de explorar un posible rol de las proteínas PTSNtr sobre la regulación  del 
metabolismo central de P. putida, se analizaron los flujos metabólicos en cepas isogénicas 
con mutaciones en cada uno de los genes de los sistemas PTS (PTSFru y PTSNtr). Los 
resultados mostraron que la utilización de carbohidratos por los pasos del ED, EMP y 
PP no se vio afectada por ninguna de las mutaciones. Sin embargo, el hallazgo más 
importante en este análisis de flujos fue que la proteína EIIANtr/PtsN regula el desvío del 
piruvato (pyruvate shunt) que controla la conexión entre el piruvato y el ciclo de Krebs. Esta 
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influencia de EIIANtr en el desvío del piruvato se verificó mediante ensayos de actividad 
de la enzima málica y la piruvato carboxilasa. Los efectos de PtsN sobre el metabolismo 
central se atribuyen a la sola presencia/ausencia de esta proteína, independientemente 
de su estado de fosforilación. Por tanto, nuestros datos sugieren un papel de PtsN en la 
regulación del metabolismo central para ajustar los flujos y concentraciones 
intracelulares de algunos metabolitos para satisfacer las demandas anabólicas y 
energéticas de la célula. 
 
2. Capítulo II. El regulador transcripcional Cra de P. putida y su relación 
con el sistema PTSFru: estudios in vitro 
 
El regulador transcripcional Cra, es un sensor global que regula los flujos en el 
metabolismo central de bacterias Gram-negativas, sin embargo, el efector real (o 
efectores) de esta proteína que se encarga(n) de dar la señal a la proteína no se han 
determinado de forma inequívoca. Para abordar esta pregunta, la proteína Cra de P. 
putida se purificó, caracterizó, y su estructura tridimensional fue determinada. Análisis 
por ultracentrifugación analítica, de filtración en gel y ensayos de movilidad 
electroforética (EMSA) mostraron que Cra es un dímero que se une al operador 
identificado en la región promotora del operón fruBKA. Además, se observó que la 
fructosa 1-fosfato (F1P) fue el único metabolito capaz de disociar el complejo Cra/ADN. 
Los parámetros termodinámicos de la interacción F1P-Cra-ADN calculados por 
calorimetría de titulación isotérmica revelaron que el factor transcripcional se une 
fuertemente a la secuencia de ADN 5'-TTAAACGTTTCA-3' (KD = 26.3 ± 3.1 nM) y 
que la F1P se une a la proteína con una estequiometría aparente de 1.06 ± 0.06 
moléculas por monómero de Cra con una KD de 209 ± 20 nM. Otros efectores como la 
fructosa 1,6-bisfosfato (FBP; que hasta ahora se ha considerado como un posible efector 
de Cra) no mostraron ninguna afinidad por el regulador. Por otra parte, la estructura de 
Cra y su co-cristal con F1P sugieren que cualquier otra molécula pequeña distinta a F1P 
difícilmente puede ajustarse a la geometría del sitio de unión del efector. Por tanto, 
nuestros resultados apuntan a la F1P como el único efector del regulador bacteriano 
Cra. 
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3. Capítulo III. Regulación de la proteína Cra sobre los sistemas PTS de P. 
putida: estudios in vivo 
 
La proteína Cra es un regulador transcripcional dual que controla el metabolismo 
central en enterobacterias, sin embargo, sus funciones en otras familias de bacterias con 
un nicho ecológico distinto, no han sido exploradas todavía. Continuando con nuestros 
estudios sobre el funcionamiento y regulación de los sistemas PTS de P. putida, en este 
capítulo, se estudió a través de experimentos in vivo el efecto de la mutación de Cra sobre 
los sistemas PTS (PTSFru y PTSNtr). En primer lugar, de determinó la actividad del 
promotor del operón de la fructosa y las concentraciones intracelulares de F1P y FBP en 
P. putida en diferentes fuentes de carbono. Los resultados revelaron que PTSFru se 
expresa solamente en fructosa y mantiene bajos niveles en glucosa y succinato (fructosa 
>> glucosa > succinato). Por otro lado, el análisis de este promotor en el mutante Cra, 
reveló que la ausencia de este regulador produce la desrepresión del sistema PTSFru en 
todas las fuentes de carbono probadas.  
Finalmente, se observó que  Cra controla bajo ciertas condiciones metabólicas el estado 
de fosforilación de PtsN  a través del cross-talk con la proteína FruB. Por tanto, nuestros 
resultados sugieren que Cra es un modulador del estado de fosforilación de PtsN y por 
tanto del sistema PTSNtr. 
 
V. CONCLUSIONES 
 
El trabajo descrito a lo largo de esta Tesis ha dado lugar a las siguientes conclusiones: 
 
1. El metabolismo central en P. putida se lleva a cabo a través de una versión cíclica de la ruta Entner-
Doudoroff. Las diferencias entre el metabolismo central de P. putida y otras especies tales 
como E. coli, indican una clara especialización de la maquinaria metabólica como 
resultado del hábitat y las necesidades nutricionales de cada especie. 
 
2. El Sistema PTSNtr desempeña funciones regulatorias sobre el metabolismo central de P. putida. Esta 
regulación es llevada a cabo por la proteína EIIANtr (PtsN), donde hemos demostrado 
que esta proteína controla la conexión entre el piruvato y el ciclo de Krebs reprimiendo 
la actividad del desvío del piruvato (pyruvate shunt). 
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3. La F1P es el único efector del regulador transcripcional bacteriano Cra. En este trabajo, hemos 
estudiado la proteína Cra de P. putida, sin embargo, consideramos que todas nuestras 
observaciones sobre su efector pueden ser generalizadas a otras especies como E. coli y S. 
typhimurium, debido a la alta similitud en la secuencia y estructura tridimensional del sitio 
de unión en las proteínas Cra de estas especies. Por lo tanto, nuestros resultados indican 
que F1P es el único efector del regulador bacteriano Cra. 
 
4. Cra es un represor transcripcional del sistema PTSFru de P. putida. Experimentos in vitro e in vivo 
demostraron que Cra es un represor muy fuerte del operón de la fructosa, donde el 
proceso de expresión está controlado enteramente por las concentraciones intracelulares 
de F1P. 
 
5. Cra es un modulador del sistema PTSNtr de P. putida. La regulación ejercida por Cra sobre el 
operón fructosa modula el estado de fosforilación de la proteína PtsN bajo ciertas 
condiciones metabólicas. 
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The catabolite repressor/activator (Cra) protein is a global
sensor and regulator of carbon fluxes through the central meta-
bolic pathways of Gram-negative bacteria. To examine the
nature of the effector (or effectors) that signal such fluxes to the
protein ofPseudomonas putida, theCra factor of this soilmicro-
organism has been purified and characterized and its three-di-
mensional structure determined. Analytical ultracentrifuga-
tion, gel filtration, and mobility shift assays showed that the
effector-free Cra is a dimer that binds an operator DNA
sequence in the promoter region of the fruBKA cluster. Further-
more, fructose 1-phosphate (F1P) was found to most efficiently
dissociate the Cra-DNA complex. Thermodynamic parameters
of the F1P-Cra-DNA interaction calculated by isothermal titra-
tion calorimetry revealed that the factor associates tightly to the
DNA sequence 5-TTAAACGTTTCA-3 (KD  26.3  3.1 nM)
and that F1P binds the protein with an apparent stoichiometry
of 1.06 0.06molecules per Cramonomer and aKD of 209 20
nM. Other possible effectors, like fructose 1,6-bisphosphate, did
not display a significant affinity for the regulator under the assay
conditions. Moreover, the structure of Cra and its co-crystal
with F1P at a 2-A˚ resolution revealed that F1P fits optimally the
geometry of the effector pocket. Our results thus single out F1P
as the preferred metabolic effector of the Cra protein of P.
putida.
The central metabolism of bacteria is controlled through the
interplay of global and specific regulators, the outcome of
which depends on the nature of the carbon and energy sources
and the particular culture conditions (1). The catabolite repres-
sor/activator (Cra) protein (also known as FruR) is a pleiotropic
regulatory protein that plays a key role in the control of carbon
flow in Escherichia coli and Salmonella typhimurium (2). This
factor was first identified as a repressor that inhibited expres-
sion of the fructose operon of these two bacteria when the sugar
was not available, thereby the earlier nameFruR (3). Laterwork,
however, revealed that the same protein represses genes for
many other enzymes of the central metabolism (pfkA, pykA,
pykF, acnB, edd, eda,mtlADR, and gapB; Refs. 2 and 4–6) and
activates others (ppsA, fbp, pckA, acnA, icd, aceA, and aceB;
Refs. 2 and 7–10), suggesting a dual character of Cra as both a
transcriptional repressor and an activator.
From a structural point of view, the Cra protein has been
classified as a member of the GalR-LacI superfamily of DNA-
binding transcriptional regulators (11, 12). In E. coli, the Cra
monomer is organized in two functional domains. The
N-terminal helix-turn-helix module accounts for the bind-
ing of the protein to the cognate DNA operator sequence,
whereas the C-terminal portion mediates the interactions
between subunits and triggers changes in the protein upon
effector binding (12).
Earlier studies of the Cra proteins of E. coli and S. typhimu-
rium suggested that the regulator is a tetramer that recognizes
an imperfect palindromic DNA sequence to which it binds
asymmetrically (2). It is generally believed that promoters con-
taining a Cra operator upstream of the RNA polymerase bind-
ing site might become activated by the factor, thereby stimulat-
ing transcription of downstreamgenes. In contrast, Cra binding
sites overlapping those bound by RNA polymerase originate a
typical negative regulation scenario (2). Whether positive or
negative, the effects of Cra on transcription can be counter-
acted in vitro bymicromolar concentrations of fructose 1-phos-
phate (F1P)3 or millimolar concentrations of fructose-1,6-bis-
phosphate (FBP, Refs. 2, 3, 5, 13). In fact, the nature of the
metabolic effector(s) alleged to make Cra release target DNA
sites is intriguing. This is because F1P and FBP are originated by
different metabolic routes and produced at levels that depend
on the consumed carbon source. Furthermore, electronic den-
sities of these two chemicals are not alike, making it puzzling
that the same effector recognition pocket can bind both of
them. Conflicting publications on this matter bear witness of
* This work was supported by grants of the CONSOLIDER program of the
SpanishMinistry of Science and Innovation, by the BACSINE andMICROME
Contracts of the European Union, and by funds of the Autonomous Com-
munity of Madrid. This work was also supported by a doctoral scholarship
of theUniversidaddeCostaRica and theCSIC (toM. C.). C. S.was supported
by the Centro Nacional de Biotecnología, Consejo Superior de Investiga-
ciones Científicas.
□S The on-line version of this article (available at http://www.jbc.org) contains
supplemental Figs. S1–S4 and Table S1.
The atomic coordinates and structure factors (codes 3O74, 3O75, and 2IKS)
have been deposited in the Protein Data Bank, Research Collaboratory for
Structural Bioinformatics, Rutgers University, New Brunswick, NJ
(http://www.rcsb.org/).
1 Both authors contributed equally to this work.
2 Towhom correspondence should be addressed: Centro Nacional de Biotec-
nología-CSIC, Campus de Cantoblanco, Madrid 28049, Spain. Tel.: 34-91-
585-4536; Fax: 34-91-585-45-06; E-mail: vdlorenzo@cnb.csic.es.
3 The abbreviations used are: F1P, fructose 1-phosphate; FBP, fructose 1,6-
phosphate; PTSFru, phosphoenol pyruvate phosphotransferase carbohy-
drate system of P. putida; ITC, isothermal microcalorimetry; F6P, fructose
6-phosphate; G6P, glucose 6-phosphate; MES, 4-morpholineethanesulfo-
nic acid; H, reaction enthalpy; G, change in free energy; S, change in
entropy; T, absolute temperature; KA, binding constant.
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suchaproblem in the relevant literature.Gel retardationexperi-
ments with a labeled DNA fragment bearing a Cra operator (3,
5) could authenticate F1P as one bona fide effector, but not FBP.
Some studies suggest that the in vitro response of Cra to FBP is
due to a possible contamination of FBP with F1P (3). Yet, other
authors have produced evidence that FBP is an authentic effec-
tor of Cra (5, 14). The consensus at this point is that F1P is the
major agonist of the enterobacterial regulator, but FBP can do
the same at much higher concentrations. But what is the situa-
tion in other types of bacteria?
Thiswork addresses the nature of themetabolic signal(s) that
control(s) binding of Cra to its genomic binding sites in the soil
microorganism Pseudomonas putida. This bit of information is
important for setting reliable connections between the central
fluxes for catabolism/anabolism of carbohydrates (which are
often reported by FBP levels, Ref. 3) and the metabolic and
non-metabolic transcriptome (14) in this bacterium. The Cra
regulator of P. putida is an ortholog of the virtually identical
gene/protein found in E. coli. But in contrast to the protein of
E. coli, crystals of the purified CraP. putida diffracted at a very
high resolution (see below), thereby revealing an unprece-
dented structural detail of the effector-protein interaction that
could not be attained with the enterobacterial variant (11). As
shown below, analysis of such a structure along with other bio-
chemical and biophysical tests indicates that F1P is the pre-
ferredmetabolic effector of CraP. putida. As a sidelight, we could
produce evidence that this Cra variant represses expression of
the fructose-related phosphoenol pyruvate phosphotransferase
carbohydrate system of P. putida in a fashion (predictably)
dependent on F1P binding.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Protein Purification—The DNA
sequence encoding the Cra protein of P. putida KT2440
(PP0792) was amplified from the chromosome of this bacte-
rium with primers Cra-F (5-GGGAATTCCATATGAAACT-
CAGCGATATCGCCCGT-3) and Cra-R (5-CCGGCTCGA
GTCAGGCCACTGAGAT-3). The resulting PCR product
was digested with NdeI/XhoI and cloned into the bacterial
expression vector pET28a (Novagen), which adds six histidines
to the N terminus of the encoded protein. Note that we
included a stop codon (TCA) in the Cra-R primer immediately
after the XhoI sequence to avoid addition of more His residues
in the C terminus by the vector. The resulting plasmid
(pET28aCra) was transformed into the specialized host strain
E. coli BL21(DE3). For expression of the His6-tagged protein,
the transformed strain was grown at 37 °C in LB to A600 0.5,
and 0.5 mM of isopropyl--D-thiogalactoside was added, after
which the cultures were grown for an additional 3 h. Cells were
then harvested by centrifugation and the pellets frozen at
80 °C until further use. For purification, cells were thawed,
resuspended in 50 mM sodium phosphate buffer (pH 7.0) and
200mMNaCl (1mlof culture,A6000.5 in 50l), andmechani-
cally lysed using a French press (Thermo Electron Corp.). Cell
debris was removed by centrifugation (20,000 g for 30 min at
4 °C) and the native His6-Cra protein isolated to apparent
homogeneity from the supernatant of the cell lysate using
TALON metal affinity resin (Clontech) according to the man-
ufacturer’s instructions (see supplemental Fig. S1 for details).
The purified protein was kept in the elution buffer at 4 °C until
its utilization as indicated in each case. On the other hand,
selenium-methionine (Se/Met)-derivatized P. putida Cra was
purified as before from cells grown inM9minimalmedium (15)
in the presence of 0.2% glucose, selenium-methionine, and
other amendments known to inhibit methionine biosynthesis
(for protocol details see Ref. 16). All buffers for (Se/Met)-Cra
purification were supplemented with 5 mM dithiothreitol, but
the isolation procedures were otherwise identical to those
employed for the non-derivatized protein.
Identification and Synthesis of the Cra Operator—The refer-
ence E. coli consensus sequence for Cra binding sites was
retrieved from the PRODORIC database (17). The resulting
DNA motif (Fig. 1A) was then searched in the genome of
P. putida KT2440 (18) by means of the Virtual Footprint soft-
ware (version 3.0, Ref. 19), which revealed the presence of at
least 89 possible Cra binding sites. One of these sites (5TTA-
AACGTTTCA3) happened to occur within the intergenic and
divergent promoter region of the fruR/fruBKA gene cluster
(P. putida chromosomal coordinates 908211–915030, Fig. 1B)
which, because of its proximity to the cra (fruR) gene of this
bacterium was likely to be functional. This plausible operator
was synthesized as part of a 22-bp double-stranded DNA
fragment (see below) and employed in the mobility shift and
isothermal microcalorimetry (ITC) assays described under
“Results.”
NonRadioactive EMSA—The 22-bp DNA fragment used for
EMSA with the Cra protein was prepared by heating an
equimolar (50 nmol) mixture of complementary oligonucleo-
tides containing the presumed Cra binding site of the fruR/
fruBKA promoter region (forward, 5-TCAGATTAAACGTT-
TCAGCTGC-3; and reverse, 5-GCAGCTGAAACGTTTAA-
TCTGA-3) in 1ml of TE buffer (10mMTris/HCl, pH 8.0; 1mM
EDTA) at 95 °C for 10min and then keeping the annealed prod-
uct chilled on ice until further use. The Cra-DNA binding reac-
tion was assembled in a final volume of 20 l containing 2 l of
TGED binding buffer 10 (final concentrations, 10 mM Tris-
HCl (pH 8.0), 5% v/v glycerol, 0.1 mM EDTA, 1 mM dithiothre-
itol, 20 g/ml poly (deoxyinosinic-deoxycytidylic), 200 g/ml
BSA, 0.75 M Cra site-containing DNA fragment) and increas-
ing amounts of the pure Cra. Mixtures were incubated for 15
min at 30 °C and electrophoresed in a nondenaturing 10% (w/v)
polyacrylamide (bisacrylamide gel in Tris-glycine buffer 1
(pH 8.9)). Finally, the gels were stained with ethidium bromide
and visualized using a Gel Doc XR (Bio-Rad). In the experi-
ments for identification of potential effectors, Cra was incu-
bated with the DNA fragment in the presence of 1 mM fructose
(Fluka, 99% purity), 1 mM F1P (Sigma, 100% purity), FBP
(Sigma, 98% purity), fructose 6-phosphate (F6P, Sigma, 98%
purity), glucose 6-phosphate (G6P, Sigma, 100% purity), and
then the samples were run in a gel and analyzed as described
before.
ITC—ITC experiments were performed on a VP microcalo-
rimeter (MicroCal, Northampton,MA) at 25 °C. Prior to exper-
iments, Cra was thoroughly dialyzed in 25mMTris-HCl, 50mM
NaCl, and 1 mM DTT (pH 8.0). After dialysis, the protein solu-
tionwas filtered through a 0.45-m filter, and its concentration
The Cra Protein of Pseudomonas putida
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was determined by UV absorption spectroscopy using an
extinction coefficient of 1.217  105 cm M1 at 280 nm (20).
Effectors were prepared by diluting pure powdered products in
filtered dialysis buffer so that the ligand and protein solvent
were the same. Each titration involved a single 1.6-l injection
and a series of 4.8-l injections of a 250M preparation of each
of the effectors into a 7.5 M protein solution deposited in the
1.4-ml chamber of the apparatus. For DNA binding studies, the
22-bp DNA fragment used in EMSA experiments (see above)
was dialyzed so that the DNA and protein solvent were the
same. In this case, the assays consisted of the injection of 4.8-l
aliquots of 60 M DNA into a protein solution of 10 M in the
same 1.4-ml chamber. The mean enthalpies measured from
injection of the ligands into the bufferwere subtracted from raw
titration data prior to data fitting using the One Binding Site
model of the MicroCal version of the ORIGIN software. From
the curves thus fitted, the parameters H (reaction enthalpy),
KA (binding constant, KA  1/KD), and n (reaction stoichiom-
etry) were determined. From the values of KA and H, the
change in free energy (G) and in entropy (S) were calculated
with the equation: G -RT lnKAH - TS, where R is the
universal molar gas constant andT is the absolute temperature.
Analysis of the Cra Oligomerization State—Analytical ultra-
centrifugation experiments were performed in a Beckman
Optima XL-A analytical ultracentrifuge with a UV-visible
absorbance detection system. Sedimentation velocity measure-
ments were carried out on an An50Ti eight-hole rotor in phos-
phate buffer with 150mM imidazole and 200mMNaCl (pH 7.0)
(elution buffer in protein purification) at 45,000 rpm, with 400
l of protein solution (0.5, 1, and 1.3 mg/ml) in each cell, using
double-sector Epon-charcoal centerpieces. Differential sedi-
mentation coefficient distributions c(s) were calculated by least
squares boundary modeling of sedimentation velocity data
using the SEDFIT program (21, 22). From this analysis, the
experimental sedimentation coefficients (s) were corrected for
solvent composition and temperature to obtain the corre-
sponding standard s values (s20,w, standard solvent conditions,
purewater at 20 °C) using the SEDNTERPprogram (23). Partial
specific volume of 0.7312 ml g1 at 20 °C was calculated from
the amino acid composition (24). Sedimentation equilibrium
experimentswere performed at 20 °C by centrifugation of 80-l
samples of Cra at 11,000, 13,000, and 19,000 rpm in theOptima
XL-A ultracentrifuge. Conservation of mass in the cell was
verified in all the experiments. After the equilibrium scans, a
high-speed centrifugation run (45,000 rpm) was done to esti-
mate the corresponding baseline offsets.Weight-average buoy-
ant molecular weights were determined by fitting a single-spe-
cies model to the experimental data using the Hetero-Analysis
program (25). The absolutemolecularweight of theCra protein
was determined using the partial specific volume (0.7312 ml
g1) and the solvent density (1.0207 mg/ml). In addition, the
oligomerization form of P. putida Cra was confirmed by size
exclusion chromatography. To this end, a protein solution of
1.0mg/mlwas run through a Superdex 200 column (Amersham
Biosciences) in 25 mM Tris-HCl and 50 mMNaCl (pH 8.0). The
molecular weightmarkers were run under the same conditions.
Proteins in the eluted fractions were monitored by SDS-PAGE.
Protein Crystallization—The affinity-purified His-tagged
Cra protein (see above) was concentrated to 15 mg/ml for its
crystallization. During concentration, the sample buffer was
diluted 50 times against 25 mM Tris (pH 8.0), 50 mM NaCl,
and 1mMDTT.This procedure allowed a high concentration of
the protein and avoided amorphous precipitation while simul-
taneously clearing the samples of the potentially disturbing
imidazole left after eluting the protein from themetallo-affinity
column. Crystals of the native Cra protein were then generated
from a 15-mg/ml protein sample by the sitting-drop vapor-
diffusion method. Drops were prepared by mixing 150 nl of
protein with 150 nl of crystallization solution and equili-
brated against 100 l of the crystallization solution in
Greiner plates. Crystals appeared after 2 days in drops pre-
pared with a solution containing 15% (w/v) of polyethylene
glycol 8000, 0.2 M sodium acetate, and 0.1 M MES buffer (pH
6.5). Selenium-methionine (Se/Met)-derivatized Cra protein
was crystallized using identical conditions. The resulting
crystals were dialyzed against the same solution supple-
mented with 20% glycerol before cryofreezing in liquid
nitrogen (see below). For the ligand binding experiments,
native Cra protein crystals were soaked for 4–7 h in the
cryofreezing solution containing 1 mM of each tested candi-
date effectors (F1P, FBP, F6P, G6P, and fructose).
DataCollection and Structure Resolution—Datasets from the
native, effector-less Cra protein, its (Se/Met)-derivatized vari-
ant, and the ligand-containing complexes F1P and FBP were
collected at the European Synchrotron Radiation Facility
(Grenoble, France) at beamlines ID14–1, ID23–1, and ID14–2
(crystals soaked with F6P, G6P, and fructose did not show any
diffraction). The crystals, which belonged to the space group
P21, contained two Cra molecules in the asymmetric unit and a
solvent content around 43%. Diffraction data were processed
with X-ray detector software (XDS) (26) and scaled with
SCALA (27). The structure of the protein without effector was
solved first by the Single-wavelength anomalous dispersion
(SAD) method using the Autorickshaw server (28) and diffrac-
tion data extending up to a 2.5-Å resolution. Structure resolu-
tion and phasing in the server was carried out by the SHELX
programs (29). The initial model built by RESOLVE (30) gave
R-factor/R-free values of 22 and 28%, respectively. The model
was manually adjusted using Coot (31) and refined using PHE-
NIX 1.6-289 (32) with data up to a 2.0-Å resolution to a final
R-factor andR-free of 18.4 and 21.8, respectively (supplemental
Table S1). Crystal structures of the Cra protein in complex with
F1P and FBP were determined by the molecular replacement
method using the effector-less structure and the PHASER pro-
gram (33), followed by refinement with PHENIX 1.6-289 (32,
supplementary Table S1). The structure of the Cra protein pre-
pared by soaking the crystal with FBP gave an electron density
map in the effector binding site that was indistinguishable from
the Cra-F1P complex and therefore has not been included sep-
arately in supplemental Table S1 (not shown). All residues are
in the most favored region (91.7%) or the additional allowed
regions (7.9%) of the Ramachandran plot, except the effector-
binding Asp-148 that lies in a disallowed region in all struc-
tures. Coordinates of the Cra structure and its complex with
The Cra Protein of Pseudomonas putida
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F1P have been deposited in the Protein Data Bank with the
following codes: PP-Cra, 3O74 and PP-Cra/F1P, 3O75.
RESULTS ANDDISCUSSION
Identification and Gross Characterization of the Cra Protein
of P. putida—The genome of the soil bacterium P. putida bears
anORF for a protein (PP0792) of 331 amino acid residues (coor-
dinates 909206–908211) and 38.4-kDa molecular mass that
shares 74% similarity and 48% identity with the E. coli Cra pro-
tein (supplemental Fig. S2). This identity goes up to 70% in the
predictedDNAbinding domain of the proteins, suggesting that
the target genomic sequences ought to be similar (if not identi-
cal) as well. All these criteria qualifies PP0792 as a bona fide
ortholog of the reference enterobacterial counterpart. Yet,
unlike E. coli and S. typhimurium, the craP. putida variant maps
adjacent and divergently oriented to the fruBKA operon (Fig.
1B and supplemental Fig. S3). This gene cluster encodes pro-
teins for phosphorylation and transport of fructose (34)
through the phosphoenol pyruvate phosphotransferase carbo-
hydrate system of P. putida (Ref. 34; PTSFru). Because of this
proximity, PP0792 was formerly annotated as FruR, not as Cra
(18). To ensure the functional assignment, the craP. putida
sequence was amplified, a metallo-affinity His6-tag was added,
and the protein was purified to apparent homogeneity as
explained under “Experimental Procedures” (see supplemental
Fig. S1). On the other hand, analysis of the intergenic region
(Fig. 1B) revealed the presence of a motif (5-TTA-
AACGTTTCA-3) with a high score to the consensus binding
site for theCra regulator ofE. coli and Salmonella (Fig. 1A, Refs.
3, 35, 36). To examine whether such a sequence was in fact the
operator of CraP. putida, a 22-bp double-stranded DNA frag-
ment containing the candidate target was synthesized and
employed in themobility shift assay shown in Fig. 2. The results
indicated the formation of one specific complex between the
DNA and the CraP. putida, the abundance of which increased
with Cra concentration (Fig. 2A). The molar ratio where the
DNA band disappeared entirely from the gel grossly corre-
sponded to amolar DNA:Cra ratio of 1:2. These results verified
the interaction of the protein with its predicted binding site
within the fruR/fruBKA promoter region and laid the basis for
determination of key parameters as explained below.
The Cra Regulator of P. putida Is a Dimeric Protein—The
oligomerization state of purified CraP. putidawas determined by
means of analytical ultracentrifugation experiments. The sedi-
mentation profile (Fig. 3A) showed the occurrence of one main
species to 3.9S with s20,w of 4.8  0.1 (f/f0  1.35), which
accounted for 88–94% of the observed molecules and which
was compatible with a dimeric form of the protein. The sedi-
mentation equilibrium results (data not shown) predicted a
mass value of 72.4 6.0 kDa, which was slightly lower than the
theoretical mass for the dimeric form of the protein. But taken
together, the velocity and equilibrium sedimentation results
indicated that Cra existed mainly as a dimer in solution at the
concentrations used. The protein oligomerization state was
confirmed by size exclusion chromatography (Fig. 3B), inwhich
one main peak of 60–80 kDa (i.e. a dimer) was followed by
much less abundant species, tailing between the 21–50 kDa
markers (i.e. a monomer). These results thus consistently doc-
umented that the Cra protein of P. putida occurs predomi-
nantly in a dimeric form, a feature that differs from the same
regulator of E. coli, known to be a tetramer (37–39). However,
this divergence is understandable because the leucinemini-zip-
per that causes tetramerization of proteins of the LacI family
through their carboxyl-terminal regions is conserved in E. coli
Cra (8) but not in the P. putida counterpart (Fig. 3C). On the
other hand, the Cra binding site in the fruBKA promoter region
FIGURE 1. E. coli Cra binding consensus sequence and regulatory region
of the fructoseoperonofP. putida.A, the E. coli consensus sequence for the
Cra binding site was retrieved from the PRODORIC database (17). This
sequence forms an incomplete palindrome in which the left half-site is con-
siderably better conserved than the right half-site. B, the regulatory region of
the fruBKA operon in P. putida was analyzed and one single operator identi-
fied as shown. The sequence TTAAACGTTTCA (in red) corresponds to the pal-
indromic Cra-binding motif, whereas the black boxes show the putative
35/-10 promoter region upstream of the fruBKA operon.
FIGURE 2. Nonradioactive EMSA of Cra and its binding site in the inter-
genic fruR/fruBKA region of P. putida. A, EMSA experiment with increasing
concentrations of pure Cra protein. Molar ratios of DNA:Cra were 1:0 (lane 1),
1:0.5 (lane 2), 1:1 (lane 3), 1:2 (lane 4), 1:4 (lane 5), and1:8 (lane 6).B, Cra effector
identification. DNA (0.75M) was incubated with pure protein (1.5M) in the
presence of 1mM of different metabolites: F1P (lane 3), FBP (lane 4), F6P (lane
5), G6P (lane 6), and fructose (lane 7). Lanes 1 and 2 correspond to DNA in
theabsenceandpresenceofCra, respectively,without anyaddedmetabolite.
Note that only F1P prevents the binding of the protein to DNA.
The Cra Protein of Pseudomonas putida
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of E. coli contains two nearby operators, O1 (TGAAACGTT-
TCA) and O2 (TGAATCGTTTCA), which could accommo-
date the cognate repressor tetramer (3). In contrast, the same
region of theP. putida genome has only oneCra site (Fig. 1B). A
plausible consequence of this is that the affinity of the Cra
dimer for the single site in the fruBKA promoter region of
P. putida ought to be high to compensate the more extended
range of interactions of the tetramer/two-operator scenario of
the same regulatory device in E. coli. This possibility was
addressed next.
Cra Strongly Binds Its Single Operator in the fruR/fruBKA
Region of P. putida—The interaction parameters of the
CraP. putida protein with the operator DNA found within the
fruBKA promoter segment (Fig. 1B) were examined by means
of ITC. The corresponding results are shown in Fig. 4A. Note
that in the upper panel peaks go upwards, which indicates that
the binding of Cra to DNA is an endothermic process (H 
7.66  0.09 kcal/mol). Because enthalpy changes are unfavor-
able, binding ought to be entirely entropy-driven (TS 
17.68  0.15 kcal/mol, G  10.02  0.10 kcal/mol). This
situation is not infrequent, as the binding of proteins to DNA is
often endothermic but also fostered by the positive entropic
effect of the displacement of DNA-boundwatermolecules (40).
Subsequent calculations allowed us to determine a protein-
DNA dissociation constant (KD) of 26.3 3.1 nM that reflects a
very strong interaction and that likely enables CraP. putida to
exert a considerable repression on expression of the fruBKA
genes.
Surveying Metabolic Intermediates as CraP. putida Effector
Candidates—To shed light on the nature of Cra effector(s),
DNA samples were incubated with pure Cra protein in the
presence of different metabolites and submitted to EMSA
experiments as before, except for the addition of candidate
molecules to the binding mixtures prior to loading the gel. The
chemical species that were listed as possible Cra inducers able
to release its strong binding to DNA included fructose, F1P,
FBP, F6P, and G6P. The EMSA experiments shown in Fig. 2B
(lanes 3–7) indicated that at 1.0 mM of the effector in the bind-
ingmixture, only F1Pwas able to prevent binding of the repres-
sor to the fruBKA regulatory region (Fig. 1B), confirming this
metabolite as a Cra binder.
The experiment shown in Fig. 1B, however, did not alto-
gether rule out that the other small molecules could interact
with the target protein at much higher concentrations not suit-
able for the conditions of the EMSA test. Furthermore, the gel
of Fig. 2B revealed the persistence of a fraction of the Cra-DNA
complex that did form even in the presence of F1P (Fig. 2B, lane
3). To elucidate these ambiguities, we again resorted to the ITC
technology described before. First, we ran isothermal titration
experiments with purified Cra and the various candidate effec-
tors as the interaction partners. The results shown in Fig. 4B
indicated that binding of F1P to Cra was both enthalpy-driven
(H  5.94  0.39 kcal/mol) and entropy-driven (TS 
3.16 0.4 kcal/mol), producing a total free energy change (G)
of 9.10  0.06 kcal/mol. Favorable (negative) enthalpy
changes can be attributed to bond formation between F1P and
amino acids in the cognate binding site, whereas favorable (pos-
itive) entropy changes are generally caused by the ligand-in-
duced release into the medium of otherwise bound water,
thereby increasing the disorder (entropy) of the system. Further
calculations revealed not only an apparent stoichiometry of
1.06  0.06 molecules of F1P per Cra monomer, but also de-
monstrated a high protein-effector affinity (KD 209 20 nM).
It is noteworthy that this affinity value is significantly higher
than the corresponding figures for other transcriptional regu-
lators of the GalR-LacI family. For instance, the KD of isopro-
pyl--D-thiogalactoside binding to LacI is 2.8 M (41), that of
2-ketogluconate to PtxS, 15M (42), and so on. In contrast, ITC
experiments indicated that Cra had little (if any) affinity for the
other metabolites examined. Specifically, the test run with FBP
as a Cra effector-to-be (assay I in Fig. 4B) did not produce any
indication of interaction, at least at the concentrations
employed in the assay. The same was true for other candidate
effectors (e.g.G6P, glucose, and fructose; supplemental Fig. S4),
indicating that the repressor is highly selective for F1P. Finally,
to clarify whether some residual Cra-DNA complex could still
FIGURE3.Oligomerizationof theCraproteinofP. putida.A, distributionof
sedimentation coefficient population (c(s)) against sedimentation coefficient
(s), obtained by sedimentation velocity experiments. The assays were per-
formed with 0.5, 1, and 1.3 mg/ml of pure Cra protein. The sedimentation
profile was dominated by a species of 3.9S, accounting for 88–94% of the
observed molecules, followed by a small peak at 2.4S (2.3–8.9%). The pre-
dominant species with sedimentation coefficient of 3.9S was corrected to
s20,wusing theviscosity valueof the solution (measured inaviscometerAnton
Paar AMVn). The corrected sedimentation coefficient was 4.8S, which is com-
patible with a globular dimer of the protein. Equilibrium sedimentation
experiments predicted that the dominant peak has a molecular mass of
72.4 6.0 kDa. B, gel filtration. The oligomerization form of P. putida Cra was
confirmed by size exclusion chromatography as shown. The main peak of
60–80 kDa is consistent with a dimer, whereas the minor tail of 21–50 kDa
surely corresponds to residualmonomeric species. The chromatogramshows
the superposition of two different runs: Cra alone (red line) and standards
used as molecular mass marker (black line). The proteins in the elution frac-
tions were monitored by SDS-PAGE. Molecular weight markers were run
under the same conditions. Chymotrypsin (21 kDa) (1), albumin (50 kDa) (2),
BSA (70 kDa) (3), Ab (170 kDa) (4), and Dextran (5). C, alignment of the C-ter-
minal amino acid sequence of regulators Cra (E. coli), LacI (E. coli), and Cra
(P. putida). Note that the E. coli tetrameric regulators Cra and LacI contain a
leucinemini-zipper,which seems tobe required to tetramerization. Thismini-
zipper is absent in the P. putida Cra protein.
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be formed in the presence of F1P, a mixture of Cra and F1P was
incubated with the same target DNA employed above for the
repressor-operator binding experiments. The resulting ITC
curves (Fig. 4A, assay II) confirmed that the Cra-F1P complex
was altogether unable to bind DNA. This set of data clearly
points at F1P as the preferred metabolic effector of Cra,
whereas it raised doubts regarding whether the role FBP as an
inducer of this repressor reported in the literature for the enter-
obacterial protein (5, 14) held true for the counterpart of
P. putida.
Cra Crystallization and Structure Resolution—Although the
results above confirmed the nature of F1P as aCra effector, they
did not discount that the effector-binding site of the repressor
could accommodate other, thus far unidentified, metabolites.
To shed light on this possibility, we set out to determine the
actual three-dimensional structure of such a pocket in both the
effector-less and the effector-bound Cra structure by x-ray
crystallography. The protein was crystallized as described
under “Experimental Procedures.” SDS-PAGE of extensively
washed crystals showed a single, sharp band of30 kDa for the
crystallized sample, smaller than the theoretical size of 38 kDa.
This suggested a precise excision of an8-kDa fragment from
the protein body during the crystallization process (see below).
MALDI-time-of-flight analysis of the truncated protein pro-
duced a predominant peak of 30.4 kDa, confirming the previous
observation. Proteolytic removal of nonstructured or unstable
polypeptides often help the crystallization of the rest of the
protein core (43). This appeared to be our case because the
occurrence of such a cleavage during the concentration and
crystallization of Cra was ultimately beneficial. Crystals were
obtained that belonged to the P21 space group, contained two
Cra molecules in the asymmetric unit, and did diffract to a
resolution of 2 Å (see supplemental Table S1).
The structure of the Cra protein was determined for both the
effector-free and the F1P-bound forms, in which last-case crys-
tals were soaked in a solution containing a 1.0 mM concentra-
tion of the metabolite (see “Experimental Procedures”). The
corresponding three-dimensional architectures are shown in
Fig. 5A. Note that the dimers of the effector-less Cra and its
F1P-bound counterpart were very similar, with a root mean
square deviation of 0.48 Å for 270 residues. Note also that, as
expected, the crystal structure lacks the leading N-terminal 59
amino acid residues. Asmentioned above, this deletion is irrele-
vant (if not beneficial) for our purpose because the missing
segment includes the DNA-binding domain and a short linker
(supplemental Fig. S2) but leaves intact the effector-binding site
of the protein.
As shown in Fig. 5A, both Cra monomers are related by a
pseudo 2-fold axis and share an interface surface of 1700 Å2 per
monomer. The N-terminal regulatory subdomain (N-RSD)
comprising residues from Thr-63 to Ser-161 and from His-293
to Val-320, specifically  helices I and II and  strand B (Fig.
5A), contributes most of the interactions to form the dimer.
Residues from this region are implicated in 12 salt bridges and
80% of the hydrogen bonds between domains. In contrast, the
C-terminal regulatory subdomain (C-RSD, residues Asp-163 to
Ala-290 and Tre-323 to Lys-325) contributes only with six
hydrogen bonds to the interaction through helices VII and IX
(Fig. 5A). Structural comparisons using the DALI server (44)
FIGURE 4. ITC assays with Cra, effectors, and DNA. The upper panels plot raw data from representative ITC experiments, whereas the lower panels show the
fitted curves of the same results but integrated and corrected for dilution.A, titration of Cra proteinwithDNA in the absence (I) andpresence (II) of F1P. Positive
peaks represent an endothermal event. Note that no interaction between Cra and the DNA is detected in the presence of F1P. The thermodynamic values
calculated for protein-DNA interaction were KD 26.3 3.1 nM,H 7.66 0.09 kcal/mol, TS 17.68 0.15 kcal/mol, andG10.02 0.10 kcal/mol.
B, titration of Cra protein with (I) FBP and (II) F1P. The experiment covered concentrations of the effectors in the chamber ranging from 300 nM to 20M. Note
that only the titration with F1P produces a heat change in the experiment at the tested concentrations. Negative peaks are indicative of an exothermic event.
The thermodynamic values calculated by curve fitting were KD 209 20 nM, H5.94 0.39 kcal/mol, TS 3.16 0.40 kcal/mol, and G9.10
0.06 kcal/mol. The sigmoidal shape of the binding curve allows determination of the protein-effector stoichiometry, which corresponds to the molar ratio (x
axis in lowerpanel) at thepoint of inflectionof the curve. In this case, suchamolar ratiowas1:1, indicating thatonemolecule (calculated, 1.060.06molecules)
of F1P interacts with one molecule of Cra monomer.
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gave a top solution with a Z score of 33 and a sequence identity
of 44% with the fructose repressor (Cra/FruR) of E. coli depos-
ited in the RCSB data base (PDB code 2IKS) but not yet pub-
lished. Structural comparison is shown in Fig. 5B. The folds
observed in both proteins were close to the domain organiza-
tion of other members of the family such as LacI (45) and PurR
(46). These were defined by a central parallel-sheet formed by
six  strands (A–E and K) surrounded by four  helices (I–III
and X) for the N-RSD, and a parallel  sheet composed of four
 strands (G–I), an antiparallel sheetwith two strands (J and
L)with fourhelices (IV–VII), and two310 helices (VIII and IX)
for the C-RSD.
Geometry of the Cra Inducer-binding Pocket—The F1P mol-
ecule could be coherently fitted in the electronic density maps
obtained after refinement of the structures determined for the
crystal soaked in F1P (Fig. 6). Yet, an attempt was made to
generate an additional complex between FBP (instead of F1P)
and Cra by soaking effector-less protein crystals in a 1mM solu-
tion of this metabolite as above. The structures obtained from
crystals exposed to F1P and FBP were virtually identical, with a
root mean square deviation for their superposition in the range
of 0.45 Å. But once the structure of the putative FBP-Cra com-
plex was inspected, it was found that the molecule occupying
the effector site was no other than F1P. These results suggested
FIGURE 5.Crystal structure of Cra in complexwith F1P. A, ribbon representation of the crystal structure of the regulatory subdomain of Cra in complexwith
its ligandF1P.-strands are colored inmagenta, helixes in cyan, 310 helixes in red, and loops inorange. F1P is shownwith sticks,with carbons indicated in yellow,
phosphorus in orange, and oxygens in red. TheN andC termini aremarkedwith lowercase letters and the secondary structure elementswith uppercase letters.
TheN-regulatory subdomain consists of strandA (aminoacids 63–68), helix I (74–89), strandB (93–98), helix II (103–115), strandC (120–123), helix III (133–139),
strand D (144–147), strand E (157–164), helix X (293–310), and strand K (316–320). The C-regulatory subdomain is composed of helix IV (163–175), strand F
(181–187), helix V (192–204), strand G (211–217), helix VI (222–236), strand H (242–245), helix VII (239–248), helix VIII (263–265), strand I (269–273), helix IX
(277–280), strand J (286–290), and strand L (323–325). B, lateral stereo view (C representation) of the superimposed regulatory domains of Cra from P. putida
(red) and E. coli (blue, PDB code 2IKS).
FIGURE 6.Detail of the interactionbetweenCra andF1P.A, stick representation of F1P and FBPwith the same color code as in Fig. 5A. B, F1P-Cra interactions
in theproteinbindingpocket. Theelectrondensitymap (Fo-Fc) determined in theabsenceof theF1Pmolecule is representedas agreenmeshat a3.5- contour
level. C atoms are represented in gray, oxygens in red, and nitrogens in blue. Hydrogen bonds are indicated as dashed red lines andwatermolecules are shown
as red spheres. C, Ligplot scheme of F1P interaction with Cra (54); the color code is as in B. C atoms are marked in black, and hydrophobic interactions are
indicated by red arcswith spokes radiating toward the interacting atom.
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that it was the residual F1P present in the nominally 98% pure
FBP preparation (see “Experimental Procedures”) the protein
recognized as sole interaction partner. That such selective
binding to F1P happened even in the presence of a large excess
of FBP confirms the very high affinity for the first, consistently
detected with the other procedures described above.
The cavity where F1P molecules bind Cra is formed by por-
tions of the N-RSD and C-RSD subdomains (Fig. 5A), at the
intermodule cleft. Incubation of Cra native crystals with 1 mM
F1P for 1 h was enough to obtain an equimolecular 1:1 associ-
ation of the ligand to each domain present in the asymmetric
unit of the crystals. The F1P molecule fitted to perfection the
electron density map of the cognate protein cavity determined
in the absence of the effector (Fig. 6B). The F1P molecule has a
solvent-accessible area of 372Å2, which is completely buried by
contacts with the interacting protein residues and solvent mol-
ecules. Interactions occur with polar and aromatic residues in
that cavity through direct hydrogen bonds with residues Tyr-
76, Ser-75, Asn-73, and Asp-148 of the N-RSD, as well as Arg-
149, Arg-197, Ser-247, and Tyr-248 of the C-RSD (Fig. 6, B and
C). Moreover, two residues (Gln-291 and Gln-322) of the hinge
regions connecting both domains contribute with two extra
direct hydrogen bonds to the interactions. In addition, water-
mediated hydrogen bonds connect F1P with Asn-73 and Asp-
101 of the N-RSD and Asp-275 and Gln-291 of the C-RSD.
Hydrophobic interactions also play a role in the strong affinity
and specificity of Cra for F1P. These involve the furanose ring of
the effector, which sits between the side chains of Tyr-76 (part
of Ser-75 and Asp-148) and Phe-220. These amino acids pro-
vide not less than five interactions that trap the sugar ring
between two hydrophobic surfaces. The dense constellation of
interactions between F1P andCra shown in Fig. 6 creates a high
degree of specificity that accounts for the extraordinary prefer-
ence of the P. putida regulator for this (and not for other) pos-
sible effectors.
CONCLUSION
The biochemical and structural results presented above con-
stitute strong evidence that F1P is the most favored effector of
the Cra protein of P. putida. The extensive contacts of F1Pwith
Cra lead to a high affinity binding interaction (KD 200 nM). In
contrast, we found no proof of binding to either FBP or other
metabolites at the concentrations employed in the assays, a
body of (negative) data, which somehow diverges from the
results reported for the enterobacterial protein (5, 14). Further-
more, the extensive similarity between the proteins of P. putida
andE. coli suggest that they could also share the same structural
transmission pathway to regulate its function, which is likely to
be identical to that of known members of the family (46, 47).
That F1P is the preferred effector of CraP. putida opens inte-
resting questions because current metabolic models for this
microorganism entertain F1P appearance only as a result of
fructose phosphorylation by the PTSFru system (48–50). Fur-
thermore, in contrast to E. coli, P. putida lacks a real glycolytic
route, which makes virtually impossible any significant accu-
mulation of FBP when cells grow in glucose (51). Although the
regulatory scope of Cra in P. putida remains to be explored, it
could well happen that (similarly to E. coli) the factor controls a
large number of genes (4, 52), in which case there must be
alternative ways of producing F1P as a descriptor of metabolic
activity (14) in this bacterium. One way or the other, it is likely
that the first regulatory duty of Cra was that of a repressor of
fructose metabolism which was later co-opted as a global regu-
lator (2).
A sidelight of the results presented in this work is the evi-
dence that Cra regulates the PTSFru system in P. putida by
binding strongly as a dimer to a single palindromic sequence
within the cra/fruB intergenic region (which is different to
those of E. coli and S. typhimurium), and that only F1P can lift
such down-regulation. Because there is cross-talk between
PTSFru and the nitrogen-related branch of the PTS system in
this bacterium (53), it is possible that Cra closes the loop that
connects N consumption and metabolic C fluxes. These
hypotheses are being actively examined in our laboratory.
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